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More than 1.5 billion people, or 24% of the world’s population are infected with parasitic 
helminth infections worldwide [1]. A parasitic relationship is one in which one species, the 
parasite, lives off and benefits at the expense of the other, the host. Helminths have lived in 
what until recently has been considered a non-mutual symbiotic relationship with humans for 
millennia. The earliest documented case of human schistosomiasis occurred over 5000 years 
ago [2] and of concurrent infection with Schistosoma haematobium, Taenia species, Trichinella 
spiralis, and Plasmodium falciparum at approximately 3000 years ago [3]. The co-existence and 
co-evolution of worms and humans has profoundly shaped and altered the human immune 
response and even the human genetic composition. Greater diversity and load of parasitic 
worms has been correlated with more extensive single nucleotide polymorphisms (SNP) 
variation in immunological loci and reduced incidence of immunopathological diseases which 
have been linked to genetic loci that increase the likelihood of developing these diseases in 
Western countries [4]. Considering this co-evolution, responses which may be beneficial under 
strong infection pressure may now result in the development of undesirable pathologies. 
Until recently, the epidemiological course of human diseases had substantially remained 
unchanged with a life expectancy of 40 or 50 years [5]. However during the last decades 
of the 19th century and throughout the 20th century, improvements in healthcare and 
hygiene have revolutionized the epidemiological landscape in Westernized countries, with 
a significant increase in human lifespan and a shift from infectious to chronic degenerative 
diseases as prevailing causes of death [6]. A larger incidence of allergy, autoimmune disorders, 
cardiovascular diseases and metabolic disorders has been observed; interestingly all of these 
diseases have a strong chronic inflammatory component. Although in low- to middle-income 
countries the prevalence of helminths is still high in rural areas, urban centers have seen a 
significant decrease in helminth infections accompanied by an increase in non-communicable 
disorders [7].
It has been proposed that the decrease in infectious diseases is directly related to the 
increase in hyper-inflammatory disorders due to insufficient education of the immune system by 
microbes and parasites and an insufficient development and maturation of the regulatory arm 
of the immune response leading to uncontrolled inflammatory responses against innocuous or 
self-antigens [8]. Numerous epidemiological studies show that in populations with high rates 
of parasitic infections the prevalence of allergic diseases, such as asthma, eczema and allergic 
rhinitis, is significantly lower [9]. The protective effect of helminth infections is very likely due to 
the down-regulation of the immune system by the parasite during chronic infection to ensure 
its own survival, which extends to bystander allergens and leads to defects in the establishment 
of immune tolerance. 
The mechanisms and consequences of immunomodulation induced by helminth 
infections are therefore of tremendous interest as it now seems that the relationship between 
helminths and humans may in fact in some contexts be mutually symbiotic, although this is 
a rather fine balance and the negative consequences of parasitic infection may still result in 
excessive morbidity if the level and severity of infection is not controlled. Indeed helminths 




investigated as targets for therapeutic applications in the treatment or even prevention of 
hyper-inflammatory disorders [10]. On the other hand the down-regulation of the immune 
response induced by helminth infections may adversely affect immune responses against other 
pathogens, the efficacy of drug treatments and may furthermore present challenges for the 
delivery of prophylactic vaccines where a hyper-responsive immune system is desirable. 
Consequently an investigative approach which studies the immune response in all of its 
complexity simultaneously should provide novel insights which can then be harnessed and 
exploited to either abrogate or conversely strengthen suppressed immune responses in order 
to respectively combat helminth infections and inflammatory diseases. 
This thesis is centered around schistosomiasis and the way the immune system is affected 
during this infection. In the following two sections, the parasite life cycle will be introduced and 
important aspects of immune responses to these parasites will be described.
Schistosomiasis
Schistosomiasis, also known as bilharzia, is a chronic parasitic disease caused by trematodes 
belonging to the genus Schistosoma. Several species of schistosomes can infect humans, of 
which S. haematobium, S. mansoni and S. japonicum are most prevalent, while S. intercalatum, 
S. mekongi and S. guineensis have a more limited distribution. The disease is found in tropical 
and sub-tropical areas of Africa, Asia, South America, the Caribbean and in the Middle East. 
Approximately 85% of the world’s cases of schistosomiasis are in Africa, where prevalence rates 
can exceed 50% in local populations and infections are most prevalent in poor communities 
without access to safe drinking water and adequate sanitation (the schistosome life cycle is 
illustrated in Figure 1). Schistosomiasis affects almost 240 million people worldwide, and more 
than 700 million people live in endemic areas. It is estimated that more than 200,000 deaths 
per year are due to schistosomiasis in sub-Saharan Africa and several million are considered 
to suffer from severe consequences of the infection. Schistosome infections rank second only 
to malaria in terms of morbidity, imposing considerable burden on the social and economic 
development of communities in endemic countries. Schistosomiasis is readily treated with 
praziquantel; however, as treatment is not preventative, a large portion of the population in 
endemic areas requires regular treatment due to continuous re-exposure and a high rate of re-
infection. It is for this reason that a vaccine against schistosomiasis is needed and remains the 
most potentially effective means for the control of this disease [11].
A short introduction to immune responses during schistosome infection
Epidemiological studies among populations in which schistosomiasis is endemic provide 
evidence that age-dependent partial immunity against schistosomes can develop with age 
and that resistance to schistosomiasis is gradually acquired and can be attributed to cumulative 
exposure to infection. Protective IgA, IgE and IgG levels have been demonstrated [12,13], and 
resistance to (re)-infection is correlated with an increased ratio of IgE (low in children, high in 
adults) and IgG4 (high in children, low in adults) [14] and increased levels of CD23 (the low-
affinity IgE receptor (FcγRII))+ B cells [15,16]. Antibody responses clearly play an important role 




and function of B cells in the course of schistosomiasis. Recent technical developments, such as 
immunoglobulin analysis with flow cytometry, have allowed us to study B cell biology in much 
greater detail.
Whole blood assays on the other hand provide a simple technological solution, while 
keeping the cells in their natural environment and in vivo composition, to study in larger 
numbers of individuals the innate and adaptive cytokine responses [17]. Innate immune 
responses are not well characterized in the context of human schistosomiasis. Toll-like receptors 
(TLRs), the most extensively studied class of pathogen recognition receptors (PRRs), have been 
shown to be altered in S. haematobium-infected individuals [18,19]. Moreover, another class 
of PRRs, the C-type lectins (CLRs), have also been shown to be important for recognition of 
schistosomal ligands [20]. However, relatively little is known about innate immune responses in 
human schistosomiasis in particular in terms of longitudinal studies. A greater understanding 
of the innate immune response and of the molecules that regulate and activate it may provide 
a way to manipulate the immune system such that beneficial responses will be enhanced and 
deleterious ones ameliorated. 
Adaptive responses during the course of schistosome infection are relatively well 
Figure 1: Life cycle of schistosomes
Snails are the intermediate host and humans the definitive hosts in the schistosome transmission cycle. 
Following penetration of the human skin the cercariae transform into schistosomula, which migrate in 
the blood stream through the lungs to the liver, where the female and male worms mature and develop 
into schistosomes. After mating the adult worms migrate in the case of intestinal schistosomiasis to the 
mesenteric vessels lining the intestine, or in the case of urinary schistosomiasis to the vessels of the bladder. 
The female worm lays eggs, some of which get trapped in the surrounding tissue and the rest are excreted 
with stool or urine. When the eggs come in contact with fresh water, they mature into miracidia which 
penetrate the snail host where they undergo asexual changes and develop into cercariae [11]. Photographs 




characterized. Acute stages of schistosome infection are characterized by a dominant T helper 
1 (Th1)-mediated immune response, hallmarked by high levels of interferon (IFN)-γ. This 
changes markedly following parasite maturation and egg production; Th1 responses are down-
regulated and a strong Th2 response emerges typified by high production of IL-4, IL-5, IL-13, IgE 
synthesis, and eosinophilia [21]. Maintaining a balanced and controlled Th1 and Th2 response 
ensures formation of protective granulomas around parasite eggs without excessive pathology 
thereby minimizing host immunopathology. 
Hypo-responsiveness is another feature of chronic infection which results in reduced 
proliferation and cytokine production which are thought to contribute not only to keeping 
pathology at bay but also allow parasite survival. The effect of long-term anthelminthic 
treatment on adaptive immune responses is still not fully understood, nor is the relationship 
between adaptive and regulatory responses in the course of infection. While Th2 responses 
are instrumental in modulating potentially life-threatening outcomes in the initial stages of 
infection, excessive and prolonged Th2 responses contribute to the development of pathology 
and chronic morbidity. During the chronic phase of infection, Th2 responses are in turn 
modulated by regulatory responses, leading to diminished Th2 responses and a reduction in 
granuloma size. Regulatory responses in schistosomiasis have been predominantly attributed 
to increased levels of Forkhead box protein 3 (FOXP3)+ regulatory T cells (Treg), which express 
molecules involved in the inhibition of immune responses, such as cytotoxic T-lymphocyte-
associated protein 4 (CTLA-4) and secrete the suppressory cytokines, IL-10 and TGF-β; together 
these lead to down-modulation of effector responses [22–24]. More recently IL-10 producing 
regulatory B cells (Breg) have been shown to be associated with helminth infections and 
modulation of inflammatory responses [25]. Regulatory B cells are now known to influence 
T cell proliferation, down-regulate CD4+, CD8+, NK T cell activation and promote FOXP3+ Treg 
induction [26].
 Regulatory responses induce immune hypo-responsiveness characterized by reduced in 
vitro proliferation of T lymphocytes and decreased Th1- and Th2-type cytokine production not 
only to schistosomal antigens but also to third party antigens including allergens, vaccines 
or self-antigens [27–31]. Indeed the relationship between helminth infections and reduced 
prevalence and severity of not only auto-immune disease but also metabolic and cardiovascular 
diseases is currently an area of intense investigation. Central to studies that aim to understand 
how this infection should be combatted or how this infection might relate to inflammatory 
diseases is an in depth characterization of the immune response.
Outline and aims of this thesis
The general objective of this thesis is to study the characteristics of the immune response during 
schistosomiasis, caused by chronic infection, in an endemic setting. An innovative approach 
of concurrently investigating innate, adaptive and regulatory responses will further increase 
our fundamental knowledge of how these responses are connected during helminth infection. 
While field studies in endemic settings may be logistically challenging, there is no substitute 
for real-life biological settings of infection. Moreover, these studies are of great importance 





More specifically several aims can be distinguished. Innate immune responses have not 
been studied in much detail previously and may therefore provide novel targets for therapy 
with a view to enhancing beneficial responses or ameliorating deleterious ones. To this end we 
investigate in detail whole blood innate responses not only between S. haematobium-infected 
and uninfected schoolchildren but also between African and European populations. Regulatory 
responses are key to parasite survival and reduced host tissue damage and therefore further 
understanding of regulatory networks and mechanisms may contribute to new possibilities for 
control of infection and pathology. Thus, we investigate both regulatory T cells and the more 
recently described regulatory B cells in our populations. Furthermore we characterize B cells in 
terms of antibody isotypes and different memory subsets during infection. Adaptive antigen 
specific responses are also measured to allow an integrated characterization of the various arms 
of the immune response during S. haematobium infection and how they relate to each other. 
Study population and study design
The studies described in this thesis were conducted between April 2008 and September 2009 
at Centre de Recherches Médicales de Lambaréné (CERMEL; formerly Medical Research Unit 
(MRU) [32]) (Figure 2) of the Albert Schweitzer Hospital, Lambaréné, Gabon. The city counts 
35,000 inhabitants, with another 50,000 living in the surrounding rural areas, and is located 75 
km south of the equator in the Central African Rainforest. The hospital is situated at the banks 
of the Ogooué River – one of the largest rivers in Central Africa, in the Moyen- Ogooué province. 
Study participants were recruited from local schools either from the semi-urban Lambaréné 
or from the surrounding rural villages within an approximate 30 km radius. The majority of 
inhabitants in the urban area have access to tap water or public wells however in the rural areas 
streams neighbouring the houses represent the main source of drinking water. Latrines are 
common, even in the urbanised areas. Income is generated mainly from farming, fishing and 
services. Gabon has a rainy season from September to May, broken up by a short dry period 
from December to January, and a longer dry season from June to September. Plasmodium 
falciparum malaria, schistosomiasis as well as soil-transmitted helminths including hookworm, 
Ascaris lumbricoides and Trichuris trichiura are endemic in the area [33,34]. 
 All study participants were screened for helminth and malaria infections prior to inclusion 
in the studies. Haemogram data was likewise collected. For all the studies heparinized blood 
was collected from participants and processed according to study protocols at the CERMEL 
laboratory. All of the studies performed included schoolchildren infected with S. haematobium 
and comparable uninfected control schoolchildren. The first 2 studies included in this thesis 
had a cross-sectional design, whereas the later studies were longitudinal in nature. For the 
longitudinal studies the schoolchildren received praziquantel every 2 months between baseline 
and follow-up measurements 6-7 months later. For a subset of the individuals measurements 
were also taken at 6 weeks post-treatment. Field work was coordinated and carried out by local 
field staff.
For the comparison between African and European children, peripheral blood samples 






























Approaches to characterization of immune responses during schistosome 
infection
In Chapters 2, 3 and 4 we utilize the whole blood assay to investigate both innate and 
adaptive immune responses in schoolchildren. This assay was developed to measure immune 
responses ex vivo and is ideal for field conditions due to small blood volume needed and no 
need for cell separation. For innate responses we targeted innate receptors including TLRs and 
CLRs and to measure adaptive responses we stimulated cells with schistosomal antigens. In 
Chapters 4-7 peripheral blood mononuclear cells (PBMCs) isolated by Ficoll-Hypaque density 
gradient centrifugation were used for more detailed immunological studies. In Chapters 5-7 
magnetic-activated cell sorting (MACS) was used to separate B cells on the basis of surface 
CD19 antigen expression and to deplete regulatory T cells on the basis of CD25 expression 
from PBMCs. Isolated B cells were then cultured with different stimuli to understand the 
effect of infection on B cell biology. Total PBMCs or Treg depleted PBMCs were cultured with 
different antigens to delineate the role that Tregs play in controlling antigen specific responses. 
Enzyme Linked Immunosorbent Assay (ELISA) or Luminex were used to quantify cytokines and 
antibodies whereas flow cytometry (FACS) was used to characterize in detail various regulatory 
and memory B and T cell subsets in circulating PBMC populations and to measure proliferation 
rates in cultured PBMCs. 
Scope and outline of this thesis
Innate and adaptive, as well as regulatory immune responses of individuals with and without S. 
haematobium infection were studied by developing and applying field applicable methods to 
the study population described above.
In Chapter 2, we compare PRR responses between African and European schoolchildren 
using identical reagents and experimental protocols in order to assess whether innate 
responses are affected by environmental factors. 
In Chapter 3 we assess cross-sectionally how innate and adaptive immune responses vary 
between S. haematobium-infected schoolchildren and uninfected controls.
In Chapter 4 we compare immune responses of S. haematobium-infected children before 
and after treatment with praziquantel. Uninfected subjects were also followed up to control for 
any technical and seasonal effects on immunological parameters measured.  
In Chapter 5 we analyze regulatory T cell responses before and after praziquantel treatment, 
and we add to our phenotypic studies of these cells, the assessment of their functional activity 
by performing Treg depletion experiments.
Recently regulatory B cells have also been shown to be important players in immune 
regulation. In Chapter 6 we investigate whether schistosome infection can induce functional 
Breg cells.
Antibody responses play a key role in the control of S. haematobium infections, yet the 
phenotype and function of B cells in human schistosomiasis has not been studied extensively. 
In Chapter 7 we compare circulating memory B cell subsets in schistosome infected and 
uninfected schoolchildren and assess their response to B cell receptor (BCR) and TLR stimulation.
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Although differences in immunological responses between populations have been found 
in terms of vaccine efficacy, immune responses to infections and prevalence of chronic 
inflammatory diseases, the mechanisms responsible for these differences are not well 
understood. Therefore, innate cytokine responses mediated by various classes of pattern-
recognition receptors including Toll-like receptors (TLR), C-type lectin receptors (CLRs) 
and nucleotide-binding oligomerisation domain-like receptors (NLRs) were compared 
between Dutch (European), semi-urban and rural Gabonese (African) children. Whole blood 
was stimulated for 24 hours and the pro-inflammatory tumor necrosis factor (TNF) and the 
anti-inflammatory/regulatory interleukin-10 (IL-10) cytokines in culture supernatant were 
measured by enzyme-linked immunosorbent assay (ELISA). Gabonese children had a lower pro-
inflammatory response to poly(I:C) (TLR3 ligand), but a higher pro-inflammatory response to 
FSL-1 (TLR2/6 ligand), Pam3 (TLR2/1 ligand) and LPS (TLR4 ligand) compared to Dutch children. 
Anti-inflammatory responses to Pam3 were also higher in Gabonese children. Non-TLR ligands 
did not induce substantial cytokine production on their own. Interaction between various TLR 
and non-TLR receptors was further assessed, but no differences were found between the three 
populations. In conclusion, using a field applicable assay, significant differences were observed 
in cytokine responses between European and African children to TLR ligands, but not to non-
TLR ligands.
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Introduction
Geographical variations in responses to vaccines have been reported; for example, protection 
against pulmonary tuberculosis by the Bacillus Calmette–Guérin (BCG) vaccine varies from 0% 
to 80% in adults, with higher protection in populations living at higher latitudes [1], or the 
rotavirus vaccine which provided little protection against rotavirus diarrhea in Gambian infants 
but showed promising results in Europe [2]. With respect to immunological changes following 
vaccination, a study in infants and adolescents from the United Kingdom showed that BCG 
vaccination induced a marked increase in interferon-γ (IFN-γ) response to Mycobacterium 
tuberculosis purified protein derivative (Mtb PPD), but not in infants and adolescents from 
Malawi [3]. Differences in the innate immune system and immune responsiveness caused 
by factors such as genetic variability and/or environmental exposures are thought in part to 
underlie the varying vaccine efficacies between populations. 
Pattern-recognition receptors (PRRs) enable the innate immune system to recognize 
pathogens through interaction with pathogen-associated molecular patterns. Activation 
of the innate immune system via the PRRs induces cytokine production and expression of 
costimulatory molecules, which in turn control the activation of the adaptive immune system 
[4,5]. Several PRR families have been identified, including the Toll-like receptors (TLRs), the 
cytosolic nucleotide-binding oligomerisation domain (NOD)-like receptors (NLRs) and the cell-
surface C-type lectin receptors (CLRs), each with their own specificities and signaling pathways. 
Integration of information from multiple PRRs enables the immune system to tailor its response, 
for example through cytokine production, to counteract specific exogenous and endogenous 
dangers [5,6]. As PRRs form the starting point of the innate immune response, which ultimately 
shapes the adaptive immune response, the magnitude as well as the type of cytokines (e.g. 
pro- or anti-inflammatory) produced in response to stimulation of these receptors could have 
a major impact on health. Alterations in PRR responses can determine responses not only to 
vaccines or pathogens but also to commensals, allergens or self-antigens [7–9].
Geographical differences in PRR responsiveness might also be linked to inflammatory-
related diseases that are found to differ between populations. In high-income countries, allergic 
diseases like asthma, hay fever and eczema [10], and chronic inflammatory disorders such as 
type 1 diabetes mellitus [11,12], multiple sclerosis and inflammatory bowel disease [13] have 
increased, while the prevalence of these diseases is still low in low-income countries [14–16]. 
Although a better understanding of immunological differences could aid in the development 
of population-specific vaccines and treatment modalities against infectious, allergic and 
chronic inflammatory diseases, few studies have so far compared PRR responsiveness between 
populations.
The present study is part of the SCHISTOINIR project that aims to explore innate immune 
responses in schistosomiasis (www.york.ac.uk/res/schistoinir). The aim of this study was 
to compare PRR responsiveness between European, semi-urban African and rural African 
populations. To that end, pro- and anti-inflammatory responses to various TLR and non-TLR 
ligands were compared, using identical methods and reagents, between children living in the 
Netherlands, and those living in semi-urban and rural Gabon. Significant differences in TLR 




stimulation and enhanced pro-inflammatory response to TLR2/1, TLR2/6 and TLR4 stimulation 
for Gabonese children as compared to Dutch children.
Figure 1. Whole blood cytokine responses to TLR ligands. 
A) TNF responses to poly(I:C), FLS-1, Pam3 and LPS in European children (the Netherlands), and semi-urban 
and rural African children (Gabon). B) IL-10 responses to TLR stimulation. C) Pro/anti-inflammatory ratio as 




































































The study population consisted of 21 Dutch children (median age: 9y, age range: 8-11, sex ratio: 
12m/9f ), 15 semi-urban Gabonese children (median age: 10y, age range: 6-15, sex ratio: 7m/8f ) 
and 30 rural Gabonese children (median age: 10y, age range: 7-16, sex ratio: 17m/13f ). The 
groups did not differ significantly in distributions of age and sex. Gabonese children differed 
in positivity for S. haematobium; semi-urban children were negative for schistosomiasis, 
whereas 57% of rural children were positive for this infection. Furthermore, 17% of semi-urban 
children were infected with geohelminths (Trichuris trichiura), while 44% of rural children were 
geohelminth positive (hookworm, Ascaris lumbricoides and/or Trichuris trichiura). A single 
case of malaria and of microfilaria and 5 cases of fungal skin infections were also detected 
amongst the rural Gabonese children, and 1 case of fungal skin infection amongst the semi-
urban children. Rural children had higher levels of leukocyte (median: 6.50∙109/L vs. 9.15∙109/L, 
p=0.003) and eosinophil (median: 0.28∙109/L vs. 1.31∙109/L, p=0.001) counts compared to 
semi-urban children. While there was no parasitological data for Dutch children, exposure to 
helminths and malaria is unlikely. The Dutch hematological reference values are 4.5-13.5∙109/L 
for leukocyte count and <0.4∙109/L for eosinophil count [23].
Cytokine responses to TLR ligands in European and African children 
To compare innate immune responses of Dutch children with semi-urban and rural Gabonese 
children, whole blood was stimulated with different TLR and non-TLR ligands. Following poly(I:C) 
(TLR3 ligand) stimulation, TNF responses were lower in Gabonese children as compared to 
Dutch children, while IL-10 responses were low for all groups (Figure 1A and B). This resulted in 
a lower TNF/IL-10 ratio for Gabonese children (Figure 1C). Conversely, TNF responses to FSL-1 
(TLR2/6 ligand), Pam3 (TLR2/1 ligand) and LPS (TLR4 ligand) were higher in Gabonese children 
(Figure 1A); IL-10 responses to FSL-1 and LPS did not differ between the groups and response to 
Pam3 was higher in Gabonese children (Figure 1B). When considered as ratio, Gabonese children 
exhibited a higher TNF/IL-10 ratio in response to these TLR ligands (Figure 1C). No differences 
were found between semi-urban and rural Gabonese children in whole blood responses to any 
of the TLR ligands tested. Comparison of responses by Schistosoma or geohelminth infection 
status did not result in significant differences (data not shown).
Spontaneous production of cytokines (response to medium) was low (Supplementary 
figure 1A). Despite the low levels, spontaneous IL-10 production was significantly higher 
for rural Gabonese children as compared to Dutch children, with a similar trend for higher 
spontaneous TNF production. No differences were observed between the groups in response 
to the positive control, the mitogen PHA (Supplementary figure 1B).
Interaction between TLR and non-TLR ligands in European children
Non-TLR ligands iE-DAP (a NOD1 ligand), mannan (ligand of mannose receptor (MR) and/or 
dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN)), 




alone did not induce substantial TNF or IL-10 production (Supplementary figure 2). However, 
they did influence TLR-mediated responses significantly. A synergistic effect was observed for 
the production of TNF, in particular in the interaction between TLR receptors and Dectin-1, 
while for IL-10 production both synergistic and inhibitory effects were observed (Table 1 and 
Supplementary figure 3).
Table 1. Degree of interaction between TLR and non-TLR ligands in Dutch children.
TNF IL-10
poly(I:C) FSL-1 Pam3 LPS poly(I:C) FSL-1 Pam3 LPS
iE-DAP ++ + + + + +
mannan + + + + +
KOdiA-PC − +
curdlan ++ ++ ++ − −
The degree of interaction between two ligands was calculated for e.g. poly(I:C) and iE-DAP by: 
(TNFpoly(I:C)+iE-DAP − TNFmedium) / ((TNFpoly(I:C) − TNFmedium) + (TNFiE-DAP − TNFmedium)). Values above 1 are regarded as 
synergy (+), and above 2 as strong synergy (++). Values below 1 are regarded as inhibition (−). Shown are 
statistically significant differences (p<0.05) according to the Wilcoxon signed rank test, when comparing 
the response to combined stimulation with the sum of separate stimulation (after background subtraction). 
See Supplementary figure 3 for details.
Comparison of PRR interaction profiles in European and African children
Interactions between TLRs and NOD1 (by iE-DAP) and MR/DC-SIGN (by mannan) were further 
compared between Dutch children and semi-urban and rural Gabonese children. Combination 
of Pam3 and iE-DAP or mannan resulted in significant synergistic effects for both TNF and IL-
10 in all groups of children; other combinations were more variable (Figure 2, Supplementary 
figure 4). Of interest, while in Dutch children combined stimulation with poly(I:C) and iE-DAP or 
mannan led to significant synergy, Gabonese children exhibited a tendency towards inhibitory 
responses.
Discussion
This is the first study to systematically examine innate immune responses to several classes 
of PPRs in European and African children that originate from a semi-urban and a close-by 
rural area. African children from both a semi-urban and a rural area were included to take into 
account differences in environmental factors and genetic diversity between the African and 
European populations.
We report that Gabonese children had a reduced pro-inflammatory response to TLR3-
ligand poly(I:C) and an enhanced pro-inflammatory response to TLR2/6-ligand FSL-1, TLR2/1-
ligand Pam3 and TLR4-ligand LPS as compared to Dutch children. We further show that the 
concomitant engagement of TLRs with the receptors NOD1, CD36, MR/DC-SIGN or Dectin-1 
can modify TLR responses, but no clear differences in the responses between Dutch and semi-
urban and rural Gabonese children were seen, indicating that innate immune responses to the 
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Figure 2. Degree of interaction between TLR and non-TLR ligands. 
A) Degree of interaction for TNF production upon stimulation with poly(I:C), FSL-1, Pam3 or LPS combined 
with iE-DAP. This was calculated for e.g. poly(I:C) and iE-DAP by: (TNFpoly(I:C)+iE-DAP − TNFmedium) / ((TNFpoly(I:C) − 
TNFmedium) + (TNFiE-DAP − TNFmedium)). B) Degree of interaction for IL-10 production for combinations with iE-
DAP. C) Degree of interaction for TNF production for combinations with mannan. D) Degree of interaction 
for IL-10 production for combinations with mannan.
non-TLR ligands studied are similar in European and Gabonese children. 
Geographical differences in immune responses have not been studied extensively. One of 
the most field-applicable methods is the whole blood assay, which has been used here and in a 
few other studies to profile immune responses in populations residing in different geographic 
areas. In a recent study comparing responses of 2-year-old children to various PRRs across four 
continents, Smolen et al. [25], have shown that despite very distinct genetic and environmental 
background, the cytokine responses were largely similar in European, North American and South 
American children. However, the response of children from Africa was poor compared with 
the other three continents when stimulated with ligands to surface (TLR2, TLR4) or endosomal 
(TLR3, TLR7/8) PRRs but similar when targeting the cytosolic PRR (NOD2). However, our results 
are different. First, we find higher innate responses to LPS, Pam3 and FSL-1, stimuli which engage 
surface TLRs, in African (Gabonese) compared to European (Dutch) children. Currently, we are 























































































































































































emphasized that the age of the study subjects was substantially different in the two studies and 
differences in immune responses between Africans and Europeans has been found to be age-
dependent [26]. Second, we see differences in immune responses between the genetically-
distinct European and African children, but not in the genetically-similar semi-urban and rural 
African children. These results would suggest that genetic differences play an important role in 
the distinct innate responsiveness of African and European children. Polymorphisms have been 
described for TLR receptors and for molecules in downstream signaling pathways, for example 
for the gene coding for TIR domain-containing adapter protein/MyD88 adapter-like (TIRAP/
Mal) that interacts with MyD88, and in TRIF [27]. Alternatively, it is possible that the difference 
between the semi-urban and rural African areas studied is too small to have a substantial effect 
on innate immune responsiveness. 
The differences we observed in cytokine production in response to TLR ligands between 
Dutch and Gabonese children might be explained by variations in TLR expression levels. Van 
den Biggelaar et al. analyzed cord blood mononuclear cells (CBMCs) of newborns from a low-
income country (Papua New Guinea; PNG) and a high-income country (Australia), showing 
less TNF and IL-10 in response to TLR2- and TLR4-specific stimulation, but more IFN-γ and IL-
10 in response to BCG (recognized by TLR2, TLR4, and putatively TLR9) in PNG newborns [28]. 
The same study measured TLR mRNA expression and found that PNG CMBCs had higher TLR2 
and TLR9 expression levels, but lower levels of TLR4. In contrast, Gabonese CBMCs have been 
shown to have lower TLR2 expression compared to Austrian CBMCs, but this was measured 
on freshly isolated cells that were fixed and then analyzed by flow cytometry [29] whereas the 
PNG study assessed mRNA expression in cryopreserved cells. Altogether, these data indicate 
how important technical differences can be when comparing studies conducted by different 
groups. 
Downstream signaling pathways may also contribute towards differences observed in TLR 
responsiveness. TLR3 signals via Toll-IL-1 receptor (TIR) domain-containing adaptor inducing 
interferon-β (TRIF), while TLR2/6 and TLR2/1 signal via myeloid differentiation primary response 
protein 88 (MyD88) and TLR4 signals via both [30]. Thus, the enhanced pro-inflammatory 
response upon TLR3 stimulation in Dutch as compared to Gabonese children may be due to 
altered signaling via TRIF. Similarly, the enhanced pro-inflammatory response upon TLR2/6, 
TLR2/1 and TLR4 stimulation in Gabonese children may result from differences in MyD88 
signaling. With the emergence of evidence for ‘trained innate immunity’ where a ‘memory’ of an 
earlier innate triggering in natural killer cells, macrophages and monocytes can be imprinted 
and can affect response to an innate ligand encountered later [31], it is possible that differential 
exposure to viruses, bacteria and parasites in the Dutch and Gabonese populations may explain 
the observed differences in innate responses [32–34].
Interaction of TLRs with other PRRs can modulate the type and the strength of an immune 
response. In Dutch children, combinations with curdlan resulted in the highest degree of 
synergy in TNF production, as described before [35]. Interestingly, despite the strong synergy 
between curdlan and TLRs that engage MyD88, no synergy was seen with the TLR3-ligand 
poly(I:C) which engages TIR. NOD1 has been found previously to synergize with TLR3 and TLR4 
to induce IL-12p70 production [36], and our data indicate that synergy (by iE-DAP) can also 
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occur for TNF with TLR2/1, TLR3 and TLR4. Mannan was shown to synergize with TLR3, TLR2/6 
and TLR2/1 for TNF production and with TLR2/6 and TLR4 for IL-10 production, in addition to the 
already described MR synergy with TLR2 [37]. CD36, stimulated by KOdiA-PC, did not synergize 
with TLRs for TNF production, while IL-10 production was variably affected. 
The degree of interaction between PRRs did not differ considerably between Dutch 
children and those from semi-urban and rural Gabon. However, synergy between iE-DAP or 
mannan with poly(I:C) for TNF production occurred for Dutch children, but not for Gabonese 
children. This might suggest that NOD1 and MR are expressed to a lower extent in Gabonese 
children. However, when stimulating with LPS or FSL-1, children from rural Gabon showed 
higher activity of MR and NOD1 respectively. Therefore, it is unlikely that receptor expression 
explains the differences observed but rather the downstream pathways involved might be 
differently shaped.
Innate responses did not differ significantly between semi-urban and rural Gabonese 
children, and furthermore S. haematobium infection did not lead to differences in PRR 
responsiveness. This is in contrast to studies where helminth infections were found to influence 
TLR responses or expression levels [18,34,38,39]. This may be due to the difference between 
whole blood responses measured here and isolated peripheral blood mononuclear cells used 
in the other studies. Indeed, a larger follow-up study carried out in the same area measuring 
cytokine responses in whole blood cultures did not show differences in innate responses 
(submitted). While whole blood assays are ideal for field conditions as cell separation is not 
required, their main disadvantage is that the number of cells cultured is unknown and not 
controlled for. In this study, leukocyte and eosinophil counts did differ significantly between 
semi-urban and rural Gabonese children, most likely due to the higher rate of S. haematobium 
infection in the rural area. This however did not result in significant differences in innate cytokine 
responses. Future studies using isolated peripheral blood mononuclear cells and intracellular 
cytokine staining combined with receptor expression measurements would give more detailed 
information about differences in immunological responses at the population level.
Our study is one of the few to compare, using identical protocols, not only children in Europe 
and Africa but also children from rural and semi-urban Africa. The reduced pro-inflammatory 
response to TLR3 stimulation and enhanced pro-inflammatory response to TLR2/1, TLR2/6 and 
TLR4 stimulation in African children could affect the efficacy of vaccines or treatments and 
should be taken into account in future studies. Furthermore, the distinct PRR responses might 
be of interest when trying to understand differences between populations in terms of allergic 
and chronic inflammatory diseases.
Materials and methods
Ethics statement
The study was approved in Gabon by the Comité d’Ethique Régional Indépendant de 
Lambaréné (CERIL N°06/08) and in the Netherlands by the UMC Utrecht Medical Research 
Ethics Committee. Written informed consent was obtained from parents or legal guardians of 





In June-July 2008, 15 schoolchildren were recruited from Lambaréné, a semi-urban municipality 
in Gabon, and 30 children from the neighboring rural village Zilé in which Schistosoma 
haematobium infection is endemic. Lambaréné [17] and Zilé [18] have been previously 
described in detail. 
S. haematobium infection was determined prior to blood collection by examining a filtrate 
of 10 mL of urine passed through a 12-µm-pore-size filter (Millipore, Billerica, MA, USA). Children 
were classified S. haematobium-infected when at least one S. haematobium egg was detected in 
the urine, or uninfected when three consecutive urine samples were negative. Infections with 
intestinal helminths Ascaris lumbricoides and Trichuris trichiura were determined by analyzing 
one fresh stool sample using the Kato-Katz method [19]. Hookworm larvae were determined in 
a 7-day coproculture of the same stool sample [20]. Infection with P. falciparum and microfilaria 
was determined by Giemsa-stained thick blood smears [21]. 
After collection of blood samples, all S. haematobium-infected children were treated with a 
single dose of praziquantel (40 mg/kg), and those with intestinal helminths received a single dose 
of albendazole (400 mg) in accordance with the guidelines of the World Health Organization. 
Children with fungal skin infections received therapy according to local guidelines. 
Hematological parameters were analyzed using ADVIA 120 Hematology System (Bayer 
HealthCare LLC, Diagnostics Division, Tarrytown, NY, USA) and erythrocyte sedimentation rate 
was measured manually. 
In September-October 2008, peripheral blood samples from 21 Dutch children, participating 
as controls for allergic children in a European study (EuroPrevall, www.europrevall.org), were 
also collected [22]. No hematological or parasitological data was available for this population, 
although exposure to helminths and malaria is thought to be unlikely.
Whole blood culture
Heparinized venous blood was processed for culture within 6 hours after venipuncture. Whole 
blood was diluted 2 times in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented 
with 100 U/mL penicillin (Astellas Pharma BV, Leiden, the Netherlands), 10 μg/mL streptomycin 
(Sigma-Aldrich, Saint Louis, MO, USA), 1 mM pyruvate (Sigma-Aldrich) and 2 mM L-glutamine 
(Sigma-Aldrich) and stimulated with 50 µg/mL polyinosinic-polycytidylic acid high molecular 
weight (poly(I:C); InvivoGen, San Diego, CA, USA), 50 ng/mL Pam2CGDPKHPKSF (FSL-1; 
InvivoGen), 100 ng/mL Pam3CSK4 (Pam3; EMC Microcollections GmbH, Tübingen, Germany), 
100 ng/mL ultrapure lipopolysaccharide (LPS; InvivoGen), 10 µg/mL β-D-Glu-mDAP (iE-DAP; 
InvivoGen), 100 µg/mL mannan (Sigma-Aldrich), 100 µg/mL curdlan (Wako Chemicals GmbH, 
Neuss, Germany) or 5 ng/mL 1-(palmitoyl)-2-(5-keto-6-octene-dioyl)phosphatidylcholine 
(KOdiA-PC; Cayman Chemicals, Ann Arbor, MI, USA), alone or in combination (Table 2). Medium 
was used as a negative control and 2 µg/mL phytohemagglutinin (PHA; Remel, Dartford, UK), a 
mitogen, as a positive control. 100 µL of ligand(s) in medium was added to wells containing 100 
µL of diluted blood in 96-well round-bottom plates (Nunc; Roskilde, Denmark) and incubated in 
the presence of 5% CO2 at 37°C for 24 hours. Supernatants were harvested and stored at −80°C. 
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Table 2. Ligands used in the study, their receptors and adapters.




LPS TLR4 MyD88, TRIF
iE-DAP NLR: NOD1 -
KOdiA-PC CD36/SR-B2 -
mannan CLR: MR, DC-SIGN -
curdlan CLR: Dectin-1 -
PRR, pattern-recognition receptor. TLR, toll-like receptor. NLR, NOD-like receptor. NOD, nucleotide-binding 
oligomerisation domain-containing protein 1. SR, scavenger receptor. CLR, C-type lectin receptor. MR, 
mannose receptor. DC-SIGN, dendritic cell-specific intercellular adhesion molecule-3-grabbing non-
integrin. TRIF, TIR-domain-containing adapter-inducing interferon-β. MyD88, myeloid differentiation 
primary response gene 88.
Cytokine analysis
Tumor necrosis factor (TNF) and interleukin-10 (IL-10) levels were measured in supernatants 
by an enzyme-linked immunosorbent assay (ELISA) according to manufacturers’ instructions 
using half of the reaction volume (Sanquin, Amsterdam, the Netherlands). Levels below 
detection limit were replaced by half the detection limit, 1.4 pg/mL and 1.2 pg/mL for TNF and 
IL-10 respectively. 
Statistical analysis
Data analysis was performed using IBM SPSS Statistics version 20 for Windows (Armonk, NY, 
USA: IBM Corp.; 2011). Cytokine concentrations in response to stimulation were corrected for 
spontaneous cytokine production by subtracting medium responses. Negative values and 
zeros were subsequently replaced by the lowest positive value, 0.08 and 0.04 for TNF and 
IL-10 respectively. The pro/anti-inflammatory TNF/IL-10 ratio was calculated by: (TNFstimulated 
− TNFmedium) / (IL-10stimulated − IL-10medium). The degree of interaction between two ligands was 
calculated for e.g. poly(I:C) and iE-DAP by: (TNFpoly(I:C)+iE-DAP − TNFmedium) / ((TNFpoly(I:C) − TNFmedium) 
+ (TNFiE-DAP − TNFmedium)). This could result in a synergistic or inhibitory effect. Mann-Whitney U 
test and Kruskal-Wallis test with Dunn’s post-test were used to compare groups. Fisher’s exact 
test and Pearson chi-square test were used to compare categorical data of the population 
characteristics. Wilcoxon signed rank test was used to compare the (synergistic) response 
to combined stimulation with the sum of cytokines produced in two separate stimulations 
(after background subtraction) and for comparing the response to stimulation with medium 
condition. p-values less than 0.05 were considered statistically significant. 
Graphs were made with GraphPad Prism version 6 for Windows (La Jolla, CA, USA: GraphPad 
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Supplementary material
Supplementary Figure 1. Whole blood cytokine production in negative and positive control samples. 
A) Spontaneous TNF and IL-10 production in negative control samples (medium). B) TNF and IL-10 
production in positive control samples (PHA).
Supplementary Figure 2. Whole blood cytokine responses to non-TLR stimulation. 
A) TNF production in response to non-TLR ligands (iE-DAP, mannan, KOdiA-PC and curdlan). B) IL-10 
response to non-TLR ligands. * p-value when comparing two areas. # p-value when comparing stimulated 

















































































Supplementary Figure 3. Interaction between TLR and non-TLR ligands in Dutch children.
A) TNF responses to stimulation with poly(I:C), FSL-1, Pam3 or LPS combined with iE-DAP, mannan, KOdiA-
PC or curdlan. B) IL-10 responses to combined stimulations. C) Degree of interaction between two ligands 
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Supplementary Figure 4. Interaction between TLR and non-TLR ligands. 
A) TNF responses to stimulation with poly(I:C), FSL-1, Pam3 or LPS combined with iE-DAP. B) IL-10 responses 
to TLR ligands combined with iE-DAP. C) TNF responses to TLR ligands combined with mannan. D) IL-10 
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Background: Schistosoma infection is thought to lead to down-regulation of the host’s immune 
response. This has been shown for adaptive immune responses, but the effect on innate 
immunity, that initiates and shapes the adaptive response, has not been extensively studied. 
In a first study to characterize these responses, we investigated the effect of Schistosoma 
haematobium infection on cytokine responses of Gabonese schoolchildren to a number of Toll-
like receptor (TLR) ligands.
Methodology: Peripheral blood mononuclear cells (PBMCs) were collected from S. 
haematobium-infected and uninfected schoolchildren from the rural area of Zilé in Gabon. 
PBMCs were incubated for 24h and 72h with various TLR ligands, as well as schistosomal egg 
antigen (SEA) and adult worm antigen (AWA). Pro-inflammatory TNF-α and anti-inflammatory/
regulatory IL-10 cytokine concentrations were determined in culture supernatants.
Principal Findings: Infected children produced higher adaptive IL-10 responses than 
uninfected children against schistosomal antigens (72h incubation). On the other hand, 
infected children had higher TNF-α responses than uninfected children and significantly higher 
TNF-α to IL-10 ratios in response to FSL-1 and Pam3, ligands of TLR2/6 and TLR2/1 respectively. 
A similar trend was observed for the TLR4 ligand LPS while Poly(I:C) (Mda5/TLR3 ligand) did not 
induce substantial cytokine responses (24h incubation).
Conclusions: This pilot study shows that Schistosoma-infected children develop a more pro-
inflammatory TLR2-mediated response in the face of a more anti-inflammatory adaptive 
immune response. This suggests that S. haematobium infection does not suppress the host’s 
innate immune system in the context of single TLR ligation.
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Introduction
Schistosomiasis is a parasitic disease of major public health importance and is largely chronic 
in nature. The WHO estimates that more than 207 million people are infected worldwide [1,2]. 
Chronic helminth infections are generally assumed to cause down-regulation of immune 
responses allowing long-term survival of the parasite on the one hand and minimizing 
immune immunopathology on the other [3] with important consequences to the host’s health 
[4–7]. Effects of schistosomal infection on adaptive immunity are widely studied in this context 
and it has been shown that chronic schistosomiasis inhibits in vitro proliferation of human 
lymphocytes in response to schistosomal antigens [8,9]. The anti-inflammatory cytokine 
interleukin (IL)-10 plays an important role in this down-regulation [10–14]. Van den Biggelaar 
and colleagues have demonstrated that children chronically infected with schistosomes 
produce more IL-10 together with IL-5 and IL-13 in response to adult worm antigen (AWA), 
than those free of Schistosoma infection [15]. Helminth-induced immunomodulation may also 
have an impact on other infections and vaccine effectiveness. For example, in filarial infections, 
IL-10 down-regulates responses to unrelated antigens such as tetanus toxoid [16,17]. Similar 
mechanisms might explain the impaired reaction to tetanus toxoid observed in Schistosoma 
mansoni-infected individuals [18]. Another feature of IL-10 is that it might suppress atopy in 
Schistosoma haematobium-infected children [15,19].
Although it is becoming clearer how chronic schistosomiasis impacts on adaptive immune 
responses in terms of immunoregulation, the effects of schistosomal infection on innate 
immunity is a less studied area. In general, the innate immune system detects invading 
pathogens through a set of ‘pattern-recognition receptors’ (PRRs) which recognize ‘pathogen-
associated molecular patterns’ (PAMPs) [20,21]. Engagement of PRRs, such as Toll-like receptors 
(TLRs) initiates early immune events prior to the full activation of adaptive immunity. TLRs act as 
homo- (e.g. TLR3 or TLR4) or heterodimers (e.g. TLR2/1 or TLR2/6), or in combination with other 
PRRs such as C-type lectins. Most TLRs induce IL-12p70 which in turn promotes differentiation 
of Th1 cells and inflammatory responses, characterized by production of tumor necrosis factor 
α (TNF-α) and interferon γ (IFN-γ). On the other hand, C-type lectins can be in part responsible 
for the induction of anti-inflammatory responses [22]. The interplay between innate receptors 
is thought to form the signals that will determine the development of adaptive immune 
responses [21,23].
The present study is part of the SCHISTOINIR project that aims to explore innate immune 
responses in schistosomiasis (for further information: www.york.ac.uk/res/schistoinir). This 
pilot study was set out to investigate how chronic schistosomiasis affects the peripheral blood 
mononuclear cell (PBMC) response to various TLR ligands. Here, we report the results from 
children living in a S. haematobium-endemic rural area near Lambaréné, Gabon.
Results
Characteristics of the study population
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infected and uninfected groups of schoolchildren were comparable. Although S. haematobium-
infected children tended to be more anemic and to have higher eosinophil levels, there were 
no significant differences between the groups for any of the parameters. In addition, the 
prevalence and infection intensity of A. lumbricoides, T. trichiura or N. americanus did not 
significantly differ between S. haematobium-positive and -negative children (data not shown 
for infection intensity). S. haematobium infection intensities were low (<50 epg/10ml) in 14/17 
infected children [38]. Malaria and filariasis are endemic in this area [39]. However, only one 
study participant was infected with P. falciparum and one with microfilariae.
Cytokine responses to TLR-ligands
TLR-induced cytokine production by PBMC cultures from infected and uninfected groups was 
measured at 24h (Figure 1A, upper panel). While Pam3, FSL-1 and LPS led to substantial and 
significant cytokine production in both groups compared to medium control, the TLR3 ligand 
poly(I:C) did not stimulate significant levels of TNF-α or IL-10. Pam3, FSL-1 and LPS tended to 
induce the production of greater quantities of the pro-inflammatory cytokine TNF-α in infected 
compared to uninfected children (Pam3; p<0.01), while the production of IL-10 was comparable 
between the two groups.
There was a stronger pro-inflammatory index for PBMC responses of infected children 
(Figure 1B, upper panel) upon TLR-stimulation (except poly(I:C)) than those from uninfected 
children. These differences were significant for both Pam3 and FSL-1 (p<0.05) which are ligands 
for TLR2.
Furthermore, S. haematobium infection intensity was positively associated with TLR-2- and 
TLR-4-mediated TNF-α but not with IL-10 responses. This was significant for Pam3 (ρ =0.80) 
and FSL-1 (ρ =0.66). Also, pro-inflammatory indices tended to be positively associated with 
infection intensity (significant for Pam3 with ρ =0.60).
In order to get an idea of the dynamics of the innate response, TLR responses were also 
measured after 72h. Cytokine responses to TLR ligands decreased over time, being less 
pronounced after 72h. Nevertheless, the difference between infected and uninfected subjects 
was similar to that observed in 24h cultures with a largely pro-inflammatory TLR response in 
infected subjects (Figure 1, lower panels).
Cytokine responses to schistosomal products
We examined adaptive immune responses by analyzing cytokine production by PBMCs after 
72h of incubation with schistosomal antigens (Figure 2, lower panels). Since these products not 
only contain antigenic components but also innate ligands [40–47], cytokine production was 
assessed at both 24h (innate) and at 72h (adaptive response).
SEA- and AWA-induced IL-10 was detected in PBMC culture supernatants after 24h and 
increased further in 72h cultures. IL-10 production in infected children was consistently higher 
than in uninfected children at 24h but this difference was only significant at 72h: both SEA- and 
AWA-induced IL-10 responses were significantly higher in infected children at 72h (Figure 2A).
After 24h, AWA-stimulated cultures from infected children secreted significant levels of 





After 24h, the cytokine ratios following stimulation with schistosomal products seemed 
more anti-inflammatory than pro-inflammatory (i.e. increased IL-10 : TNF-α; Figure 2B, upper 
panel). After 72h, the pro-inflammatory index tended to increase in uninfected children, and 
was significantly higher than in infected children upon stimulation with AWA (Figure 2B, lower 
panel).
Discussion
In this pilot study we investigated the effects of chronic Schistosoma infection on TLR-mediated 
cytokine production. We showed that innate TNF-α responses and TNF-α : IL-10 ratios upon 
TLR2 stimulation of PBMCs were significantly higher in S. haematobium-infected children 
compared with those without infection, in the face of enhanced regulatory adaptive responses 
to schistosomal antigens. This suggests that schistosomal infection is associated with elevated 
Figure 1. Cytokine production in response to TLR ligands in PBMC cultures.
White and grey boxes correspond to S. haematobium-free and infected children respectively with the 
whiskers indicating minimal and maximal concentrations. * p < 0.05; ** p < 0.01. Panel A: At 24h, the 
‘innate’ time-point, infected children produced significantly more TNF-α in response to the TLR2/1 ligand 
Pam3CSK4 (Pam3) compared with uninfected children. TLR-mediated IL-10 production did not significantly 
deviate between infection groups. When innate cytokine responses faded at 72h, similar trends were 
observed. These plots were not adjusted for spontaneous cytokine production. Panel B: At both time points, 
pro-inflammatory indices (i.e. cytokine ratio induced by one of the stimuli relative to the spontaneously 
produced ratio) induced by the TLR2 ligands, Pam3 and FSL-1, were significantly higher in infected versus 
uninfected children.
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Figure 2. Cytokine production in response to schistosomal products in PBMC cultures.
PBMCs were stimulated with schistosomal egg antigen (SEA) or adult worm antigen (AWA). White and grey 
boxes correspond to S. haematobium-free and infected children respectively with the whiskers indicating 
minimal and maximal concentrations. * p < 0.05; ** p < 0.01. Panel A: Cytokine production did not differ 
between groups at 24h (mainly innate response) but the adaptive IL-10 response after 72h of incubation 
to both schistosomal products was significantly higher in infected children than in S. haematobium-free 
children. Furthermore, only infected children produced a significant innate TNF-α response to schistosomal 
products at 24h. These plots are not adjusted for spontaneous cytokine production. Panel B: After 
24h (predominantly innate), most cytokine ratios induced by schistosomal products were more anti-
inflammatory than the ratios induced by medium alone. When the adaptive response had developed after 
72h however, only infected children produced significant anti-inflammatory cytokine balances while pro-
inflammatory indices were lower in infected children than in uninfected children (AWA; p < 0.05).
pro-inflammatory TLR2 responses.
While cytokine responses upon TLR stimulation tended to decrease over time, the reverse 
was seen after stimulation with schistosomal products. Although at 24h, TNF-α levels tended to 
be more pronounced in infected than in uninfected children, analogous with the observed TLR-
mediated cytokine responses, after 72h of stimulation, PMBCs from S. haematobium-infected 
children produced significantly more IL-10 than uninfected children, as has been described 
elsewhere [15]. Schistosomal products are more complex than single TLR stimuli. SEA and AWA 
stimulate the innate immune system through TLRs, C-type lectins and other innate receptors 
[40–47] but in addition, they contain antigens which can be processed and presented to the T 
cell receptor forming the basis of acquired immune responses. Schistosomal products are thus 
able to activate both innate and adaptive pathways. This may explain the observed trend of 
an initial pro-inflammatory-like immune response. Concurrent with a fading innate cytokine 
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in infected children at 72h.
To our knowledge there are only two other human studies on TLR-mediated cytokine 
profiles in schistosomiasis. Van der Kleij et al. reported reduced TLR responses in Gabonese S. 
haematobium-infected as compared to uninfected children [24]. These results seem to contradict 
the current findings, but can be explained by differences in the selection of the uninfected 
control groups. While in the present study both infected and uninfected children were from 
the same S. haematobium-endemic rural area (Zilé), Van der Kleij et al. recruited the uninfected 
control group from a non-endemic neighboring semi-urban area to ensure that the negative 
subjects were truly negative with no history of exposure. However, when we examined the 
dataset of the Van der Kleij study to compare the infected (n=5) and uninfected (n=10) groups 
from the same rural area of Zilé, infected children tended to produce higher TNF-α levels as 
well as higher pro-inflammatory indices in response to LPS than their uninfected counterparts, 
which is in line with our results.
The second study of TLR-mediated cytokine profiles was carried out in Brazil and also 
corresponds with our results. Although they did not highlight it, Montenegro et al. showed that 
48h whole blood cultures from S. mansoni-infected adults produced more TNF-α than those of 
uninfected adults in response to LPS [48].
In addition, a mouse model of infection pointed towards a similar association between TLR 
function and schistosomal infection and suggests that schistosomal infection induces elevated 
pro-inflammatory TLR responses [49].
Few field studies on TLR responses in other helminth infections than schistosomiasis have 
been published and show varying results. In contrast to S. haematobium infection, a negative 
association has been found between infection with the filarial nematode Wuchereria bancrofti 
and intracellular pro-inflammatory cytokine expression upon TLR stimulation in lymphocytes 
and monocytes in a population in South India [50,51]. In addition, W. bancrofti was associated 
with reduced pro-inflammatory cytokine responses upon TLR stimulation of PBMCs in a 
population from the same area with latent tuberculosis [52]. On the other hand, Jackson et 
al. showed infections with intestinal nematodes, i.e. hookworm and Trichuris trichiura, to be 
associated with pro-inflammatory cytokine production, but not with regulatory cytokine 
production, upon TLR2 and TLR4 stimulation of monocytes from children from Pemba Island 
[53]. Apparently, the effect of helminth infections on the innate immune responses is species 
specific; some helminth species may be associated with more pro-inflammatory TLR responses 
while other helminths are associated with more anti-inflammatory TLR responses. In the 
present study, S. haematobium-infected and uninfected children did not significantly differ 
with respect to the number and species of other helminth infections. However, information 
on soil-transmitted helminth infections was not available for some of the participants and we 
cannot entirely rule out that these infections may have altered the observed innate cytokine 
responses. In addition, other parasites such as malaria may influence immune balances [54]. The 
duration as well as the intensity of infection might further influence innate immune responses. 
It is therefore important to confirm our findings in a larger study population and in varying 
epidemiological settings. 
In conclusion, this pilot study on innate immune responses in schistosomiasis shows a 
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more pro-inflammatory response to single TLR2 ligands in the face of an anti-inflammatory 
adaptive immune response in S. haematobium-infected children. Whilst the precise biological 
mechanisms for these observations remain to be ascertained, it seems that the commonly 
accepted view that schistosomal infection suppresses the host’s immune system does not hold 
for ligation of single TLRs. Many receptors – TLRs as well as non-TLRs such as C-type lectins – are 
involved in innate signaling and their interactions as well as down-stream pathways are at the 
basis of the immune response to invading pathogens [21,55]. Given the fact that a Schistosoma 
worm is a complex mix of ligands stimulating the innate immune system, further research into 
this innate cross-talk is necessary.
Materials and methods
Ethics statement
The study was approved by the “Comité d’Ethique Regional Independent de Lambaréné” 
(CERIL). Written informed consent was obtained from parents or legal guardians of all children 
participating prior to inclusion into the study.
Study site and population
This pilot study was performed in Zilé, a rural area situated 16 km from Lambaréné, Gabon 
[24,25]. This area is endemic for S. haematobium, but with important focal differences. Within 
Zilé there are two smaller communities, one with high (PK15) and one with low transmission 
(PK17), 2 km apart from each other. In June and July 2008, we recruited 17 S. haematobium-
infected schoolchildren from PK15 and 13 uninfected from PK17, and compared their immune 
profiles. Study participants had no history of anti-helminthic treatment within the last 3 months 
prior to this study.
Parasitological examination
S. haematobium infection was determined a maximum of seven days prior to blood collection 
by examining the residue of 10 ml of urine passed through a filter of 12-µm pore-size 
(Millipore). Children were classified as S. haematobium-infected if at least one S. haematobium 
egg was detected in the urine, or uninfected if three consecutive urine samples were negative. 
Geometric mean infection intensity was calculated for infected children using the first urine 
reading. Infections with intestinal helminths Ascaris lumbricoides and Trichuris trichiura were 
determined by analyzing one fresh stool sample using the Kato-Katz method 30-45 minutes 
after preparation [26]. Necator americanus larvae were detected in a 7-day coproculture of 
the same stool sample. To this end the classical charcoal culture procedure was used [27–29]. 
Infection with Plasmodium falciparum and microfilaria was determined by Giemsa-stained thick 
blood smears [30]. 
After collection of blood samples, all S. haematobium-infected children were treated with 
a single dose of praziquantel (40 mg/kg), and those with intestinal helminths were given a 
single dose of albendazole (400 mg). Children with other infections or clinical complaints were 





Hematological parameters were analyzed using the ADVIA® 120 Hematology System (Bayer 
Health Care) and erythrocyte sedimentation rate was determined manually.
PBMC cultures
PBMCs were isolated from heparinized venous blood by density centrifugation on Ficoll 
(AZL pharmacy, The Netherlands) and cultured in 200 µl of IMDM supplemented with 5% 
fetal bovine serum (Greiner Bio-One), 100 U/ml penicillin (Astellas), 10 µg/ml streptomycin, 1 
mM pyruvate and 2 mM L-glutamine (Sigma) in 96-well round bottom plates (Nunc). PBMCs 
were seeded at 1 x 106 cells/well for stimulation with schistosomal egg antigen (SEA) or adult 
worm antigen (AWA), and at 5 x 105 cells/well for stimulation with specific TLR ligands and 
phyto-hemagglutinin (PHA; positive control). IMDM medium was used as a negative control. 
Supernatants were collected after 24h and 72h of incubation at 37°C in a 5% CO2 atmosphere 
and stored at -80°C until cytokine analysis.
Innate and adaptive stimuli
A panel of four TLR ligands was used: 
1.  TLR2/1 ligand, Pam3CSK4 (Pam3), a synthetic bacterial triacylated lipopeptide (final 
concentration of 100 ng/ml; EMC microcollections GmbH), 
2.  TLR2/6 ligand, FSL-1, a synthetic diacylated lipoprotein mimicking the N-terminal part 
of LP44 from Mycoplasma salivarium (50 ng/ml; InvivoGen),
3.  TLR3 ligand polyinosinic-polycytidylic acid (poly(I:C)), a synthetic analogue of viral 
double-stranded RNA (50 µg/ml; InvivoGen),
4.  TLR4 ligand, ultrapure lipopolysaccharide (LPS) derived from Escherichia coli (100 ng/
ml; InvivoGen).
In addition to the classical innate ligands, we used the schistosomal antigen-containing 
products SEA and AWA from S. haematobium at a final concentration of 10 µg protein/ml. 
Purified PHA (Remel) was used as a positive control at a final concentration of 2 µg/ml.
 
Cytokine analysis
Two cytokines were measured in this pilot study; one key pro-inflammatory cytokine, 
TNF-α  [31–33], and the anti-inflammatory/regulatory cytokine IL-10 [12,34–37]. Cytokine 
concentrations were measured in supernatants from single PBMC cultures by ELISA according 
to the manufacturer’s instructions, using half of the reaction volume (PeliKine CompactTM, 
Human TNF-α and IL-10 ELISA kit, Sanquin).
A pro-inflammatory index was computed as the TNF-α : IL-10 ratio upon stimulation relative 
to the spontaneously produced TNF-α : IL-10 ratio (i.e. in medium):
([TNF-α]stimulus A/[IL-10]stimulus A)/([TNF-α]medium/[IL-10]medium)
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Statistical analysis
Differences between schistosome-infected and uninfected groups were determined by the 
Fisher’s exact test for sex and intestinal helminth infections and by the Mann-Whitney U test 
for helminth infection intensity, body mass index (BMI) and hematological parameters. Age 
was normally distributed and differences between infection groups were tested using the 
independent student’s T test. As cytokine concentrations were not normally distributed, 
nonparametric tests were used. Differences in an individual’s cytokine response to different 
stimuli (e.g. medium versus stimulus-induced cytokine concentration, or ratio) were tested by 
the Wilcoxon matched-pair signed-rank test.
Differences between infection groups in cytokine concentrations and pro-inflammatory 
indices were tested by the Mann-Whitney U test. Cytokine concentrations were corrected for 
spontaneous cytokine production. This was done by subtracting the spontaneously induced 
cytokine concentration (i.e. in medium) from the stimulus-induced cytokine concentration. 
For the pro-inflammatory index, this was done by dividing the stimulus-induced ratio by the 
spontaneously induced ratio (see formula above). Similarly, Spearman’s ρ was calculated to 
estimate the correlation between cytokine responses and infection intensity.
SPSS 18.0 (SPSS Inc.) and GraphPad Prism 5 (GraphPad Software, Inc.) were used for 
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Schistosomiasis is a chronic infection that affects over 200 million people in particular 
children in developing countries. To answer the question how infection affects the immune 
system, we conducted a longitudinal study in schoolchildren with and without Schistosoma 
haematobium infection before and after treatment with praziquantel living in an endemic 
area in Gabon. We used whole blood assays to investigate innate immune responses, by 
stimulating pattern recognition receptors, and adaptive immune responses, by stimulating 
with schistosomal antigens. We also characterized the CD4+ T cell memory compartment 
and assessed the frequency of CD4+CD25+FOXP3+ T cells. After removal of S. haematobium 
infection by praziquantel, the most prominent effect was seen on parasite antigen-specific 
cytokine responses. An increase was seen in schistosome-specific antigen responses following 
treatment, which was inversely associated with a decrease in CD4+CD25+FOXP3+ T cells. These 
results for the first time provide evidence for the association between schistosome infection, 
regulatory T cells and antigen specific immune hypo-responsiveness in humans. 
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Abstract
Background: Schistosoma haematobium infection results in alterations in immune function, 
yet the concurrent interplay between the various arms of the immune system and the effect 
of parasite removal following anthelmintic treatment has not been studied extensively. We 
conducted a longitudinal study to investigate the effect of S. haematobium infection and its 
clearance on innate and adaptive immune responses, on CD4+ T cell memory compartment and 
on CD4+CD25+FOXP3+ T cells.
Methods: Cytokine responses of Gabonese schoolchildren infected with S. haematobium 
(n=40) were studied in whole blood at pre- and 7 months post-praziquantel (PZQ) treatment; 
responses of uninfected children (n=39) were studied at the two time points as controls. To assess 
adaptive immune responses, the production of interferon gamma (IFN-γ), interleukin-2 (IL-2), 
IL-5, IL-10 and tumor necrosis factor (TNF) was measured after stimulation with schistosome 
soluble egg and adult worm antigens and the mitogen PHA. Innate immune responses were 
assessed by the production of IL-10, IL-1β, IL-1ra and TNF following culture with Pam3, mannan 
and curdlan, alone or in combination. Cytokines in supernatants were quantified by Luminex. 
Flow cytometry was used to characterize the memory T cell compartment and to assess 
CD4+CD25+FOXP3+ T cell frequencies.
Results: Schistosome-specific responses increased in S. haematobium-infected schoolchildren 
following treatment with PZQ, but the effect of removal of infection on innate immune responses 
was marginal. Furthermore PZQ treatment resulted in increased effector memory T cells (TEM) 
in infected schoolchildren. CD4+CD25+FOXP3+ T cell frequencies, which were higher in infected 
children, decreased following anti-schistosome treatment. In S. haematobium-infected children 
there was a significant negative association between the decrease in CD4+CD25+FOXP3+ T cell 
frequencies and the increase in schistosome-specific IL-5 and IL-10 cytokine levels observed 
upon treatment.
Conclusions: This study supports the notion that schistosome infections in humans can lead to 






Schistosomiasis, caused by the parasitic trematodes of the genus Schistosoma, affects over 200 
million people worldwide, especially children [1]. Chronic infections with schistosomes are 
associated with immune hypo-responsiveness characterized by reduced in vitro proliferation 
of T lymphocytes and decreased Th1- and Th2-type cytokine production in response to not 
only schistosomal antigens [2] but also to third party antigens such as Mycobacterium 
tuberculosis purified protein derivative (Mtb PPD) [3] and the influenza vaccine [4]. Treatment 
with antischistosomal drug praziquantel leads to clearance of infection [5] and elevated 
antigen-specific proliferation [6] and cytokine production [7,8]. The mechanisms of T cell hypo-
responsiveness during chronic schistosomiasis are not well understood, but a number of recent 
reports have shown that in addition to impaired dendritic cell activity during schistosome 
infection [9], regulatory T cells [10] and regulatory B cells [11] are expanded in schistosome-
infected compared to uninfected individuals. However, few studies have examined the effect 
that parasite elimination by chemotherapy has on CD4+CD25+FOXP3+ T cells and how this is 
linked to effector T cell responses.
Moreover there are very few studies on innate immune responses in the context of human 
schistosomiasis. Responses to and expression levels of the Toll-like receptors (TLRs) have been 
shown to be altered in Schistosoma haematobium-infected individuals. For example, myeloid 
dendritic cells (mDCs) from infected individuals had reduced capacity to respond to TLR ligands 
[9], PBMCs from infected children produced higher levels of TNF in response to TLRs [12], but 
TLR2 expression was significantly reduced in children infected with schistosomes compared to 
uninfected age-matched individuals [13]. Another class of pattern recognition receptors (PRRs), 
the C-type lectins (CLRs) which includes DC-SIGN and mannose receptor (MR), has also been 
shown to be important in the recognition of schistosomal ligands [14]. It has been proposed 
that innate immune responses could be fine-tuned via interaction between distinct PRRs 
[15,16]. For example schistosomal glycolipids activate DCs to produce inflammatory cytokines 
through the cooperation of TLR4 and DC-SIGN [17]. However, altogether, little is known about 
innate immune responses in humans during the course of schistosome infection and the data 
available come from studies that were cross-sectional in design.
To our knowledge there are no reports that have examined, within one study, the effect of 
schistosome infection on different components of the immune system. Here we have conducted 
a longitudinal study where both adaptive and innate immune responses were examined in S. 
haematobium-infected individuals before and after treatment with praziquantel. To this end, 
we have analyzed cytokine responses to schistosomal antigens as well as to stimuli that trigger 
PRRs. In order to assess how schistosome infection affects the different components of the 
adaptive immune system, we have characterized the CD4+ T cell memory compartment and 
have determined the frequency of CD4+CD25+FOXP3+ T cells during infection and after removal 
of schistosomes by chemotherapy.
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Figure 1: Cytokine production in response to schistosomal antigens in whole blood cultures at 
baseline and 7 months follow-up. 
Whole blood from S. haematobium infected schoolchildren and uninfected controls was stimulated with 
schistosomal egg antigen (SEA) and adult worm antigen (AWA). After 72 hours of culture levels of Th1 (A), 
Th2 (B), regulatory (C), pro-inflammatory (D) and IL-2 (E) cytokines were measured by Luminex. The follow-
up samples were obtained at 7 months post-treatment with praziquantel of children that were infected 
with S. haematobium at pre-treatment. The uninfected controls were also examined at the same follow-up 
period but did not receive praziquantel. 
Results
Study population characteristics
We recruited S. haematobium-infected (N = 40) and -uninfected (N = 39) schoolchildren; Table 
1 shows the demographic, parasitological and hematological characteristics of the two study 
groups. There were no significant differences between these two groups in the prevalence 
of P. falciparum, A. lumbricoides, T. trichiura and hookworm or in hematological parameters at 
baseline. Similarly, the number of females and males was comparable but infected children 
were approximately one year older. Schistosome infection parameters as assessed by egg 
counts, plasma CAA, hematuria and RSI score are given in Table 2; and as expected all were 
significantly correlated with each other (p < 0.001). Praziquantel treatment significantly reduced 
all infection parameters in the infected schoolchildren (p < 0.001; Table 2).
Cytokine responses to schistosomal antigens and mitogen 
Age-adjusted mean cytokine levels following whole blood stimulation with SEA and AWA 
before and 7 months after praziquantel treatment are shown in Figure 1 and Table 3. At baseline, 
S. haematobium infected schoolchildren responded to SEA and AWA, by producing IFN-γ,IL-2, 
IL-5, IL-10 and TNF while uninfected controls did not (Figure 1). There were no differences in 
response to PHA between infected and uninfected controls. Following removal of worms 
by treatment, cytokine responses were enhanced. Specifically, IL-5, IL-10 and IL-2 levels in 
response to SEA and IL-5, IL-10 and TNF levels in response to AWA were significantly increased 
in S. haematobium-infected children (Figure 1 and Table 3), as was IL-10 in response to PHA 
(p=0.001). No differences were observed in the uninfected control children between baseline 
and 7 month follow-up time point. In addition, no differences were seen in spontaneous 
cytokine production (in unstimulated cultures) between infected and uninfected children or 
between pre- and post-treatment responses (Supplementary figure 1B). 
Cytokine responses to TLR and CLR ligands
There were no differences in cytokine responses to Pam3 (TLR1/2 ligand) between S. 
haematobium-infected schoolchildren and uninfected controls at baseline (Figure 2). Over the 
7 month study period, the levels of IL-1β and IL-10 decreased significantly in all study subjects, 
which might reflect the decrease that was seen in P. falciparum infection and/or infection 
load in both S. haematobium infected (baseline 18/40 infected vs. follow-up 10/38 infected; 
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over time. However, TNF response to Pam3 decreased significantly, after treatment of S. 
haematobium infected subjects, a response that was different from that observed in uninfected 
controls, indicating that removal of S. haematobium infection is associated with decrease in 
TNF production in response to Pam3. Responses to mannan (DC-SIGN/MR ligand) and curdlan 
(Dectin-1 ligand) alone were largely not detectable (data not shown). However when combined 
with Pam3, significant synergy for pro-inflammatory responses (TNF and IL-1β) was observed. 
For anti-inflammatory/regulatory responses (IL-10 and IL-1ra) combined stimulation of Pam3 
with mannan led to synergistic increase but with curdlan resulted in inhibition (Supplementary 
table 1). There were no significant differences between S.haematobium-infected and uninfected 
schoolchildren in these interactions. No differences in unstimulated responses were observed 

































































Figure 2: Cytokine production in response to TLR2/1 stimulation in whole blood cultures at baseline 
and 7 months follow-up. 
Whole blood from S. haematobium infected schoolchildren and uninfected controls was stimulated 
with Pam3 (TLR2/1). After 24 hours of culture TNF (A), IL-1β (B), IL-10 (C) and IL-1RA (D) were measured 
by Luminex. Differences between groups were tested with GLM Univariate analysis adjusted for age and 
within groups with a paired samples T test. Results are shown as age-adjusted geometric means. * p< 0.05, 




Figure 3: Memory T cell analysis at baseline and 7 months follow-up. 
CD4+ T cells were identified and Boolean gating combinations were used to determine proportions of T cell 
subsets based on CD45RA and CD27 expression (A). Proportion of CD4+-gated cells that were CD45RA- (B, 
memory), CD45RA+ (C, naïve), CD45RA-CD27+ (D, TCM early), CD45RA
-CD27- (E, TEM) and CD45RA
+CD27- (F, 
TEMRA) were determined for S. haematobium-infected and uninfected controls at baseline and follow-up. 
(B-F) Differences between groups were tested with GLM Univariate analysis adjusted for age and within 
groups with a paired samples T test. Results are shown as unadjusted values. Horizontal bars represent 
median. * p< 0.05, ** p< 0.01, *** p< 0.001.
T cell memory subpopulation analysis
To investigate the effect of schistosome infection on the frequencies of circulating memory 
T cell subsets we compared peripheral T cells from infected and uninfected children by flow 
cytometry (Figure 3A). There were no significant differences in total CD4+ T cell levels between 
schistosome-infected and –uninfected children (34.9% and 37.6% respectively; p=0.508). 
Naïve and total memory T cells were defined using CD45RA expression. The proportion of 
memory T cells was significantly higher in infected children at baseline and remained elevated 
at follow-up; no differences were observed between pre- and post-treatment levels (Figure 
3B). Concomitantly levels of naïve T cells were significantly lower in infected children (Figure 
3C). Additional staining with CD27 distinguished between central and effector memory T cells 
resulting in three distinct populations: central memory (TCM) (CD45RA
-CD27+), effector memory 
(TEM) (CD45RA
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[21]. While no differences in the proportion of various subsets were seen at baseline (Figure 3D-
F), there was a significant increase in the frequency of effector memory cells (Figure 3E) in the 
infected children following treatment but not in the uninfected controls. 
CD4+CD25+FOXP3+ T cells analysis
We next assessed frequencies of circulating CD4+CD25+FOXP3+ T cells in a subset of infected 
and uninfected children, at pre- and 7 months post-treatment and also included samples that 
were available at an additional time point of 6 weeks post-treatment. The subset of children 
included in this analysis was representative of the whole study population, as no differences 
Figure 4: CD4+CD25+FOXP3+ T cell analysis at baseline and 6 weeks and 7 months follow-up. 
CD4+CD25+FoxP3+ T cells were identified and enumerated with flow cytometry with initial gating steps 
performed like in Figure 3 (A) and frequencies determined for S. haematobium-infected children and 
uninfected controls at baseline and at follow-up (B). Differences between groups were tested with GLM 
Univariate analysis adjusted for age and within groups with a paired samples T test. Results are shown as 
unadjusted values. Horizontal bars represent median. * p< 0.05, ** p< 0.01, *** p< 0.001.
were found in the characteristics of this subset and the whole population. By analyzing the 
expression of CD4, CD25 and FOXP3 by flow cytometry (Figure 4A) we showed that the 
proportion of CD4+CD25+FOXP3+ T cells was significantly higher in infected children at baseline 
and these frequencies were significantly reduced to levels comparable to the uninfected 
control group following treatment (Figure 4B). The decrease in CD4+CD25+FOXP3+ T cell levels 































Association between CD4+CD25+FOXP3+ T cells and cytokine levels in response 
to schistosomal products
As the decrease in CD4+CD25+FOXP3+ T cell levels over time mirrored the increase in cytokine 
responses to schistosomal antigens in infected children, we further explored this longitudinal 
association by using linear mixed-effects models (Table 4). We assessed the relationship between 
CD4+CD25+FOXP3+ T cell levels and cytokine response and found that CD4+CD25+FOXP3+ T cell 
levels were significantly and negatively associated with IL-5 and IL-10 levels in response to both 
SEA and AWA.
Table 4: Association between CD4+CD25+FOXP3+ T cells and cytokine levels in response to 
schistosomal antigens.
S. haematobium infected children
Cytokine Stimulus Estimate β (95% CI) p value 
IFN-γ SEA  -0.60 (-1.61 - 0.42) 0.227
AWA  -0.11 (-0.77 - 0.56) 0.737
IL-5 SEA  -1.04 (-1.91 - -0.18) 0.024
AWA  -1.15 (-1.69 - -0.62) 0.001
IL-10 SEA  -1.08 (-1.76 - -0.41) 0.005
AWA  -0.60 (-1.02 - -0.18)  0.010
TNF SEA  -0.37 (-0.96 - 0.22) 0.188
AWA  -0.64 (-1.43 - 0.15) 0.102
IL-2 SEA  -0.30 (-1.04 - 0.44) 0.378
 AWA  -0.47 (-0.94 - 0.00)  0.050
IFN, interferon; IL, interleukin; TNF, tumor necrosis factor; SEA, schistosomal egg antigen; AWA, adult 
worm antigen. Parameter estimates are from linear mixed-effects models assessing associations of level 
of CD4+CD25+FOXP3+ T cells and each cytokine/stimulus combination within groups indicated by the 
subheadings. 
Discussion
This is the first study to concurrently examine both innate and adaptive cellular immune 
responses, T cell memory and levels of CD4+CD25+FOXP3+ T cells in schoolchildren infected with 
S. haematobium and to assess the effects of treatment with praziquantel on these responses. 
Using this approach we show that whereas antigen specific responses are suppressed during 
infection, this does not extend to innate immune responses. Importantly, we provide evidence 
that the reduction in CD4+CD25+FOXP3+ T cells upon treatment is correlated with increase in 
effector T cells and antigen specific cytokine production.
In the current study whole blood innate pro-inflammatory (TNF and IL-1β) or anti-
inflammatory/regulatory (IL-10 and IL-1ra) cytokine responses in response to TLR stimulation 
were not affected by current S. haematobium infection. This is in contrast to our own previous 
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studies which showed evidence of altered cytokine response upon TLR activation [9,12,22] 
and may be due to differences between using whole blood, which contain granulocytes in the 
current study and isolated PBMCs or cell subsets in our other studies. We also observed that 
IL-1β and IL-10 in response to Pam3 were lower at the 7 months follow-up time point after 
treatment in all subjects. This might have resulted from the change in P. falciparum infection 
and/or load which decreased in both the infected and uninfected groups over time and 
demonstrates why inclusion of appropriate controls, i.e. uninfected controls which are similarly 
followed over time is important. A prominent decrease in the levels of TNF was observed in 
the infected group treated with praziquantel; this is in line with the findings that show TNF to 
be associated with schistosome infection [23,24]. The function of DC-SIGN/MR and Dectin-1 
which do not generally induce cytokine responses on their own can be studied by looking at 
their ability to enhance TLR responses. We did not find any differences between infected and 
uninfected schoolchildren or between pre- and post-treatment responses in the combined TLR 
and CLR stimulations.
For adaptive responses anti-schistosome treatment over a 7 month period resulted in 
enhanced responses to both SEA and AWA. Enhanced cytokine responses at 6-7 weeks post-
treatment have been seen in a number of studies before [6–8,25]. Recently, a study examining 
immune responses at 1- and 2-yr after treatment of Kenyan schoolchildren infected with S. 
mansoni, observed an increase in Th2 responses (IL-4, IL-5, IL-9 and IL-13) to both SEA and 
AWA, however pro-inflammatory responses (IL-1β, TNF, CCL5 and IL-6) were either decreased 
in response to SEA or unchanged in response to AWA following treatment [26]. It is interesting 
to speculate that the decrease in IL-1β, TNF, CCL5 and IL-6 in the Kenyan cohort may represent 
an innate component of the immune response and may be in line with our own results where 
a decrease in TNF was observed following treatment. However, it should be noted that the 
children recruited in the Kenyan study all presented with hepatomegaly and exhibited 
predominant pro-inflammatory responses at pre-treatment whereas children in our study 
were free of pathology as assessed by ultrasonography of the bladder (unpublished data). Our 
current study indicates that the removal of parasites over a longer period of time in children 
without pathology is associated with sustained enhancement of antigen-specific responses, in 
agreement with the short-term treatment studies and with the increase in Th2 responses seen 
in the long-term treatment in the Kenyan study. 
Down-regulation of immune responses has been ascribed to a strong immunomodulatory 
network induced by schistosomes [27]. In this study we show that S. haematobium infection 
is associated with increased frequency of CD4+CD25+FOXP3+ T cells and as seen previously 
for CD4+CD25hi Tregs in S. mansoni infected adults [10] CD4+CD25+FOXP3+ T cell numbers 
decrease after removal of infection. Importantly, the decrease in the level of CD4+CD25+FOXP3+ 
T cells over time following treatment was inversely associated with an increase in IL-5 and 
IL-10 cytokine production. The source of IL-10 measured here is not clear as cells other than 
CD4+CD25+FOXP3+ T cells are also known to produce IL-10. Moreover this may reflect a general 
increase of responsiveness leading to more cytokines and possible expansion of schistosome-
specific T cell responses as suggested by the increase in effector memory T cells. Future 




their suppressive function. In addition, CD4+ T cell intrinsic regulation via increased expression 
of surface inhibitory receptors such as CD200R [28] or increased expression of the E3 ubiquitin 
ligase GRAIL (gene related to anergy in lymphocytes) [29] may also play a role in observed 
hypo-responsiveness and likewise warrants further investigation. 
When evaluating total memory T cells, we found higher proportions of memory T cells 
in infected children suggesting that exposure to parasite antigens drives the expansion of 
the memory T cell pool. This is in contrast to a recent study from Zimbabwe which showed 
a decrease in CD4+ memory T cells, although this difference was only observed in individuals 
older than 13 years of age [30]. We specifically observed an increase in the effector memory T 
(TEM) cells in the infected children following treatment which mirrored the increase in adaptive 
cytokine production suggesting that hypo-responsiveness may also in part be linked to the 
memory T cell pool. Whether this hypo-responsiveness is due to decreased cell numbers kept 
under control by regulatory responses or cell quiescence and/or exhaustion of effector cells, 
remains to be investigated. In this regard, a recent interesting study of the memory T cell pool 
in chronic hepatitis infection before and after treatment has shown that inhibitory molecules, 
PD-1 and CD244, on memory T cells were down-regulated following treatment while effector 
molecules perforin, granzyme B and IFN-γ were up-regulated resulting in enhanced recovery 
of memory T cells [31]. Future studies should investigate the phenotype of memory T cells in 
more depth to further understand how the phenotypic profiles affect the functional capacities 
of the CD4+ T cells.
In summary, this study shows that infection with S. haematobium is associated with 
antigen-specific hypo-responsiveness, alterations of the T cell memory pool and increased 
levels of CD4+CD25+FOXP3+ T cells and that praziquantel treatment leads to increased effector 
T cell frequencies and decreased levels of CD4+CD25+FOXP3+ T cells which was associated with 
increased antigen-specific cytokine production. 
Materials and methods
Ethics statement
The study was approved by the “Comité d’Ethique Régional Indépendent de Lambaréné” 
(CERIL; N°06/08). Written informed consent was obtained from parents or legal guardians of all 
schoolchildren participating in the study.
Study population and parasitology
Between November 2008 and February 2009, 100 schoolchildren were invited to participate in a 
longitudinal study to investigate the effect of S. haematobium infection on innate and adaptive 
immune responses. Children were recruited from a rural area surrounding Lambaréné (Gabon) 
where S. haematobium infection is endemic as previously described [12]. To be included in 
the study, participants had to meet the following criteria: (1) attendance at the local school; 
(2) no praziquantel treatment in the previous year; (3) no fever (body temperature < 37.5ºC) 
and (4) no other symptoms of acute illness. Seventy-nine schoolchildren returned for follow-
up performed 7 months later between June and September 2009. There were no significant 
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differences between the schoolchildren that returned for follow-up and those that did not.
S. haematobium infection was determined prior to blood collection by examining a filtrate 
of 10 mL of urine passed through a 12-µm-poresize filter (Millipore). Children were classified 
S. haematobium-infected if at least one S. haematobium egg was detected in the urine, 
or uninfected if three consecutive urine samples were negative. Infections with intestinal 
helminths Ascaris lumbricoides, Trichuris trichiura and hookworm were determined by analyzing 
one fresh stool sample using the Kato-Katz method [18]. Infection with Plasmodium falciparum 
was determined by PCR [19] with a cut-off value of 35 Ct. After collection of blood samples, 
all S. haematobium-infected children were treated with a single dose of praziquantel (40 mg/
kg) three times every two months. Intestinal helminth- and malaria-infected children received 
respectively a single dose of albendazole (400 mg) or an artemisinin-based combination 
therapy as per the local guidelines. 
Hematological parameters were analyzed using ADVIA 120 Hematology System (Bayer 
Health Care) and erythrocyte sedimentation rate was determined manually.
Circulating anodic antigen (CAA) testing of plasma samples was performed using the 
upconverting phosphor (UCP) technology lateral flow assay as previously described [20]. 
Reagent strips (Cobas) were used to assess hematuria, leukocyturia and proteinuria. 
Individual scores for each of these parameters, ranging from 0 to 3, were added together for 
calculation of the combined reagent strip index (RSI).
Whole blood culture
Five hours following venipuncture, heparinized blood was diluted 2 times with RPMI 1640 
(Invitrogen) supplemented with 100 U/mL penicillin (Astellas), 10 µg/mL streptomycin, 1 mM 
pyruvate and 2 mM L-glutamine (all from Sigma-Aldrich). To assess adaptive responses whole 
blood was incubated for 72 hours with S. haematobium soluble egg antigen (SEA) or adult worm 
antigen (AWA) (both 10 µg/mL) or 2 µg/mL PHA (Remel). To assess innate responses whole 
blood was incubated for 24 hours with 100 ng/mL Pam3CSK-SKKKK (EMC Microcollection), 
100 µg/mL mannan (Sigma-Aldrich) or 100 µg/mL curdlan (prepared in 15mM NaOH; Wako 
Chemicals) alone or in combination. Medium without stimulus was used as a negative control. 
100 µL of ligand(s) in medium was added to wells containing 100 µL of diluted blood in 96-well 
round bottom plates (Nunc) and incubated at 37°C in the presence of 5% CO2. Supernatants 
were stored at -80°C. 
Cytokine analysis
Supernatants were analyzed simultaneously for IFN-γ, IL-2, IL-5, IL-10 and TNF or IL-10, IL-1β, IL-
1ra and TNF using customized Luminex cytokine kits (Invitrogen) according to manufacturers’ 
recommendations. Samples were acquired with Luminex-100 cytometer (Luminex Corporation). 
Samples with concentrations below the detection limit were assigned values corresponding to 
half of the lowest value detected. For the IFN-γ, IL-2, IL-5, IL-10 and TNF multiplex assay the 
lowest values detected were 0.090 pg/mL for IFN-γ, 0.063 pg/mL for IL-2, 0.044 pg/mL for IL-5, 
0.063 pg/mL for IL-10, and 0.051 pg/mL for TNF. For the IL-10, IL-1β, IL-1ra and TNF multiplex 




mL for IL-1RA and 0.016 pg/m for TNF. 
Characterization of memory and CD4+CD25+FOXP3+ T cells in peripheral blood
For immunophenotyping memory T cells freshly isolated PBMCs were fixed in 2.4% 
formaldehyde solution (Sigma-Aldrich) for 15 minutes at room temperature and, subsequently, 
frozen in RPMI 1640 medium supplemented with 20% fetal bovine serum (Greiner Bio-One) 
and 10% dimethyl sulfoxide (Merck) and stored at −80°C until flow cytometric analysis. 
After thawing, cells were washed and stained for 30 minutes with anti-CD4-PE-Cy7 (RPA-T4; 
eBioscience), anti-CD45RA-Horizon V450 (HI100; BD Biosciences) and anti-CD27-FITC (L128; BD 
Biosciences). To assess levels of CD4+CD25+FOXP3+ T cells, ex-vivo PBMC were fixed with the 
FOXP3 fixation/permeabilization kit (eBisocience) and stored as described above. After thawing 
cells were stained with CD4-PE-Cy7 (SK3; BD Biosciences), CD25-PE (2A3; BD Biosciences) and 
FOXP3-APC (PCH101; eBioscience). Cells were acquired on FACSCanto II flow cytometer (BD 
Biosciences) and analyzed in FlowJo software v9 (Tree Star Inc.); Boolean gates were used for 
memory T cell analysis.
Statistical analysis
Data were analyzed using IBM SPSS Statistics 20.
Differences between the study groups for gender, malaria and intestinal helminth infections 
were tested using Fisher’s exact test. Differences in malaria prevalence pre- to post-treatment 
were tested with the McNemar’s test. Age, erythrocyte sedimentation rate (ESR) and hemogram 
parameters were normally distributed and differences between study groups were tested 
using the independent student’s T test. Infection indices, including schistosome egg counts, 
plasma CAA levels, hematuria and RSI scores and T cell subset differences were compared 
with the Mann-Whitney U test. Within group differences between baseline and follow-up were 
compared with the Wilcoxon matched pairs test. Correlations between infection indices were 
analyzed by Spearman’s rank correlation.
Cytokine concentrations in response to stimulation were corrected for spontaneous 
cytokine production by subtracting responses of unstimulated medium wells to obtain net 
cytokine responses, with negatives values set to half of the lowest value detected per given 
cytokine. Net cytokine responses were normalized by log(base 10)-transformation after adding 
1 pg/mL.
Interaction ratio between combined TLR and CLR stimulation was calculated by dividing 
net cytokine response to PAM3 in combination with mannan or curdlan by the sum of net 
cytokine responses obtained with each ligand alone i.e. [PAM3 + mannan]/([PAM3] + [mannan]) 
or [PAM3 + curdlan]/([PAM3] + [curdlan]). The interaction ratio could result in a synergistic or 
inhibitory effect. A paired samples T test was used to test whether the resulting interaction was 
significant by comparing combined stimulation with the sum of cytokines produced in two 
separate stimulations. 
Univariate GLM analysis adjusted for age was used to compare between infection groups 
and the resulting adjusted means were anti-log-transformed for graphing purposes. Differences 
within the same group between baseline and follow-up were compared by paired samples T 
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test. 
Linear mixed-effects model was used to assess the longitudinal association between 
CD4+CD25+FOXP3+ T cell levels and cytokine responses to schistosomal products with cytokine 
levels as the dependent variable; participant ID as a random effect; infection group as a fixed 
effect; and CD4+CD25+FOXP3+ T cell level as the covariate. The variance–covariance structure 
“Toeplitz” was used.
For all tests, statistical significance was considered at the 5% level. To adjust for multiple 
comparisons, where applicable, Bonferroni-Holm correction was taken into account. 
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Supplementary Figure 1: Cytokine production in 24hr and 72hr unstimulated whole blood cultures 
at baseline and 7 months follow-up. 
Cytokine levels were measured in 24hr unstimulated cultures (A) by Luminex (IL-5, IFN-γ, IL-2, IL-10 and 
TNF). Cytokine levels were measured in 72hr unstimulated cultures (B) by Luminex (TNF, IL-1β, IL-10 and 
IL-1ra). Differences between groups were tested with GLM Univariate analysis adjusted for age and within 
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Human schistosomiasis, one of the most common parasitic infections worldwide, survives 
within its immunocompetent host for several years. This is thought to be due to its 
ability to down-regulate host immune responses. In this study we examined the effect of 
CD4+CD25hiFOXP3+ regulatory T cells (Tregs) on cell proliferation and cytokine production 
in response to schistosome egg (SEA) and adult worm (AWA) antigens and to the vaccine-
antigen Bacillus Calmette–Guérin (BCG). These responses were studied in peripheral blood 
mononuclear cells (PBMC) of children infected with Schistosoma haematobium before and 6 
weeks after anthelmintic treatment with praziquantel. Schistosome infection was associated 
with increased frequencies of Treg cells, which decreased following treatment. The measured 
cytokine (IFN-γ, IL-5, IL-10, IL-13, IL-17 and TNF) data was integrated using Principal Component 
Analysis (PCA). The cytokines clustered into two principal components, with principal 
component 1 (PC1) reflecting regulatory and Th2-polarized cytokine responses and principal 
component 2 (PC2) reflecting pro-inflammatory and Th1-polarized cytokine responses. The 
reduction in Treg frequencies after treatment was accompanied by an increase in both PC1 
and PC2 following treatment compared to pre-treatment values. Proliferation, measured by 
CFSE dilution of dividing cells, showed no significant difference from pre- to post-treatment. 
To specifically assess Treg function, PBMC responses to antigens was measured after Treg 
depletion. Treg depletion resulted in increased values of both PC1 and PC2 at both pre-
treatment and also at 6 weeks post-treatment. Proliferative responses were for the most part 
only significantly affected by Treg depletion in infected individuals at pre-treatment. These 
results show that CD4+CD25+FOXP3+ T cells are higher in S. haematobium-infected subjects and 
decrease after treatment. Functionally, their suppressive activity on cytokine production does 
not change after treatment but their ability to influence proliferation weakens with treatment. 
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Introduction
The immune system has evolved several regulatory mechanisms to maintain immune 
homeostasis, prevent autoimmunity and restrain inflammation [1–3]. Many pathogens have 
developed mechanisms to manipulate the regulatory network of the host to their advantage, 
thereby generating conditions that ensure their survival for a prolonged period of time. In 
particular FOXP3+ regulatory T cells (Tregs) have been shown to play a major role in the control 
of various parasitic infections suppressing local tissue damage and pathology that would result 
from otherwise over-reactivity. However, enhanced Treg cell activity may also allow the long-
term survival of the parasite as the host is hampered from fighting the intruding pathogen 
effectively [4]. 
Schistosomiasis is a helminth infection affecting over 240 million people worldwide, 
especially children [5]. When chronic in nature it has been shown to be associated with general 
T cell hypo-responsiveness – evident from down-modulated antigen-specific Th1 and Th2 
cell responses [6,7]. This might results from mechanisms involving peripheral anergy and 
suppression triggered by regulatory cells, such as Tregs [8]. For example, in experimental murine 
models, it was observed that the presence of Tregs suppressed the development of pathology 
[9], and down-modulated adequate Th1 and Th2 responses [10,11], promoting parasite survival 
within the host [12,13]. Evidence for Treg cell activity in human helminth infections has been 
provided by the detection of T cells with a regulatory phenotype in lymphatic filariasis- [14], in 
onchocerciasis- [15,16] and in schistosomiasis patients [17]. 
The killing of the schistosome parasites using effective chemotherapy with praziquantel 
(PZQ) has previously been shown to result in elevated Ag-specific proliferation and cytokine 
production, in particular IL-4, IL-5, and IFN-γ [6,18–21]. Although, the frequency of Treg cells, 
defined phenotypically as CD4+CD25hiFOXP3+, appears to decrease substantially after treatment 
with praziquantel [17], their functional activity has not been studied before. One previous study 
established a positive correlation between Treg proportion and infection intensity only in 
children up to the age of 14, while in children > 14 years of age the opposite was the case [22]. 
Few studies have investigated the frequency and functional capacity of regulatory T cells on 
responses to helminth and vaccine antigens in infected children not only before but also after 
anthelmintic treatment. In the current longitudinal study we enumerated regulatory T cells in 
peripheral blood of S. haematobium-infected children at baseline and 6 weeks after treatment. 
We also evaluated proliferative and cytokine responses in total and Treg-depleted PBMC, both 
at pre- and post-treatment in order to determine the functional activity and capacity of Tregs in 
presence and absence of infection.
Results
Elevated levels of CD4+CD25hiFOXP3+ Treg cells in S. haematobium-infected 
schoolchildren
To investigate whether Schistosoma haematobium infection affects the frequency of peripheral 




Figure 1: Increased frequency of 
CD25hiFOXP3+ Treg cells during 
S. haematobium infection. 
CD4 T cells were identified and 
Boolean gating combinations were 
used to determine proportions 
of CD4+CD25hiFOXP3+ Treg cells. 
Differences between groups were 
tested with a Mann-Whitney U test 
and within groups with a Wilcoxon 
matched pairs test. Horizontal bars 
represent median. * p< 0.05, ** p< 
0.01.
Figure 2: Proliferative responses to schistosome specific and non-specific antigens.
CFSE-labeled PBMC pre- and 6 weeks post-treatment were left unstimulated (medium), or stimulated with 
S. haematobium adult worm antigen (AWA) and soluble egg antigen (SEA) and Bacillus Calmette–Guérin 
(BCG). After 4 days of culture cells were fixed, cryopreserved and after thawing CFSE division was analyzed 
by flow cytometry. Results are shown as median with IQR. Differences between pre-treatment and 6 weeks 
post-treatment responses were tested with a Wilcoxon matched pairs test. 









Arbitrary values indicate the relative loading of 
each cytokine response towards each principal 
component. Strong positive loadings (>0.500) 
are indicated in bold. IL, interleukin; IFN, 
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uninfected children by flow cytometry. We found that frequencies of CD4+CD25hiFOXP3+ Treg 
cells were significantly higher in infected children compared to uninfected children (Figure 1). 
Importantly, 6 weeks after praziquantel treatment Treg frequencies were significantly reduced 
to levels comparable to the uninfected control group. Treg frequencies in the uninfected group 
were also reduced over the same period although much less so.
Proliferation and cytokine production in response to schistosome-specific 
and non-specific antigens in S. haematobium-infected schoolchildren at pre-
treatment and 6 weeks post-treatment 
Next, we assessed the effect of anthelmintic treatment on cell proliferation and cytokine 
production in response to stimulation with schistosome-specific antigens SEA and AWA 
and a non-specific antigen BCG; raw cytokine values are shown in supplementary table 2. 
Proliferation was determined by calculating the division index on the basis of the dilution of 
CFSE in PBMCs. There were no significant differences in proliferation between pre-treatment 
and 6 weeks post-treatment responses (Figure 2).  Cytokine production on the other hand 
significantly changed between pre-treatment and 6 weeks post-treatment. We applied 
Principle Component Analysis (PCA) in order to provide a more global assessment of the effect 
of schistosome infection on responses to not only SEA and AWA stimulation but also to a third-
party antigen BCG. PCA converts a large dataset of variables into a set of summary variables 
called principal components which represent variables that share a high level of correlation. 
Two distinct principal components were identified: principle component 1 (PC1) which reflects 
regulatory and Th2-polarized cytokine responses due to its positive loading with IL-5, IL-10 and 
IL-13 responses; and principle component 2 (PC2) which reflects pro-inflammatory and Th1-
polarized cytokine responses due to its positive loading with IFN-γ, IL-17 and TNF (Figure 3, 
Table 1 and Table 2). We saw a significant increase in both PC1 and PC2 following treatment 
compared to baseline values (Table 3). 
Figure 3: Principal component 
analysis (PCA) of cytokine 
responses to schistosome 
specific and non-specific 
antigens.
Two distinct principal components 
were identified: principle 
component 1 (PC1) which reflects 
regulatory and Th2-polarized 
cytokine responses due to its 
positive loading with IL-5, IL-10 
and IL-13 responses; and principle 
component 2 (PC2) which reflects 
pro-inflammatory and Th1-
polarized cytokine responses due 
to its positive loading with IFN-γ, 




Depletion of Treg cells at pre-treatment resulted in enhanced spontaneous proliferation 
(medium condition) as well as in enhanced proliferation to specific schistosomal antigens AWA 
and SEA and to vaccine antigen BCG (Figure 5A).  Interestingly, at 6 weeks after anthelmintic 
treatment Treg depletion resulted in significant increase in proliferation in response to AWA 
only. A typical plot of CFSE staining showing the effect induced by depletion of Treg cells 
(Figure 5B). 
Enhanced T cell proliferation in PBMC from schistosome-infected children after 
Treg depletion
To study the suppressive effect of Treg cells on proliferation and cytokine responses, 
CD4+CD25hiFOXP3+ T cells were depleted from PBMC by magnetic beads. The CD4+CD25hiFOXP3+ 
population decreased by 60%, p < 0.0001; a representative example is shown in Figure 4. 
Table 2: Variance explained by the principal components extracted from the cytokine data.
   Initial Eigenvalues
Component Total % of variance Cumulative %
1 2.86 40.01 40.01
2 1.56 33.65 73.66
Two principal components were extracted from the data. The percentage of the data explained by 
each of the components individually and cumulatively is shown.
Table 3: Changes in cytokine production in response to antigens pre- to post-treatment.
Component Time-point Mean Rank p value
1 pre-treatment 27.04 0.004
post-treatment 41.14
2 pre-treatment 31.41 0.021
post-treatment 38.07
Figure 4: Treg depletion.
CD4+CD25hi T cells were 
depleted by magnetic bead 
separation. Representative 
examples of the depletion 
of the CD4+CD25hiFOXP3+ 
population. 
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Increased cytokine responses following Treg depletion
Next, we investigated the capacity of Tregs to suppress cytokine responses by evaluating the 
effect of CD4+CD25+FOXP3+ T cell depletion on principal component 1 (IL-5, IL-10 and IL-13) 
and principal component 2 (IFN-γ, IL-17 and TNF). We found CD4+CD25+FOXP3+ T cell depletion 
at pre-treatment resulted in increased values of both PC1 and PC2 in infected individuals, and 
similarly following treatment we also observed an increase in the values of both PC1 and PC2 in 
the now infection free schoolchildren (Table 4).  
Figure 5: Effect of Treg depletion on proliferative responses to schistosome specific and non-specific 
antigens.
CFSE-labeled total or CD4+CD25hiFOXP3+ depleted PBMC pre- and 6 weeks post-treatment were left 
unstimulated (medium), or stimulated with S. haematobium adult worm antigen (AWA) and soluble egg 
antigen (SEA) and Bacillus Calmette–Guérin (BCG). After 4 days of culture cells were fixed, cryopreserved 
and after thawing CFSE division was analyzed by flow cytometry. Results are shown as median with IQR (A). 
Differences between total and depleted PBMC were tested with a Wilcoxon matched pairs test. * p< 0.05, 
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Down-regulation of immune responses has been attributed to a strong immunomodulatory 
network induced by schistosomes and is mediated most prominently by regulatory T cells [23]. 
Here we demonstrate that CD4+CD25+FOXP3+ Treg cells are increased during S. haematobium 
infection and their numbers decrease after removal of infection with praziquantel. A much 
smaller, yet statistically significant decrease was also observed in the frequency of these cells 
in the control uninfected group. This change shows the importance of including controls 
that could indicate any technical or environmental changes that might be associated with 
longitudinal studies. 
In order to obtain a global assessment of the effect of S. haematobium infection on Th1, Th2, 
regulatory and pro-inflammatory cytokine responses we applied PCA analysis. This allowed us 
to summarize the various responses into two principal components [24]. Principle component 
1 (PC1) reflected regulatory and Th2-polarized cytokine responses due to its positive loading 
with IL-5, IL-10 and IL-13, responses commonly associated with chronic schistosome infections. 
Principle component 2 (PC2) reflected pro-inflammatory and Th1-polarized cytokine responses 
due to its positive loading with IFN-γ, IL-17 and TNF, responses more commonly associated 
with acute schistosome infection or bacterial infections such as tuberculosis. We show that S. 
haematobium infection is associated with hypo-responsiveness as demonstrated by increases 
in cytokine production represented by both PC1 and PC2. T cell division was also assessed, 
but despite the consistently higher proliferation to all stimuli tested, at post treatment, the 
change was not statistically significant. These data indicate that the increased frequency 
of CD4+CD25+FOXP3+ Tregs during schistosome infection is associated with poor cytokine 
responsiveness.
To assess the functional capacity of the regulatory T cells, a field applicable method was 
used which consists of the depletion of regulatory T cells from PBMC to assess their effect on 
cytokine production or proliferation. The data show that depletion of Tregs is associated with 
increased cytokine production, of both PC1 and PC2 which means that both Th2/regulatory 
Table 5: Changes in cytokine production in response to antigens in total and Treg depleted PBMC at 
pre- and post-treatment.
Component Time-point Total/ Treg depleted PBMCs Mean Rank p value
1 pre-tx total 32.78 0.002
depleted 42.36
post-tx total 33.58 0.002
depleted 39.38
2 pre-tx total 28.09 <0.001
depleted 43.36
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and Th1/pro-inflammatory cytokine production improves. This is the case at both pre-
treatment and post-treatment time points, although the increase appears to be stronger at pre-
treatment. Altogether, this would suggest that even though regulatory T cell numbers change 
with infection, their functional capacity to induce suppression is not affected as profoundly.
We furthermore evaluated the effect of Treg depletion on cell proliferation and in contrast 
to cytokine responses which were equally affected at pre-and post-treatment, proliferative 
responses were for the most part only significantly affected by Treg depletion in infected 
individuals at pre-treatment. These data could be explained if the ability of Treg to suppress 
proliferation would need less profound or distinct suppressive mechanisms than what is 
required for inhibiting cytokine production.  The removal of S. haematobium infection could 
then affect the Treg function partially. Tregs are thought to exert their function via a number 
of different mechanism including IL-10 and/or TGF-β production, IL-2 consumption, or cell-cell 
contact where inhibitory molecules such as CTLA-4 and PD-1 are key [25,26]. Future studies 
are needed to further delineate how Treg cells exert their suppressive role during the course 
of schistosome infection and furthermore the difference in mechanism between suppression 
of proliferation versus effector cytokine production. Additional alternative mechanism, such 
as T cell anergy due to increased expression of the E3 ubiquitin ligase GRAIL (gene related to 
anergy in lymphocytes) which has been shown in a mouse model to be linked to Th2 cell hypo-
responsiveness should also be investigate [27].
Alternatively, recently described regulatory CD8+ T cells which likewise produce IL-10, may 
also in part contribute to the differences observed [28,29]. CD25+ cell depletion will in addition 
to depleting CD4+CD25+FOXP3+ T cells also deplete the CD8+CD25+FOXP3+ T cell population 
and therefore future studies are needed to re-assess the relative contributions of these different 
subsets. Moreover studies with more extensive panels of markers associated with suppressive T 
cell functions are necessary as FOXP3 expression has been shown to be transiently up-regulated 
on activated CD4+ T cells, 
In summary, this study shows that infection with S. haematobium is associated with 
alterations of the frequency and activity of CD4+CD25hiFOXP3+ regulatory T cells and that these 
in turn affect proliferation and global cytokine responses. These data indicate that functional 
activity of regulatory T cells needs to be taken into consideration when studies consider 
coinfections, treatment or vaccine responses in areas where helminths are prevalent.
Materials and methods
Study population
Study participants were schoolchildren attending the school of PK15, approximately 15 
km south of Lambaréné in the province of Moyen-Ogouée, Gabon. The area is known to be 
endemic for Schistosoma haematobium (Table 5) (28),(33). The ethical approval for the study 
was obtained from the Comité d’ Ethique Régional Indépendant de Lambaréné (CERIL). Prior to 
inclusion of study participants, signed consent was obtained from parents or legal guardians. 
The study included 28 schoolchildren with at least one S. haematobium egg in the urine sample 
when enrolled. Exclusion criteria were (1.) anthelmintic treatment within the last 6 weeks prior 
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5 to the study, (2.) the presence of fever (tympanic body temperature > 37.5ºC) and/or (3.) others 
symptoms of acute illness. To compare the frequency of CD25hiFOXP3+ Treg cells between S. 
haematobium infected and uninfected schoolchildren an additional 17 participants were 
recruited (Supplementary table 1); 10 S. haematobium infected participants were recruited 
from PK15 and 7 uninfected participants were recruited from Lambaréné. 
Detection of S. haematobium infection
A midstream urine sample was collected between 10:00 and 14:00 hours to coincide with the 
peak of S. haematobium egg excretion in urine (34). Infection was determined by passing 10 ml 
of urine through a 12.0 µm polyamide N filter (Millipore) for the detection of S. haematobium 
eggs (14). 
Praziquantel treatment
S. haematobium infected schoolchildren were treated with a single dose of PZQ (40 mg/
kg). Three weeks later, in order to ensure clearance of parasites, the same treatment was 
administered a 2nd time. Six weeks after the first treatment efficacy of PZQ was assessed by 
measuring the egg load in urine. Donors remaining egg-positive after the 2nd treatment were 
given a third dose of PZQ and excluded from analysis, if their reduction in egg count was less 
than 90% (N=5). 
Cell isolation and depletion 
Peripheral blood mononuclear cells (PBMCs) were purified from heparinized venous blood (7-
10ml) by Ficoll-Hypaque centrifugation (Amersham Biosciences, Netherlands). Depletion of 
CD25hi T cells was performed using a suboptimal concentration of CD25 microbeads (Miltenyi 
Biotec, Bergisch Gladbach, Germany) according to the manufacturer’s instructions. 
PBMC culture for proliferation and cytokine production 
To analyse proliferation green-fluorescent dye carboxyfluorescein succinimidyl ester (CFSE; 
Sigma-Aldrich, CA, USA) was used; CFSE divides over daughter cells upon cell division and can 
be tracked by decreasing fluorescence intensity. CD25hi depleted and total PBMC were stained 
with 2 μM CFSE for 15 minutes at room temperature prior to culture. After labelling, cells were 
cultured in RPMI 1640 (Gibco, Invitrogen®, Carlsbad, CA, USA), supplemented with 10% FCS 
Table 5: Characteristics of the study population.
Pre-treatment 6 weeks post-treatment
Participants (n) 28 28
Mean age in years (SD) 10.32 (2.2) n/a
Sex (female/male) 15/13 n/a
Egg count/10 ml urine: median (IQR) 72.5 (24.5 – 296.3) 0.0 (0.0 – 1.5)
Level of haemoglobin (g/dL): mean (SD) 11.13 (0.97) 11.09 (0.94)
Level of white blood cell (x103/μl): mean (SD) 8.76 (3.18) 9.44 (2.92)
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(Greiner Bio-One GmbH, Frickenhausen, Germany), 100 U/ml penicillin (Astellas, Tokyo, Japan), 
10 μg/ml streptomycin, 1mM pyruvate and 2mM L-glutamine (all from Sigma-Aldrich, CA, USA). 
Cells were stimulated in round-bottom plates with medium, 10 µg/ml AWA, 10 µg/ml SEA or 10 
µg/ml BCG and incubated in the presence of 5% CO2 at 37.5°C. After 4 days, supernatants were 
collected and stored at -80°C, while cells were harvested, fixed with 2% formaldehyde (Sigma-
Aldrich, CA, USA) and, subsequently, frozen in RPMI 1640 medium supplemented with 20% FCS 
and 10% DMSO (Merck KGaA, Darmstadt, Germany) and stored at -80°C. 
 
Flow cytometry analysis (FACS)
After thawing, CFSE-labelled cells were incubated with CD4-PE and CD25-APC (all from BD 
Bioscience, San Diego, CA, USA), acquired on a FACSCalibur flow cytometer (BD Biosciences, 
San Diego, CA, USA ) and data were analysed in a FlowJo Proliferation application (Tree Star 
Inc., Ashland, OR, US) by calculation of the fraction of cells that had divided from the starting 
population (division index). To assess levels of CD25hiFOXP3+ Treg cells, ex-vivo PBMC were 
fixed with the FoxP3 fixation/permeabilization kit (eBisocience, San Diego, CA, USA) and frozen 
in RPMI 1640 medium supplemented with 20% FBS and 10% DMSO and stored at -80°C. For 
immunophenotyping isolated PBMCs were stained with CD4-PE/Cy7 (SK3; BD Biosciences, San 
Diego, CA, USA), CD25-PE (2A3; BD Biosciences, San Diego, CA, USA) and FOXP3-APC (PCH101; 
eBioscience, San Diego, CA, USA), cells were acquired on FACSCanto II flow cytometer (BD 
Biosciences, San Diego, CA, USA) and analysed in FlowJo software (Tree Star Inc., Ashland, OR, 
US) using Boolean combination gates.
Cytokines assays
Cytokines were measured from supernatants using Luminex 100 IS System (Invitrogen, 
Carlsbad, CA, USA) and commercially available beads and standards from BioSource (Bleiswijk, 
Netherlands) for interferon-gamma (IFN-γ), interleukin-5 (IL-5), IL-10, IL-13 and IL-17 and 
tumor necrosis factor (TNF). Beads were titrated for optimal dilution and used according to 
manufacturer’s instructions.
Statistical analysis
Data were analyzed using IBM SPSS Statistics 20.
Cytokine concentrations in response to stimulation were corrected for spontaneous 
cytokine production by subtracting responses of unstimulated medium wells to obtain net 
cytokine responses, with negatives values set to half of the lowest value detected per given 
cytokine.
To avoid type I and type II errors in multiple testing, immunological parameters were 
reduced by principal-components analysis (PCA). First, R v2.15.1 Development Core Team 
software (R Foundation for Statistical Computing, Vienna, Austria, 2012, http://www.R-project.
org) was used to estimate Box-Cox transformation parameter for each cytokine to increase 
normality of the data. Principal Component Analysis with Varimax rotation was used to reduce 
the data into a smaller number of uncorrelated variables. Rotation converged in 3 iterations. 




computed for each combination of conditions: stimuli AWA/SEA/BCG; total and Treg depleted 
PBMC; pre- and post-treatment. 
Differences between pre- and post-treatment and Treg depleted and total PBMC were 
tested with the Wilcoxon matched pairs test. For all tests, statistical significance was considered 
at the 5% level.
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Supplementary table 1: Characteristics of the study population for assessment of CD25hiFOXP3+ Treg 
cells. 
S.haematobium uninfected S.haematobium infected
Participants (n) 7 10
Mean age in years (SD) 12.9 (2.6) 12.5 (1.5)
Sex (female/male) 4/3 9/1
Egg count/10 ml urine: median (IQR) 0 19.5 (3.25 – 216.5)
Level of haemoglobin (g/dL): mean (SD) 10.86 (0.72) 11.4 (0.31)
Level of white blood cell (x103/μl): mean (SD) 6.33 (0.73) 8.82 (0.55)
Supplementary table 2: Raw cytokine values following antigen stimulation in total and Treg depleted 
PBMC at pre- and post-treatment. 
IL, interleukin; IFN, interferon; TNF, tumor necrosis factor; AWA, adult worm antigen; SEA, soluble egg 
antigen; BCG, Bacillus Calmette–Guérin (BCG)
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Schistosomes induce regulatory features in human 
and mouse CD1dhi B cells: inhibition of allergic 
inflammation by IL-10 and regulatory T cells.
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Chronic helminth infections, such as schistosomes, are negatively associated with allergic 
disorders. Here, using B cell IL-10-deficient mice, Schistosoma mansoni-mediated protection 
against experimental ovalbumin-induced allergic airway inflammation (AAI) was shown to be 
specifically dependent on IL-10-producing B cells. To study the organs involved, we transferred 
B cells from lungs, mesenteric lymph nodes or spleen of OVA-infected mice to recipient OVA-
sensitized mice, and showed that both lung and splenic B cells reduced AAI, but only splenic 
B cells in an IL-10-dependent manner. Although splenic B cell protection was accompanied 
by elevated levels of pulmonary FoxP3+ regulatory T cells, in vivo ablation of FoxP3+ T cells 
only moderately restored AAI, indicating an important role for the direct suppressory effect 
of regulatory B cells. Splenic marginal zone CD1d+ B cells proved to be the responsible splenic 
B cell subset as they produced high levels of IL-10 and induced FoxP3+ T cells in vitro. Indeed, 
transfer of CD1d+ MZ-depleted splenic B cells from infected mice restored AAI. Markedly, we 
found a similarly elevated population of CD1dhi B cells in peripheral blood of Schistosoma 
haematobium-infected Gabonese children compared to uninfected children and these cells 
produced elevated levels of IL-10. Importantly, the number of IL-10-producing CD1dhi B cells 
was reduced after anti-schistosome treatment. This study points out that in both mice and men 
schistosomes have the capacity to drive the development of IL-10-producing regulatory CD1dhi 
B cells and furthermore, these are instrumental in reducing experimental allergic inflammation 
in mice.
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Introduction
The prevalence and severity of allergic diseases and asthma has increased over the last five 
decades in industrialized countries [1]. Conversely, lower prevalence of allergic diseases is seen 
in low income countries. Many epidemiological studies have reported an inverse association 
between helminth infections, which are highly prevalent in developing countries, and allergic 
or auto-immune disorders [2–4]. In order to study the interaction between helminth infections 
and protection against allergic diseases, murine models of allergic airway inflammation (AAI) 
and helminth infection have been developed. For example, H. polygyrus or T.  spiralis infections 
protected against house dust mite-induced and/or ovalbumin (OVA)-specific AAI [5,6]. In 
addition, S. mansoni infection protected mice against OVA-induced airway hyperresponsiveness 
(AHR) [7]; protection was optimal during the chronic stage of infection, but not the acute stage 
[8]. 
Helminth infections are characterized by potent type 2 effector responses and a strong 
regulatory network [9]. Regulatory T (Treg) cells are well-known for their suppressive capacity, 
but recent studies in auto-immunity models have indicated that also B cells can be important 
players in immune regulation [10]. These so-called regulatory B cells are known to influence the 
immune system by the regulatory cytokines IL-10 and TGF-β, influencing T cell proliferation, 
downregulating CD4+, CD8+, NK T cell activation and promoting FoxP3+ Treg cell induction [11]. 
Interestingly, a number of studies have reported that B cells may have an active regulatory role 
in various parasitic infections. For example, IL-10-producing B cells in L. major-infected BALB/c 
mice are essential in suppressing type 1 responses that are necessary to clear infection [12] and 
S. mansoni-infected B cell-deficient μMT mice show more extensive hepatic granulomas [13]. In 
addition, in a model of systemic anaphylaxis or AAI, in combination with S. mansoni infection 
with adult stage worms only, B cells appeared to be major players in addition to IL-10 and Treg 
cells [7,14]. 
In auto-immunity models several Breg subsets have been identified, including marginal 
zone (MZ), transitional or CD5+CD1dhi B cells [15]. Recent studies in human auto-immune 
diseases have substantiated these findings by showing human Breg cells in peripheral blood 
characterized as CD24hiCD38hi [16], CD24hiCD27+ [17] or CD1dhi B cells [18]. 
Here, we investigated both in mice and humans whether schistosome infections can 
induce functional Breg cells. Indeed, we identified for the first time in peripheral blood of S. 
haematobium-infected children elevated numbers of IL-10-producing CD1dhi regulatory B cells, 
which were decreased after treatment. The functional capacity of those schistosome-induced 
Breg cells was confirmed in a mouse model of allergic airway inflammation where Breg-derived 
IL-10 and Breg-induced Treg cells mediated suppression.
Results
IL-10-producing B cells are important for protection against allergic airway 
inflammation
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starting from week 12 during infection (Fig. S1) [8]. To determine whether B cells are a dominant 
source of IL-10 and whether this IL-10 is essential for protection against AAI during chronic 
schistosome infections, IL-10-deficient B cell and control wild-type (WT) chimeric mice were 
generated and chronically infected with S. mansoni followed by an allergic OVA sensitization 
and challenge. The IL-10-deficiency was restricted to the B cells population (confirmed by 
intracellular flowcytometry) as described before [10]. In the uninfected allergic groups (OVA-
uninfected) for both WT and IL-10-/- B cell chimeric mice, the bronchoalveolar lavage (BAL) fluid 
contained significantly more eosinophils (Fig. 1A), lymphocytes and macrophages compared 
to uninfected non-allergic groups (PBS-uninfected) (data not shown). Nevertheless, in OVA-
infected WT mice significantly less eosinophils were found compared to OVA-uninfected WT 
mice (Fig. 1A), as previously described [8]. In contrast, eosinophilia in the OVA-infected group 
of the IL-10-/- B cell mice was restored and was similar to the OVA-uninfected IL-10-/- B cell group 
and significantly higher compared to the OVA-infected WT group. Interestingly, in the PBS-
infected group, eosinophilia was equally high, suggesting that IL-10-producing B cells were 
involved in controlling non-allergic inflammatory processes during natural infections as well. 
Furthermore, IL-5, IL-13 and/or IL-10 were equally elevated in the BAL fluid and mediastinal 
lymph nodes (MedLN) of OVA-infected IL-10-/- B cell mice compared to OVA-uninfected IL-10-/- B 
cell group, whereas these Th2 cytokines were reduced in OVA-infected WT mice (Fig. 1B, C). The 
IL-5 production in the BAL fluid and by T cells in the MedLN was also significantly increased in the 
OVA-infected IL-10-/- B cells mice compared to the OVA-infected WT mice as well. As expected, 
IL-4 remained at low levels due to the C57/Bl6 background of the chimeric mice (Fig. 1C). These 
results indicate that IL-10-producing B cells are critically involved in the downmodulation of 
eosinophilia and the Th2 response against OVA antigen leading to protection against AAI 
during chronic schistosomiasis. 
Pulmonary and splenic B cells produce IL-10 and protect against AAI
In order to identify the dominant organ with IL-10-producing B cells during infection, we 
isolated B cells from organs that have previously been described to harbor regulatory B cells 
(spleen), drain schistosome infection sites (mesenteric lymph nodes, MLN) or are the effector 
site where allergic inflammation is found (lung). Both pulmonary and splenic B cells, but not 
mesenteric B cells, from chronically-infected mice were able to produce IL-10 upon soluble 
egg antigen (SEA) stimulation, with highest production by splenic B cells (Fig. 2A). To study 
the suppressive activity of isolated B cells from different organs in downmodulating AAI, we 
adoptively transferred CD19+ B cells from OVA-infected mice into OVA-sensitized recipient 
mice. AAI was reduced by pulmonary or splenic but not by mesenteric B cells (Fig. 2B). 
Figure 1. Role of IL-10-producing B cells on OVA-specific AAI during chronic S. mansoni infection. 
Chimeric WT and IL-10-/- B cell mice were infected with S. mansoni and sensitized and challenged for OVA at 
week 11 and 12 after the start of infection. BAL fluid was collected and total BAL cells (A) and eosinophils 
were determined. (B) In the BAL fluid, IL-5 and IL-13 were measured by ELISA. (C) MedLN cells were collected 
and restimulated by OVA (10 μg/mL) for four days and IL-4, IL-5, IL-10, and, IL-13 production was determined 
using ELISA. Results are from two independent experiments and each group consists of 6 PBS- and 6 OVA-




Figure 2. IL-10 production by B cells from different organs during chronic schistosomiasis and their 
role in protection against AAI. 
(A) WT mice were treated as in Fig 1A. Splenic, pulmonary or mesenteric B cells (1 x 105) were isolated 
and cultured in the presence of SEA (20 µg/ml) for five days. IL-10 production was measured using 
ELISA and medium value was subtracted. (B) OVA-sensitized recipient mice received 5 x 106 B cells from 
different organs. After challenge, BAL cell numbers and eosinophils were determined (C) BAL numbers 
and eosinophilia of mice that received 250 µg isotype control or anti-IL-10R abs per mouse one day before 
the adoptive transfer. (D) The percentage of CD4+CD25+FoxP3+ Treg cells was determined in the lungs of 
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Interestingly, the protective effect of the transfer of splenic B cells, but not of pulmonary B cells, 
was abolished by administering a blocking IL-10 receptor antibody (Fig. 2C). Furthermore, we 
observed increased percentages of CD4+CD25+FoxP3+ T cells in the lungs of recipient mice, but 
only after administering splenic B cells (Fig. 2D). This data indicate that pulmonary B cells can 
drive IL-10 and Treg cell-independent protection against eosinophilic AAI, while splenic B cells 
protect via an IL-10-dependent mechanism and enhance local Treg cell numbers in the lungs.
  
Splenic B cells induce Treg cells, which support reduction of AAI 
Regulatory B cells are known to regulate inflammation by recruitment and generation of Treg 
Figure 3. Treg cell induction by IL-10-producing Breg cells. 
(A) Irradiated splenic B cells (1 x 105) were cultured with CD4+CD25- T cells (1 x 105) for 5 days in the presence 
of anti-CD3 and anti-CD28. Induction of CD4+CD25+FoxP3+ Treg cells (in %) by PBS-uninfected B cells was 
set at one. Fold change in Treg cell percentage for OVA-uninfected and OVA-infected B cells was calculated. 
Graph expresses results from three independent experiments. (B) OVA-sensitized DEREG mice were treated 
as in Fig. 2B in addition to a DT or PBS injection. This graph expresses two experiments, consisting of five 
mice per group. (C) WT and IL-10-/- B cell chimeras were treated as in Fig. 1A. The MedLNs were collected 
and the percentage of CD4+CD25+FoxP3+ Treg cells was determined. Figure contains two independent 
experiments and each group consists of 6 to 8 mice. (D) In vitro co-culture were performed as described in 
(A) in the presence of blocking anti-IL-10R or isotype control antibodies. Percentage of Treg cells induced in 
the presence of isotype control was arbitrarily set at 1. Fold change in Treg cell induction in the presence of 



























































































antigen-induced arthritis model utilizing similar chimeric mice, where loss of IL-10-producing 
B cells led to significant reduction of Treg cells in draining inguinal LN[22]. In OVA-infected WT 
mice, we found more CD4+CD25+FoxP3+ Treg cells in the lung-draining MedLN compared to 
OVA-uninfected mice, which was not found in OVA-infected IL-10-/- B cell mice (Fig. 3C). Using 
the same in vitro co-culture as describe above, significantly less Treg cell induction by splenic B 
cells was found when anti-IL-10R antibodies were added compared to isotype control (Fig. 3D), 
underlining the role of IL-10 for Treg cell induction both in vivo and in vitro.
cells in auto-immune disorders [10]. Therefore, we cultured irradiated splenic B cells from 
OVA-uninfected or OVA-infected mice with CD4+CD25- T cells from naive mice to evaluate 
Treg cell development. Splenic B cells from OVA-infected mice doubled the percentage of 
CD4+CD25+FoxP3+Treg cells (Fig. 3A), while pulmonary B cells did not change the level of Treg 
cells, as already confirmed in vivo. In addition, no shift towards Th1 or Th2 cytokines was found 
during the co-culture showing that the splenic B cells primarily influenced the development of 
Treg cells but not of other T cell subsets (data not shown).  
Next, we studied the contribution of B cell-induced Treg cells in protection against AAI in 
vivo using OVA-sensitized FoxP3-DTR transgenic DEREG mice[19]. The temporal loss of FoxP3+ 
Treg cells during allergen challenge only partly restored AAI, showing that in the group with 
transferred B cells from OVA-infected mice, B cell-induced Treg cells are only partially involved 
in protection against AAI (Fig. 3B).  
A causal relationship between IL-10-producing B cells and Treg cells has been suggested in 
Figure 4. MZ B cells show regulatory features. 
(A) MZ and FO B cells from PBS-uninfected and PBS-infected were sorted using flow cytometry and cultured 
for 5 days in the presence of SEA for IL-10 production as in Fig. 2A. (B) Irradiated MZ B cells or FO B cells (1 
x 105) were co-cultured with CD4+CD25- T cells as described in Fig. 3A. Treg cell induction by MZ or FO B 
cells from uninfected mice was set at one. Subsequently, fold change in Treg cell induction by MZ or FO B 
cells from OVA-uninfected and OVA-infected mice was calculated. Each graph contains three independent 
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Schistosome-induced MZ B cells exhibit regulatory activities
We compared the two main splenic B cell subsets, the follicular (FO) B cells and the MZ B cells 
(which are high in CD1d, Fig. S2) for their ability to produce IL-10 during chronic infection. Sorted 
subsets from uninfected and infected mice were cultured in the presence of SEA, showing that 
the MZ B cells from infected mice produced high IL-10 levels, while FO B cells produced only 
low levels (Fig. 4A). Production of IL-12 and IL-1β remained low in both subsets of infected 
mice, while production of TNF-α and IL-6 was increased in FO cells, but remained low in MZ B 
cells from infected mice (Fig. S3). Based on our findings regarding Treg cell induction by total 
splenic B cells, we questioned whether MZ B cells, as the strongest IL-10 producers, were also 
responsible for Treg cell induction in vitro. Therefore, irradiated FO and MZ B cells were cultured 
with CD4+CD25- T cells and the highest percentage of FoxP3+ T cells was observed in co-culture 
with MZ B cells (Fig. 4B), which was not explained by differences in proliferation as similar cell 
counts were found in cultures with either FO or MZ B cells (data not shown). These data indicate 
that MZ B cells are responsible for the regulatory features observed in total splenic B cells by 
Figure 5. MZ B cells are important in the protection against AAI.
(A) Mock-depleted splenic and the MZ-depleted B cells were injected in OVA-sensitized recipient mice. 
After challenge, total BAL cell count and the number of BAL eosinophils (B) and the percentage of 
CD4+CD25+FoxP3+ T cells in the lungs (C) was measured. Figure is representative of two independent 
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producing IL-10 and by enhancement of FoxP3+ T cells. 
Next, the contribution of the MZ B cells in vivo was investigated by depletion of the CD21hi 
cells from total splenic B cells of OVA-uninfected or OVA-infected mice by indirect magnetic 
labeling (Fig. 5A). The transfer of mock-treated B cells from OVA-infected mice resulted in a 
decrease in total BAL cell count and eosinophilia (Fig. 5B), as observed before. Importantly, the 
transfer of CD21+-depleted B cells restored the severity of AAI and the induction of pulmonary 
FoxP3+ Treg cells was lost (Fig. 5C), confirming the significance of MZ B cells in protection 
against AAI in vivo. 
Elevated levels of IL-10-producing CD1dhi B cells in S. haematobium-infected 
Gabonese children
All data regarding schistosome-induced Breg cells stems from mouse models. Therefore, we 
asked whether in humans schistosomes can also induce IL-10-producing regulatory B cells. 
PBMC were collected from 20 Gabonese children that were either S. haematobium positive 
or negative (Table 1). All samples were simultaneously analyzed for different Breg markers, 
including CD24hiCD38hi, CD24hiCD27+ or CD1dhi(CD5+) (Fig. 6A). No differences were found 
between infected or uninfected donors for CD24hiCD38hi or CD24hiCD27+ B cells (Fig. S4). 
However, significantly higher percentage of CD1dhi B cells was found in infected children 
compared to uninfected children (Fig. 6B). There was also a trend for more CD1dhiCD5+ B cells 
in infected children, however, the total numbers were so low (< 1 %) that the reliability of this 
measurement can be questioned. Importantly, after six months of treatment with praziquantel, 
CD1dhi percentages were reduced to levels comparable to the uninfected control group (Fig. 
6B). Of note, CD1dhi levels in the uninfected control group were significantly increased over 
the same period, which may reflect seasonal changes. Alternatively, 6 out of 8 donors from the 
uninfected group had an increased population of plasmablasts (CD19+CD24loCD38hi cells; Fig. 
S5), suggesting a recent, unrelated infection in Lambaréné, but not in the nearby village (~15 
Table 1. Demographic characteristics and infection status of Gabonese children.
S.h. infected S.h. uninfected
Participants pre-tx/post-tx       10/7       10/8
Mean age in years (range) 10.3 (8-14)  11.2 (8-14)
Sex male/female        5/5        4/6
Mean egg counts (range) 31.7 (1-201)         0
Co-infections:
   Plasmodium falciparum        4/10        1/10
   Ascaris lumbricoides        3/9        3/8
   Trichuris trichiura        3/9        6/8
   Hookworm        1/9        1/8
Co-infections are depicted as number of participants infected out of total number of participants tested.
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Figure 6. Presence of IL-10-producing CD1dhi B cells during S. haematobium (S.h.) infection. 
(A) The CD1dhi B cells and the IL-10 production of the total B cells were gated according to the gating 
strategy depicted in this graph. The gating of the IL-10 production of the different Breg subsets is similar 
as the total B cell gating. (B) PBMC were fixed and stained for Breg markers, including CD1d, and analyzed 
by flow cytometry. (C) Total peripheral blood B cells were cultured with anti-IgG/IgM or (D) anti-IgG/IgM 
plus SEA (10 µg/ml) for two days. Intracellular IL-10 production of the total B cells and the CD1d+ B cells was 





































































































km, PK15), which may have caused the increase in CD1dhi B cells observed in the uninfected 
children. 
To compare the IL-10 production in B cells from infected and uninfected children, total 
peripheral blood B cells were stimulated with anti-IgG/IgM. Subsequent intracellular analysis 
showed an increase in IL-10-producing B cells in the total B cell population of infected children, 
which was significantly reduced after treatment (Fig. 6A,C). Further gating on the CD1dhi B cell 
subset, confirmed that in particular CD1dhi B cells from infected children produce more IL-10 
as compared to uninfected children (Fig. 6C). Interestingly, we observed a slightly different 
pattern, when the cells were stimulated with anti-IgG/IgM plus SEA (Fig. 6D). Although also in 
this condition, both total and CD1dhi B cells from infected children produce significantly more 
IL-10, this was not downregulated upon treatment. This may reflect the presence of a small, but 
persistent population of schistosome-specific B cells in the circulation of previously infected 
children that more readily produce IL-10 in response to SEA, as its cognate antigen, compared 
to the more aspecific stimulation with antibodies directed against IgG/IgM. Although it cannot 
be excluded that SEA may also act as an adjuvant, this seems to be less likely as only little IL-10 
inducing activity of SEA is found in B cells from uninfected children. The fact that somewhat 
elevated IL-10 levels in anti-IgG/IgM plus SEA-stimulated B cells from uninfected group at post-
treatment are observed compared to pre-treatment may again reflect seasonal effects or recent 
unrelated infections, suggested by the enhanced population of plasmablasts in this group (Fig. 
S5). 
Altogether, these data confirm that also in humans, schistosomes can induce IL-10-producing 
Breg cells, of which the CD1dhi B subset is the most prominent. Therefore schistosomes can be 
recognized as powerful Breg cell inducer in both mice and humans.
Discussion
In this study we provide evidence that during chronic schistosomiasis IL-10-producing CD1dhi 
B cells are induced in both humans and mice. In mice, schistosome-induced IL-10-producing 
Breg cells were necessary for protection against AAI as shown here in chimeric IL-10-/- B cell 
mice. Splenic B cells were the most prominent source for IL-10. Interestingly, the induction of IL-
10-producing splenic B cells by infectious agents has been previously documented for L. major 
[12], murine cytomegalovirus [23] and for Schistosoma mansoni by our group and by Amu et 
al [7]. These studies favor the concept that chronic infections, drive strong immunoregulatory 
processes in which IL-10-producing B cells seem to be important players (reviewed in [24]).
However, several reports have indicated that B cells can also suppress inflammation via IL-10-
independent mechanisms. In a colitis model, mesenteric B cells were capable of reducing CD4+ 
T cell-dependent colon inflammation [25] and mesenteric CD23hi B cells of H. polygyrus-infected 
mice were capable of inhibiting inflammation both in an EAE model and in an HDM-specific AAI 
model via an unknown mechanism [26]. Furthermore, studies in S. mansoni-infected μMT mice, 
where the lack of B cells led to increased liver pathology have suggested the involvement of 
FcR-dependent mechanisms [13]. Although their mode of action is still unknown, we describe 
here that transferred pulmonary B cells also protected against AAI independently of IL-10 and 
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Treg cells. The putative role of antibodies or interaction with FcR has not been studied yet.
Further, we characterized the phenotype and function of the dominant IL-10-producing 
B cell subset, finding a regulatory function for CD1dhi MZ B cells in the spleen of schistosome-
infected mice. These data are in line with several other studies in auto-immunity models 
pointing towards MZ B cells as regulators of type 1 inflammation in SLE, ACAID or CHS [25,27]. 
In addition, it was shown that CD1dhi-expressing splenic B cells reduced inflammation in 
a chronic colitis model [25] and AAI during ‘worm only’-schistosome infection [7]. However, 
within the spleen, other regulatory subtypes have been suggested; a rare CD1dhiCD5+ B cell 
subset, termed B10 cells, which are capable of down-regulating inflammatory responses in a 
number of different auto-immune or contact hypersensitivity models [15] and transitional type 
2 MZ precursor B cells (CD21hiCD23hiIgMhi), described in mouse models for CIA [22,25] and SLE 
[28]. It is not fully clear whether these B cells are complete unique subsets because there is a 
substantial overlap between the (co-)expression of various markers, such as CD1d, CD5, CD21, 
CD23 and IgM. In addition, local inflammation or chronic infection may change the expression 
of individual markers complicating distinctions between the different proposed cell subsets. 
Here we show that helminth-induced MZ B cells not only reduced allergic inflammation via 
IL-10 but also via the induction/recruitment of active FoxP3+ Treg cells. In humans, Treg cells are 
known to be an important element in reducing allergic inflammation as a mutation in the FOXP3 
gene is associated with severe eczema, food allergy and high levels of IgE and eosinophilia 
[29]. Furthermore, children with asthma show quantitative and functional impairment of 
CD4+CD25+ Treg cells in the BAL fluid[30], while children that have outgrown their allergy have 
increased frequencies of allergen-responsive Treg cells [31,32]. Therefore, having a system that 
embraces not only one regulatory system but in fact two seems to be a very efficient strategy 
to develop tolerance to environmental stimuli and prevent allergy. Indeed, in several studies 
Breg function has been linked to induction or recruitment of Treg cells, i.e. in a model of ACAID, 
colitis, EAE, SLE [24,25] and allergic inflammation [7]. Importantly, in these studies including 
the one presented here, Breg-induced immune regulation does not fully depend on Treg cell 
activity, with the exception of the study by Amu et al. [7], where in fact an excess of regulatory 
CD1dhi B cells was transferred to recipient mice on three consecutive days, in contrast to our 
study with only one B cell injection before the challenge.
Although the majority of studies on Breg cells have been conducted in mouse models 
there are now a few reports that confirm the existence of human Breg cells, in which both 
equivalents of already described ‘mouse’ Breg cells are identified in addition to some new 
subsets. Correale et al. have reported human IL-10-producing CD1dhi B cells in helminth-
infected MS patients [18]. However, these patients were infected with a mixture of different 
helminth species. Here, we now have established a causal relation between a single species 
of helminth, schistosomes and increased levels of IL-10-producing CD1dhi B cells, which were 
reduced to ‘normal’ levels after anti-schistosome treatment. Of note, in both schistosome-
infected and uninfected children, other geohelminths were found and for ethical reasons 
both groups were treated with the antihelmintic albendazole in addition to treatment with 
praziquantel for the schistosome-infected group. Despite their initial presence, we find reduced 




schistosome-uninfected group. These data suggest that schistosomes have a more dominant 
effect on Breg cell induction than other gut-associated helminths. So far, two other human Breg 
subsets have been described, namely CD24hiCD27+ [17] and CD24hiCD38hi Breg cells in healthy 
individuals, of which the activity of the latter was impaired in SLE patients [16]. Interestingly, 
we did not observe differences in these two Breg cell subsets in peripheral blood of infected 
versus uninfected children, indicating that schistosomes primarily induce CD1dhi Breg cells. This 
discrepancy suggests that the various Breg cell subsets described so far may require different 
conditions for their development and activation. 
As illustrated above, evidence from animal studies and a few human studies points towards 
a significant role for IL-10-producing Breg cells in modulating pathogenic hyperinflammatory 
responses. As such, it would be of great therapeutic interest if Breg cell activity could be 
specifically induced. For this, helminth infections may be of particular value, as in vitro exposure 
of splenic B cells to live schistosome worms or peritoneal injection of schistosome egg-
derived glycans or filarial glycoproteins induces IL-10-producing B cells [7,33]. However, the 
identification of the exact helminth-derived molecules involved, is a critical step as enhanced 




Mice were housed under SPF conditions at the animal facilities of the Leiden University Medical 
Center in Leiden, the Netherlands. All animal studies were performed in accordance with the 
guidelines and protocols (DEC-07062, 07152, 08034, 09141) approved by the Ethics Committee 
for Animal Experimentation of the University of Leiden, The Netherlands. The human study 
was conducted according to the principles expressed in the Declaration of Helsinki. The study 
was approved by the “Comité d’Ethique Regional Independent de Lambaréné” (CERIL). Written 
informed consent was obtained from parents or legal guardians of children participating in the 
study.
Animals 
Six week-old female C57/Bl6 OlaHsd mice were purchased from Harlan. For the generation of 
chimeric IL-10-producing B cell-deficient mice, B cell-deficient μMT mice were irradiated to 
remove the bone marrow (BM). Subsequently, the irradiated mice were reconstituted with 80% 
of μMT BM and 20% IL-10-/- BM cells (IL-10-deficient) or with 80% of μMT BM and 20% wild-type 
(WT) BM as described [10]. DEREG (DEpletion of REGulatory T cells) mice were kindly provided 
by Dr. T. Sparwasser [19]. 
Parasitic infection and AAI induction
Mice were infected percutaneously with 40 S. mansoni cercariae and the infection lasted until 
14 weeks (chronic phase starts around week 12) [8]. For AAI induction, mice were sensitized 
twice by i.p. injections of OVA (10 μg/mL, Worthington Biochemical Corp) in Imject Alum (2 
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mg/ml; Pierce) at 17 and 10 days before challenge. Sensitization was initiated during week 11 
and 12 after the start of infection. Ten days after the last injection, mice received OVA aerosol 
challenges (10 mg/ml in PBS) for three consecutive days in the 14th week of infection. Mice 
were sacrificed 24 hours after the last challenge. BAL fluids were collected and phenotyped by 
flow cytometry[8].
Study population
Venous blood was obtained from 20 school children living in Lambaréné (Gabon) or from a 
nearby village (PK15) where Schistosoma haematobium is endemic. S. haematobium infection 
was detected by examining 10 ml of urine passed through a 12-µm-poresize filter (Millipore) 
and the eggs were stained with a ninhydrin solution. Children were classified as ‘infected’ if at 
least one S. haematobium egg was detected in the urine or ‘uninfected’ if three consecutive 
urine samples were negative. Infections with intestinal helminths A. lumbricoides, T.  trichiura 
and hookworm were determined by analyzing one fresh stool sample using the Kato-Katz 
method [20]. Infection with P. falciparum was determined by PCR [21]. S. haematobium-infected 
children were treated with three doses of praziquantel (40 mg/kg) every two months. Intestinal 
helminth and malaria infected children received respectively a single dose of albendazole (400 
mg) and an artemisinin-based combination therapy as per the local guidelines. 
Mouse cell purification and cell sorting
Single cell suspensions were prepared from the spleens, mesenteric lymph nodes, and 
mediastinal lymph nodes by dispersion through a 70-µm cell sieve (Becton Dickinson). Perfused 
lungs were minced to ~1 mm pieces and digested by collagenase II/Dnase for 1 hour. The 
digested lungs were sequentially dispersed through 70- and 40-µm sieves. Erythrocytes were 
removed from the spleen and lung single cell suspensions by lysis. B cells were purified using 
anti-CD19 MicroBeads (Miltenyi Biotec). Follicular B cells (CD21intCD23hi) and marginal zone B 
cells (CD21hiCD23int/low) were stained with antibodies against CD19-PE (MB19-1, eBioscience), 
CD21-APC (7G6, BD Pharmingen), and CD23-FITC (B3B4, eBioscience) and separated using 
FACSAriaII cell sorting (Becton Dickinson). The sorted subsets were routinely ~95% pure. For the 
depletion of MZ B cells, splenocytes were first incubated with CD19-PE (6D5, Miltenyi Biotec), 
followed by anti-PE multisort beads (Miltenyi Biotec) to isolate the B cells. Next, these beads 
were enzymatically removed and the isolated B cells were incubated with CD21-FITC (7G6, 
BD Pharmingen) antibody for 20 minutes. The CD21hi MZ B cell fraction was depleted using 
anti-FITC magnetic beads (Miltenyi Biotec). For the total CD19+ B cells, the CD21hi B cells were 
added back to the CD21neg B cells (mock depletion). The depletion of MZ B cells was ~92% pure. 
CD4+CD25- T cells were enriched using anti-CD4 and anti-CD25 MicroBeads with a purity of 96% 
(Miltenyi Biotec).
Human B cell isolation and characterization
PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation from 20 ml of 
heparinized blood. B cells were isolated with anti-CD19 MicroBeads (Miltenyi Biotec) with a 




2.4% PFA and stained for CD19-PB (HIB19, eBioscience), CD1d-PE (51.1, eBioscience), CD5-APC 
(UCHT2, BD), CD24-PeCy7 (ML5, ITK Diagnostics), CD27-APCeFluor780 (O323, eBioscience), and 
CD38-FITC (HIT2, BD).
Adoptive transfer of isolated mouse B cells
Recipient mice were sensitized with two injections of OVA at day 0 and day 7. Ten days after 
the last injection, the OVA-sensitized animals received i.v. injection of 5 x 106 pulmonary, 
mesenteric, splenic total or splenic CD19+ B cells depleted for MZ B cells from OVA sensitized-
uninfected or OVA sensitized-infected mice. Blocking anti-IL-10R antibody (250 µg; kindly 
provided by Schering Plough Biopharma) or isotype control antibody was given i.p., one day 
before adoptive transfer. DEREG mice, which carry a Diphtheria toxin receptor-eGFP transgene 
under the control of an additional Foxp3 promoter, were treated with two diphtheria toxin (DT, 
1 μg/ml) i.p. injections: one day before and two days after the adoptive transfer of B cells in order 
to deplete the FoxP3+ Treg cells. After two days, mice were challenged for three consecutive 
days and sacrificed 24 hours after the last challenge.
In vitro mouse B cell stimulation and co-culture with CD4+CD25- T cells
Mouse CD19+ B cells and B cell subsets (1 x 105 cells) were cultured in the presence of SEA 
from S. mansoni eggs (20 μg/mL) for five days. Supernatants were stored for later cytokine 
analysis by ELISA. For in vitro Treg induction, B cells (1 x 105 cells) were first irradiated with 2600 
RAD and subsequently, co-cultured with CD4+CD25- T cells (1 x 105 cells) in the presence of 
medium or anti-CD3 (1 µg/ml) plus anti-CD28 (1 µg/ml). An isotype control anti-β-gal (10 µg/
ml), or anti-IL-10 receptor (10 µg/ml) was added. After five days, cells were fixed according to 
the eBioscience FoxP3 fixation/permeabilization kit. Proliferation was confirmed by cell counts. 
Cytokines were measured in the cell culture supernatant using Luminex or ELISA (IL-1β,-4,-5,-6, 
-10, -12p40/70, -13, IFN-γ, TNF-α). 
Human B cell stimulation and intracellular staining for IL-10
Freshly isolated B cells (1 x 105) were stimulated for 48 hours with 2.5 µg/ml anti-human IgG/IgM 
(Jackson ImmunoResearch) in the presence or absence of 10 µg/ml SEA from S. haematobium 
eggs. For ICS of IL-10, B cells were restimulated with PMA (50 ng/ml), ionomycin (2 µg/ml), and 
LPS (100 ng/ml; Invivogen) for 6 hours with the final 4 hours in the presence of BrefA (10 µg/
ml; Sigma-Aldrich), followed by fixation with FoxP3 fixation/permeabilization kit and stained 
for CD1d-PE (51.1, eBioscience), CD20-APCeFluor780 (2H7, eBioscience), and IL-10-biotin (JES3-
12G8, Abd Serotec) followed by second incubation with streptavidin-Qdot525 (Invitrogen).
Statistical analysis
All murine results are expressed as mean ± SEM and the different groups were tested using 
the Student’s t-test (two-tailed). Differences between infection groups in humans were tested 
by the Mann-Whitney U test. Differences within the same group pre- and post-treatment were 
compared by Wilcoxon matched pairs test. Probability values less than 0.05 were considered 
significant. *** p< 0.001, ** p<0.01, * p<0.05 and # p<0.1.
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Supplementary material
Figure S1. IL-10 production by CD19+ B cells during infection. 
Mouse CD19+ B cells were isolated from the spleen at different time points during Schistosoma mansoni 
infection. The B cells were cultured in the presence of SEA from S. mansoni eggs (20 μg/mL) for five days. 
Supernatants were stored for IL-10 analysis by ELISA. This experiment represents one experiment with 3-4 
mice per group.
Figure S2. 
Geometric mean of CD1d fluorescence intensity on total B cells, FO and MZ B cells.








































Figure S3. Production of cytokines after SEA stimulation. 
MZ and FO B cells from PBS-uninfected and PBS-infected were sorted using flow cytometry and cultured 
for five days in the presence of SEA for IL-10 production as presented in Fig. 2A. In addition, we measured 
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Figure S4. 
Percentage of CD24hiCD38hi and CD24hiCD27+ B cells in peripheral blood of Gabonese children pre- and 
post-treatment, performed as described in legend to Fig. 6B.
Figure S5. 
Percentage plasmablasts in peripheral blood of Gabonese children pre- and post-treatment, performed as 
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Schistosomiasis affects over 200 million people and especially children in developing countries. It 
causes general hyporesponsiveness of the immune system, which until now has predominantly 
been described for various T cell subsets as well as dendritic cells. B cells in this context have 
not yet been investigated. To address this question we phenotyped B cell subsets present in 
peripheral blood from S. haematobium infected and uninfected schoolchildren living in an 
endemic area in Lambaréné, Gabon. Children with schistosomiasis had an increased frequency 
of various memory B cell subsets, including subsets associated with B cell exhaustion, and a 
concomitant decrease in naïve B cells. To study the effect of Schistosoma infection on B cells in 
more detail we isolated peripheral blood B cells and found that B cells from infected children 
had a reduced capacity to proliferate and produce TNF-α in response to both B cell receptor 
and Toll-like receptor stimulation. These results provide new insights into the role of B cells in 
the host immune response to schistosomiasis and may provide a novel target for therapeutic 
strategies.
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Abstract
Antibody responses are thought to play an important role in control of Schistosoma infections, 
yet little is known about the phenotype and function of B cells in human schistosomiasis. 
We set out to characterize B cell subsets and B cell responses to B cell receptor and Toll-like 
receptor 9 stimulation in Gabonese schoolchildren with Schistosoma haematobium infection. 
Frequencies of memory B cell (MBC) subsets were increased, whereas naïve B cell frequencies 
were reduced in the schistosome-infected group. At the functional level, isolated B cells from 
schistosome-infected children showed higher expression of the activation marker CD23 upon 
stimulation, but lower proliferation and TNF-α production. Importantly, 6-months after 3 rounds 
of praziquantel treatment, frequencies of naïve B cells were increased, MBC frequencies were 
decreased and with the exception of TNF-α production, B cell responsiveness was restored to 
what was seen in uninfected children. These data show that S. haematobium infection leads 





Schistosomiasis is a major parasitic disease of humans in the developing world, with over 
200 million people infected worldwide [1]. As with other chronic helminth infections, 
schistosomes cause widespread immune activation and deregulation leading to general T 
cell hyporesponsiveness supporting the long term survival of the parasite and minimizing 
immunopathology [2–4]. Resistance to schistosomiasis is only gradually acquired and is 
attributed to cumulative exposure to infection [5,6]. Mice vaccination experiments with 
radiation-attenuated S. mansoni cercariae showed less protection against re-infection in µMT B 
cell-deficient mice than in wild-type mice [7], and the transfer of serum from infected rodents 
to naïve animals can protect against infection [8,9], suggesting that antibodies are important 
for protection against infection. In human infection, protective IgA, IgE and IgG levels have 
been demonstrated against adult worm antigens [10,11], and resistance to (re-) infection is 
correlated with an increased ratio between IgE and IgG4 [12]. Furthermore, expression of CD23, 
the low affinity IgE receptor which can be strongly up-regulated by IL-4 [13], is also correlated 
with development of resistance to Schistosoma re-infection [14,15]. While B lymphocytes 
support the establishment of the strong Th2 profile associated with helminth infections [16], 
more recently they have also been shown to play an active regulatory role in the course of 
Schistosoma infections [17] mostly effecting T cell responses. 
In general, immunological memory is characterized by its ability to respond more rapidly 
and robustly to re-infection and is dependent on the generation and maintenance of memory B 
cells (MBCs) [18]. Memory B cells, originally defined as CD27+ [19], can be further characterized 
into additional subsets by co-staining with IgD into non-switched MBCs (CD27+IgD+), switched 
MBCs (CD27+IgD-) and double negative MBCs (CD27-IgD-) [20]. Furthermore, co-staining with 
CD21 can be used to separate classical MBCs (CD27+CD21+) from activated MBCs (CD27+CD21-) 
and atypical MBCs (CD27-CD21-) [21]. Based on these markers, naïve B cells can be classified as 
CD27-IgD+ or CD27-CD21+. Recent studies have shown that chronic HIV infection [21,22] as well 
as exposure to and infection with P. falciparum malaria [23,24] are associated with the expansion 
of atypical or ‘exhausted’ MBCs (CD27-CD21-). These cells are characterized by high expression 
of the inhibitory receptor FCRL4 [25,26], and it has been suggested that this population may 
contribute to diminished pathogen-specific antibody responses in infected individuals. Other 
chronic infections such as hepatitis C virus (HCV) [27] have also shown perturbations in the 
distribution of peripheral B cells subsets, most notably within the memory B cell compartment 
suggesting that MBCs may play a role in disease pathogenesis as well as insufficient immune 
response to combat the disease.
Ligation of the B cell receptor (BCR) by its cognate antigen leads to the production of 
antibodies and, depending on the cytokines produced by Th cells, to further antibody isotype 
switching and affinity maturation. B cells can also express a variety of innate receptors, most 
notably Toll-like receptors (TLRs), and can play a significant role in innate immune responses as 
B cells upregulate activation markers, proliferate and secrete cytokines upon engagement of 
these receptors [28,29]. Importantly, TLR stimulation can also potentiate the T cell-dependent 
production of antibodies [30,31]. TLR9 is highly expressed in human B cells and is ligated by 
bacterial DNA motifs containing unmethylated CpG dinucleotides. Previous studies have clearly 
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demonstrated that TLR9 stimulation is sufficient to directly induce both naïve and memory B cell 
proliferation and activation [32,33]. In addition, the role of B cells in innate immune responses 
has gained further interest as several studies have demonstrated a pathogenic role for B cells 
independent of their ability to produce antibodies. For example, systemic lupus erythematosus 
(SLE) and rheumatoid arthritis (RA) are associated with abnormally increased pro-inflammatory 
cytokine production by B cells, including TNF-α. Importantly TNF-α [34], along with more 
recently IL-17 [35], is also one of the key cytokines involved in schistosome-induced pathology 
[36,37].
Currently there is little information on the composition of the peripheral blood B cell 
compartment or the concomitant adaptive and innate functionality of B cells during the course 
of human Schistosoma haematobium infection. In this study, we compared the circulating B cell 
subsets in peripheral blood of schistosome-infected and uninfected Gabonese schoolchildren 
and their B cell response to BCR and TLR engagement. 
Results
Study population characteristics
We recruited S. haematobium-infected (N = 29) and -uninfected (N = 27) schoolchildren (8-
16 years old) for phenotypic B cell analysis. From these, we selected 10 from each group for 
more extensive immunological analyses and performed follow-up studies six months later on 
7 infected children treated with 3 rounds of praziquantel and 8 uninfected children. Following 
treatment all S. haematobium-infected children were infection free. As described in Table 1, 
there were no significant differences between the two groups in the prevalence and infection 
intensity of other parasitic infections such as P. falciparum, A. lumbricoides, T. trichiura or 
hookworm. Furthermore, age and gender were comparable between the two groups. 
Table 1: Characteristics of the study population.
S. haematobium infected S. haematobium uninfected p value
N 29 27
Age in years (mean (SD)) 11.36 (2.46) 11.7 (1.82) 0.887*
Male/female 18/11 14/13 0.590#
Egg counts (median (range)) 11 (1-1000) 0 0.000^
Co-infections
    Plasmodium falciparum 5/28 1/26 0.194#
    Ascaris lumbricoides 5/23 5/23 1.000#
    Trichuris trichiura 6/23 10/23 0.353#
    Hookworm 3/23 1/20 0.610#
Co-infections are depicted as number of participants infected out of total number of participants tested. * 




Figure 1. Serum immunoglobulin analysis.
Serum samples were analyzed for total human IgM, IgG1, IgG2, IgG3, IgG4, IgA by Luminex and IgE by ELISA. 
Bars represent median with interquartile range. Number of donors in each group: baseline S.h. –ve n = 9, 
baseline S.h. +ve n = 10, follow-up S.h. –ve n = 8 and follow-up S.h. +ve n = 7.
Serum immunoglobulin levels
In schistosomiasis, resistance is acquired slowly and it is not clear how the B cell compartment 
and B cell function are affected. To gain insight into global B cell function during S. 
haematobium infection we studied immunoglobulin isotypes and IgG subclasses in serum. 
Consistent with previously published data [43], IgG4 levels were increased in S. haematobium-
infected compared to uninfected children and were significantly reduced following 
praziquantel treatment (Figure 1). No significant differences were observed in serum IgM, 
IgG1, IgG2, IgG3, IgA and IgE between the groups. 
B cell inflammatory cytokine response, activation and proliferation
To address whether B cell function was altered during Schistosoma infection, we measured 
in vitro cytokine responses, proliferation and activation markers of peripheral blood B cells in 
response to BCR (anti-IgG/IgM) and TLR9 (CpG) signaling by flow cytometry in uninfected and 
infected children. We first focused on responses in uninfected children. Intracellular production 
of the pro-inflammatory cytokine TNF-α and expression of surface CD23, an indicator of 
TLR activation [44], were significantly induced by BCR and TLR9 engagement; dual receptor 
engagement did not further increase these levels (Figure 2A, B and S1A, B). Intracellular Ki-
67, a marker of proliferation, was not induced by BCR stimulation alone, but was increased 
following CpG stimulation, and as expected [45], dual BCR and TLR engagement was required 
for optimal B cell proliferation (Figure 2C and S1C). Frequencies of unstimulated B cells that 
produced TNF-α, expressed CD23 or were positive for Ki-67 did not differ between infected and 
uninfected children. As TNF-α production and CD23 expression levels were highest following 
CpG stimulation, with no significant enhancement when combined with anti-IgG/IgM co-
stimulation, we focused on CpG stimulations for comparison between infected and uninfected 
children. TNF-α-producing B cell frequencies were significantly lower in infected children as 
compared to uninfected children (Figure 2D), and this was not upregulated upon treatment. In 
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contrast, CD23-expressing B cell frequencies were significantly elevated (Figure 2E) and  Ki-67+ 
B cells significantly reduced (Figure 2F) in the infected children; both were restored following 
praziquantel treatment to levels observed in the uninfected children. Baseline frequencies 
of CD23+ B cells in ex-vivo PBMCs did not differ between schistosome-infected children and 
healthy controls, 33.9% versus 40.6% respectively (p = 0.932; data not shown). Taken together, 
these data suggest that Schistosoma infection leads to alterations in B cell responses, and that 
some of these changes are long lasting and persist at least six months after removal of infection.
Figure 2. B cell inflammatory cytokine response, activation and proliferation.
Total peripheral blood B cells were cultured with anti-IgG/IgM (2.5 μg/ml), CpG (5 μg/ml) or anti-IgG/IgM 
plus CpG for two days, restimulated with PMA/Ionomycin/LPS and BrefA and fixed. Levels of intracellular 
TNF-α (A), CD23 expression (B) and intracellular Ki-67 (C) were measured in S. haematobium-uninfected 
children by flow cytometry. Levels of intracellular TNF-α (D), CD23 expression (E) and intracellular Ki-67 (F) 
following CpG stimulation in infected and uninfected children at baseline and follow-up. Horizontal bars 
represent median. Number of donors in each group: baseline S.h. –ve n = 10, baseline S.h. +ve n = 9, follow-
up S.h. –ve n = 7 and follow-up S.h. +ve n = 7.
B cell subpopulation analysis
To further explore schistosome-induced alterations in the B cell compartment, we next compared 
circulating B cell subsets in peripheral blood between infected and uninfected children by flow 















































































































































were found between schistosome-infected children and healthy controls, 15.2% versus 13.7% 
respectively (p = 0.776). Four distinct CD19+ B cell subsets can be distinguished by additional 
expression of CD27 and IgD [20] (Figure 3A). These are defined as naïve B cells (CD27-IgD+), 
non-switched MBCs (CD27+IgD+) also referred to as marginal zone-like B cells, switched MBCs 
(CD27+IgD-), and double negative MBCs (CD27-IgD-). The proportion of switched MBCs (Figure 
3B) and double negative MBCs (Figure 3D) was significantly increased in schistosome-infected 
children and these levels were significantly reduced to levels comparable to the uninfected 
control group following treatment. Concomitantly there was a trend toward a lower percentage 
of naïve B cells (p = 0.062) (Figure 3E) in schistosome-infected children and following treatment 
the level of naïve B cells was significantly increased. No differences were observed in the levels 
of non-switched MBCs (Figure 3C). Interestingly, we noted a positive correlation between total 
serum IgG4 levels and the percentage of switched MBCs (Spearman r = 0.407, p < 0.05) as well 
as a trend with DN MBCs (Spearman r = 0.330, p = 0.056) and a negative correlation with naïve 
B cells (Spearman r = -0.392, p < 0.05). 
To further investigate immunoglobulin expression on B cells we evaluated an additional 8 
schistosome-infected children and 8 endemic controls with an antibody panel that included a 
brighter CD27 antibody (Figure S2A). We found similar differences with respect to an increase 
in the DN MBCs (Figure S2D) and a decrease in naïve B cells (Figure S2E) in schistosome-
infected children. Although the switched MBCs (Figure S2B) did not differ significantly in this 
cohort, when grouped with the original data (from Figure 3) the overall comparison remained 
significant. We first evaluated immunoglobulin levels on CD27+ B cells [46] and found no 
differences in the proportion of non-switched IgM+ MBCs (Figure 4A), or switched IgA+ (Figure 
4B) and IgG+ (Figure 4C) MBCs between schistosome-infected and -uninfected children. We 
next assessed immunoglobulin expression on the double negative MBCs (CD27-IgD-) and while 
there were no differences in the proportion of either IgM+ (Figure 4D) or IgA+ (Figure 4E) DN 
MBCs, the proportion of IgG+ DN MBCs was significantly increased in schistosome-infected 
children (Figure 4F). The majority of the DN MBCs were class-switched (median, 53.7%) with 
only 8.7% IgM+ cells, which may potentially be a mixture of naïve and non-switched MBCs, 
confirming their status as memory B cells. Similar differences in immunoglobulin expression 
were observed on atypical MBCs (data not shown). 
In addition to the classical characterization of the memory B cell subsets, co-staining of 
CD27 and CD21 [21] can be performed to identify four B cell subsets (Figure 5A): 1) naïve B cells 
(CD27-CD21+); 2) activated MBCs (CD27+CD21-); 3) classical MBCs (CD27+CD21+) and 4) atypical 
MBCs (CD27-CD21-). The proportion of activated MBCs (Figure 5B) was significantly increased 
and there was a trend toward a higher percentage of atypical MBCs (p = 0.058) (Figure 5D) 
in peripheral blood of schistosome-infected children and levels of both were significantly 
reduced following clearance of infection. Similarly the level of naïve B cells was significantly 
increased (Figure 5E) following treatment, while no differences were found in the proportion 
of classical MBCs either between the groups or at different time points (Figure 5C). While CD10, 
a marker of immature and germinal center B cells, was not included in these panels separate 
analysis showed the level of immature and germinal center B cells within our population to 
be ~2.75% (median) with no differences between schistosome-infected and -uninfected 
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Figure 3. MBC analysis.
PBMC were fixed and stained with B cell phenotyping markers (CD19, CD27 and IgD) and analyzed for 
B cell subsets by flow cytometry. B cell subset analysis was performed as shown in (A) (representative S. 
haematobium-uninfected child). Proportion of CD19-gated cells that were CD27+IgD- (B, switched MBC), 
CD27+IgD+ (C, non-switched MBC), CD27-IgD- (D, double negative MBC), and CD27-IgD+ (E, naïve B cells) 
were determined for S. haematobium-infected and uninfected children at baseline and follow-up. (B, C, D, 
E) Horizontal bars represent median. Number of donors in each group: baseline S.h. –ve n = 19, baseline S.h. 















































































































Figure 4. Expression of IgM, IgA and IgG on CD27+ and DN MBCs.
PBMC were fixed and expression of IgM, IgA and IgG on CD27+ B cells was evaluated [46]. Proportions 
of CD19+ gated cells that were IgM+IgD-CD27+ (A), IgA+IgM-IgD-CD27+ (B), and IgG+IgM-IgD-CD27+ (C) 
were determined for S. haematobium-infected and uninfected children at baseline. For immunoglobulin 
expression on DN MBCs, PBMC were fixed and stained with B cell subset markers (CD19, IgD and CD27) 
and DN MBCs measured for IgM, IgA and IgG expression. Proportion of CD19+CD27-IgD--gated cells that 
were IgM+ (D), IgA+ (E) and IgG+ (F) were determined for S. haematobium-infected and uninfected children 
at baseline. Horizontal bars represent median. Number of donors in each group: S.h. –ve n = 8 and S.h. +ve 
n = 7.
children, 2.7% and 2.8% respectively (p = 0.798). To study the nature of atypical MBCs (CD27-
CD21-), we determined the expression levels of HLA-DR and FCRL4, a cell surface marker that is 
characteristic for exhausted MBCs. In line with previous reports [23,25], FCRL4 was expressed at 
significantly higher levels on atypical MBCs compared to classical MBCs (CD27-CD21-) and naïve 
B cells (CD27-CD21+) in uninfected children (Figure S3A). Furthermore, HLA-DR expression was 
significantly higher on atypical MBCs and naïve B cells as compared to classical MBCs (Figure 
S3B). Both markers were not differentially expressed between B cell subsets of uninfected and 
infected children (data not shown). Taken together, these data show that Schistosoma infection 
leads to changes in the distribution of peripheral B cell subsets and that praziquantel treatment 
leads to a reduction of various memory B cell subsets and an increase of naïve B cells.
B cell subset inflammatory cytokine response, activation and proliferation
To investigate whether changes in TNF-α, Ki-67 and CD23 observed in total B cells were 
attributed to specific B cell subsets, we extended our flow cytometry analysis to include the 
various B cell subsets defined by CD21 and CD27 expression, first gating on CD10- B cells. Isolated 
B cells were stimulated with anti-IgG/IgM, CpG or a combination of the two and stained for the 
expression of intracellular TNF-α and Ki-67 and surface CD23. We found that CpG stimulation 
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Figure 5. Atypical MBC analysis. 
PBMC were fixed and stained with B cell phenotyping markers (CD19, CD21 and CD27) and analyzed for 
B cell subsets by flow cytometry. B cell subset analysis was performed as shown in (A) (representative S. 
haematobium-uninfected child). Proportion of CD19-gated cells that were CD27+CD21- (B, activated MBC), 
CD27+CD21+ (C, classical MBC), CD27-CD21- (D, atypical MBC), and CD27-CD21+ (E, naïve B cells) were 
determined for S. haematobium-infected and uninfected children at baseline and follow-up. (B, C, D, E) 
Horizontal bars represent median. Number of donors in each group: baseline S.h. –ve n = 19, baseline S.h. 

















































































































not shown); as a result it was no longer possible to differentiate the four B cell subpopulations 
with the same criteria as in Figure 5A. We therefore focused on anti-IgG/IgM-stimulated cells, 
as here we could still distinguish the four B cell populations and analyzed the responses of 
the various B cell subsets in uninfected children. We found very high frequencies of TNF-α-
producing activated MBCs, followed by classical MBCs and atypical MBCs and observed the 
lowest frequencies among naïve B cells (Figure 6A). When comparing the various B cell subsets 
for their ability to respond to BCR engagement between infected and uninfected children, we 
observed significantly less TNF-α+ activated MBCs (Figure 6B) and classical MBCs (Figure 6C) 
and a trend for lower levels in the naïve B cells and atypical MBCs in the infected children (data 
not shown). These data reflect the reduced TNF-α production in the total B cell population 
observed earlier (Figure 2A), and likewise the levels of TNF-α following treatment were not 
restored to levels observed in the uninfected children for any of the subsets (Figure 6B, C). 
These data point at a reduced capacity of B cells from infected children to produce TNF-α in 
response to anti-IgG/IgM stimulation which extends to all B cell subsets studied. While classical 
MBCs had higher frequencies of  CD23 and Ki-67 expressing cells, no differences were observed 
between infected and uninfected children for any of the subsets or upon treatment. 
Figure 6. B cell subset inflammatory cytokine response, activation and proliferation.
Total peripheral blood B cells were cultured with anti-IgG/IgM (2.5 μg/ml) for two days, restimulated with 
PMA/Ionomycin/LPS and BrefA, fixed and stained with B cell subset markers (CD10, CD19, CD21 and CD27) 
and levels of intracellular TNF-α was measured in S. haematobium-uninfected children by flow cytometry 
(A). Levels of intracellular TNF-α in activated MBCs (B) and classical MBCs (C) in infected and uninfected 
children at baseline and follow-up. Horizontal bars represent median. Number of donors in each group: 
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Discussion
Although many studies have investigated the types and frequencies of various immune cell 
subsets, including T cells and DCs [47–49], little is known about the human B cell compartment 
during the course of S. haematobium infection. In the present study, we have analyzed innate 
and antibody-driving pathways in total B cells and different peripheral B cell subsets and 
compared their responses between infected and uninfected Gabonese schoolchildren. We 
found that S. haematobium infection leads to changes in B cell function as well as alterations of 
the total B cell compartment and these changes are not restricted to a single B cell population. 
When evaluating B cell functionality, we found significantly lower frequencies of TNF-α-
producing and Ki-67+ proliferating B cells in S. haematobium-infected children (Figure 2D and F). 
Interestingly, Ki-67+ B cell frequencies were restored to levels comparable to uninfected children 
following anti-schistosome treatment (Figure 2F), but TNF-α levels remained significantly lower 
(Figure 2D). The downregulation of TNF-α and B cell proliferation in S. haematobium positive 
children may be a result of immunomodulation induced by the parasite to prolong its survival. 
This would be in line with studies showing that TNF-α might play an important role in immunity 
to helminths: TNF-α production by B cells was necessary for sustained antibody production 
and establishment of protective immunity to Heligmosomoides polygyrus [50]. Moreover, B-cell 
derived TNF-α has been shown to enhance IFN-γ production by T cells in Toxoplasma gondii-
infected mice [51] and it is thought that an effective Th1 response is key to natural acquisition 
of resistance against Schistosoma infection [12,52]. Therefore, it is tempting to suggest that the 
long lasting reduction in B cell capacity to produce TNF-α, as demonstrated post-treatment, may 
in part contribute to the slow development of resistance to Schistosoma infection, although 
presence of other unknown concomitant viral or fungal infections may also play a role. 
In the current study we analyzed CD23 as a TLR activation marker on B cells, however CD23 is 
also correlated with the development of resistance to Schistosoma infection [14]. Furthermore, 
cross-linking of CD23-bound IgE by antigen may induce cellular activation and increased IgE 
production [53,54]. Repeated rounds of treatment and S. mansoni re-infection led to a gradual 
increase in CD23 expression and resistance in a cohort of Kenyan children [15]. This seems 
partly in contrast to our results, as the elevated CD23 levels in infected children are reduced 
after treatment. However in the Kenyan cohort levels of CD23 expression were evaluated in 
fresh whole blood samples while here we measured CD23 expression on stimulated B cells 
as a marker of B cell activation. Baseline levels of CD23 expression on ex-vivo PBMCs in our 
population did not differ, however CD23 levels following treatment were not measured. It 
would therefore be of interest to measure the dynamics of CD23 expression in our population 
longitudinally following multiple rounds of treatment.
Perturbations in the frequency of various B cell subsets have been demonstrated in 
a number of disease states [34] and here we found an increase in the switched MBCs, the 
double negative MBCs and activated MBCs, as well as a trend toward a higher percentage of 
atypical MBCs and a concomitant decrease of naïve B cells in schistosome-infected children. All 
populations were restored to levels observed in uninfected children following treatment. It is 
unclear whether the increase in naïve B cells following treatment is due to de novo generation 




from a decrease in the levels of the other subsets. 
It has been shown that in HIV- [21] and malaria-infected individuals [23,24] an exhausted/
atypical memory B cell population (CD27-CD21-), was greatly expanded and that these cells 
were hyporesponsive and had a decreased ability to differentiate into antibody secreting cells, 
contributing to the diminished pathogen-specific antibody responses in infected individuals. 
Likewise, it has been suggested that double negative (CD27-IgD-) MBCs, which are increased 
in SLE, might be exhausted/terminally differentiated memory B cells [55,56]. In chronic S. 
haematobium infection we similarly see an expansion of both double negative and atypical 
MBCs. The overlap between these two MBC subpopulations, their capacity to produce 
schistosome-specific antibodies or the exact characteristics of their ‘exhausted’ state are 
currently not clear. 
Nevertheless it is interesting to note that schistosome-infected children carry higher 
frequencies of IgG+ double negative (CD27-IgD-) MBCs compared to uninfected children, 
whereas no differences are observed in the levels of IgM+ or IgA+ DN MBCs (Figure 4). Similarly, 
no differences were observed in total serum IgM, IgA nor IgG1, IgG2 and IgG3, whereas 
significant differences were only observed in IgG4 (Figure 1). Interestingly, serum levels of 
IgG4 were significantly decreased following treatment and correlated with a concomitant 
decrease in the frequency of the DN MBCs, suggesting that the increase in IgG+ DN MBCs may 
be predominantly due to an increase in IgG4-expressing B cells. As IgG4 is associated with 
susceptibility and IgE with resistance to Schistosoma infection, it would be of interest to study 
these isotypes on the different memory B cell populations in exposed but resistant individuals. 
These studies could shed further light on the various ways in which S. haematobium infection 
modulates the immune response providing further information for the design of an effective 
vaccine.
Although the function of double negative and atypical MBCs is not yet clear in the context 
of Schistosoma infection, it is tempting to speculate that these may be expanded as a result of 
the chronic nature and strong immunomodulation of S. haematobium infection. These memory 
B cells may limit the associated pathology while at the same time limiting the effectiveness of 
the immune response against the parasite. Indeed, a protective role against malaria infection 
has been proposed for atypical MBCs through regulation of the host’s immune response 
[23,24]. This parallels FCRL4+ tissue-like MBCs in lymphoid tissue, which may protect against 
invading pathogens directly or indirectly through the secretion of cytokines and their influence 
on other immune cell types [25,26]. A recent study has highlighted the dual nature of B cells 
in immune responses demonstrating that the same B cells may play both a regulatory (IL-10) 
or pathogenic (IL-6) role depending on the signals received [57]. It would be of interest to 
investigate concomitantly the production of both IL-6 and IL-10 by the various MBC subsets 
and naïve B cells to see the balance between pro- and anti-inflammatory B cell responses 
during Schistosoma infection.
As demonstrated above S. haematobium infection leads to significant changes in B cell 
function as well as alterations of the B cell compartment in peripheral blood of infected children 
as compared to healthy controls. Further studies are needed to define whether these changes 
in the frequency of the various subsets have functional consequences and what their role is in 
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the immune response against S. haematobium.
Materials and methods
Study population
In April 2008 we initiated a study to investigate the effect of S. haematobium infection on B 
cell phenotype and function. Venous heparinized blood was obtained from 56 school-aged 
children living in Lambaréné (Gabon), a semi-urban municipality or from its surrounding villages 
in which Schistosoma haematobium infection is endemic and has been previously described 
in detail [17,38,39]. S. haematobium infection was determined prior to blood collection by 
examining a filtrate of 10 ml of urine passed through a 12-µm-poresize filter (Millipore). Children 
were classified S. haematobium-infected if at least one S. haematobium egg was detected in 
the urine, or uninfected if three consecutive urine samples were negative. Infections with 
intestinal helminths Ascaris lumbricoides and Trichuris trichiura were determined by analyzing 
one fresh stool sample using the Kato-Katz method [40]. Hookworm larvae were determined 
in a 7-day coproculture of the same stool sample [41]. Infection with Plasmodium falciparum 
was determined by Giemsa-stained thick blood smears [42]. After collection of blood samples, 
all S. haematobium-infected children were treated with a single dose of praziquantel (40 mg/
kg) three times every two months. Intestinal helminth- and malaria-infected children received 
respectively a single dose of albendazole (400 mg) and an artemisinin-based combination 
therapy as per the local guidelines. The study was approved by the “Comité d’Ethique Regional 
Independent de Lambaréné” (CERIL; N°06/08). Written informed consent was obtained from 
parents or legal guardians of all schoolchildren participating in the study.
Cell isolation
PBMCs were isolated by Ficoll-Hypaque density gradient centrifugation from 20 ml of 
heparinized blood. B cells were isolated with anti-CD19 MicroBeads (Miltenyi Biotec). The 
isolated B cells were routinely ~95% pure.
Immunoglobulin assays
Plasma samples were analyzed using the Bio-Plex Pro Assays Immunoglobulin Isotyping Kit 
(Bio-Rad) for total IgM, IgG1, IgG2, IgG3, IgG4 and IgA levels according to manufacturers’ 
recommendations. Levels of total IgE were measured by ELISA according to manufacturers’ 
instructions (Allergopharma). 
B cell stimulation, staining of CD23 and intracellular TNF-α and Ki-67
Freshly isolated B cells were cultured in RPMI 1640 medium (Invitrogen) supplemented with 
10% FCS (Greiner Bio-One), 100 U/ml penicillin (Astellas), 10 µg/ml streptomycin, 1 mM 
pyruvate and 2 mM L-glutamine (all from Sigma). B cells were seeded at 1 x 105 cells per well 
and stimulated for 48 hours with 2.5 µg/ml anti-human IgG + IgM (Jackson ImmunoResearch), 
5 µg/ml CpG ODN 2006 (Invivogen) or anti-IgG/IgM + CpG. To detect intracellular TNF-α, B cells 




100 ng/ml ultrapure LPS (Invivogen) for 6 hours with the final 4 hours in the presence of 10 µg/
ml brefeldin A (Sigma-Aldrich), followed by fixation with the FoxP3 fixation/permeabilization 
kit (eBioscience) and frozen in RPMI supplemented with 20% FCS and 10% DMSO (Merck) and 
stored at -80ºC until FACS analysis. After thawing, cells were permeabilized (Permeabilization 
buffer, eBioscience) and labeled with surface anti-CD10-PerCP/eF710 (SN5c, eBioscience), 
anti-CD20-APC/eF780 (2H7, eBioscience), anti-CD21-FITC (LT21, BioLegend), anti-CD23-PE/
Cy7 (EBVCS2, eBioscience), anti-CD27-APC (L128, BD Biosciences), and intracellular anti-Ki-67-
eF450 (20Raj1, eBioscience) and anti-TNF-α-biotin (MAB11, eBioscience) followed by second 
incubation with streptavidin-Qdot525 (Invitrogen).
Characterization of B cells in peripheral blood
For immunophenotyping freshly isolated PBMCs were fixed in 2.4% formaldehyde (Sigma-
Aldrich) for 15 minutes at room temperature and, subsequently, frozen in RPMI 1640 medium 
supplemented with 20% FCS and 10% DMSO and stored at -80ºC until FACS analysis. After 
thawing, cells were washed and stained for 30 minutes with anti-CD19-PB (HIB19, eBioscience), 
anti-CD21-FITC (LT21, BioLegend), anti-CD27-APC (L128, BD Biosciences), anti-CD27-APC/
eF780 (O323, eBioscience), anti-HLA-DR-APC/Cy7 (L243, BioLegend) and anti-IgD-biotin (IA6-2, 
BD Biosciences) followed by second incubation with streptavidin-Qdot525 (Invitrogen). Anti-
FCRL4-biotin was kindly provided by M. Cooper (Emory University School of Medicine, Atlanta, 
GA, USA). Alternatively, cells were stained with anti-CD19-BV510 (HIB19, BioLegend), anti-IgA-
FITC, anti-IgA-PE (both IS11-8E10, Miltenyi Biotec), anti-CD21-PE/Cy7 (LT21), anti-CD23-APC 
(EDVCS5), anti-CD27-PerCP/Cy5.5 (L128), anti-CD38-APC/Cy7 (HB7), anti-IgD-PE/CF594 (IA6-
2), anti-IgG-PE (G18-145) and anti-IgM-V450 (G20-127) (all from BD Biosciences). Cells were 
acquired on FACSCanto II and LSR Fortessa flow cytometers (both from BD Biosciences).
Statistical analysis
Differences between study groups were tested using Fisher’s exact test for gender and co-
infections and by Mann-Whitney U test for Schistosoma infection intensity. Age was normally 
distributed and differences between infection groups were tested using the independent 
student’s T test. Serological and cellular differences between infection groups were tested by 
the Mann-Whitney U test. Differences within the same group between baseline and follow-
up were compared by Wilcoxon matched pairs test. P-values less than 0.05 were considered 
significant and less than 0.1 a trend. *** p< 0.001, ** p< 0.01, * p< 0.05 and # p< 0.1.
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Supplementary Figure 1. Gating strategy for B cell inflammatory cytokine response, activation and 
proliferation. 
Total peripheral blood B cells were cultured with anti-IgG/IgM (2.5 μg/ml), CpG (5 μg/ml) or anti-IgG/IgM 
plus CpG for two days, restimulated with PMA/Ionomycin/LPS and BrefA and fixed. Levels of intracellular 
TNF-α (A), CD23 expression (B) and intracellular Ki-67 (C) were gated according to the gating strategy 
depicted in this figure (representative S. haematobium-uninfected child). 
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Supplementary Figure 2. MBC analysis.
PBMC were fixed and stained with B cell phenotyping markers (CD19, CD27 and IgD) and analyzed for 
B cell subsets by flow cytometry. B cell subset analysis was performed as shown in (A) (representative S. 
haematobium-uninfected child). Proportion of CD19-gated cells that were CD27+IgD- (B, switched MBC), 
CD27+IgD+ (C, non-switched MBC), CD27-IgD- (D, double negative MBC), and CD27-IgD+ (E, naïve B cells) 
were determined for S. haematobium-infected and uninfected children at baseline. (B, C, D, E) Horizontal 




Supplementary Figure 3. Expression of FCRL4 and HLA-DR on B cell subpopulations.
PBMC were fixed and stained with B cell subset markers (CD19, CD21 and CD27) and measured for FCRL4 
(A) and HLA-DR (B) expression in S. haematobium-uninfected children by flow cytometry. Histograms of MFI 
underneath are from a representative child. Horizontal bars represent median. Number of donors: baseline 

















































A successful response against invading pathogens results from a complex interplay between 
the many diverse cell types of the immune system. Following pathogen exposure a non-
specific innate immune response is orchestrated by neutrophils, macrophages, NK cells and 
eosinophils which act as the first line of defense against invading organisms [1]. Pattern 
recognition receptors (PRRs), such as Toll-like receptors (TLRs) and C-type lectin receptors 
(CLRs), which recognize pathogen-associated molecular patterns (PAMPs) play a key role at this 
stage [2]. Next an antigen-specific adaptive immune response, which may take days to develop, 
is mounted. Here antigen presenting cells (APCs) play an important role in linking innate and 
adaptive immune responses and direct the initiation and polarization of T and B cell activities. 
T cells differentiate into various effector cells depending on the type of infection, while B cells 
undergo differentiation and most will become antibody-producing plasma cells [1]. The Th1 
(IFN-γ producers) / Th2 (IL-4, IL-5 an IL-13 producers) paradigm of T helper subsets has recently 
been expanded to include the immunosuppressive IL-10/TGF-β-producing CD4+CD25+FOXP3+ 
T regulatory T cells (Tregs) and the pro-inflammatory IL-17-producing T cells (Th17) [3]. 
Interaction between B cells and T cells is also important for adaptive immunity; CD4+ T cells 
provide help to B cells [4] and new data has shown that B cells also act as modulators of T cell 
responses via their effector and regulatory functions [5].
The elucidation of the various interactions and activities between these different 
components is essential to fully understand the mechanisms during human schistosome 
infection which will then in turn provide better foundation for the design and implementation 
of strategies to manage, prevent and eradicate this disease. Knowledge gained here could also 
have important bearings on other helminth infections. 
In this thesis we have investigated cross-sectionally and longitudinally the effect of 
schistosomes on several aspects of the immune system, including innate, adaptive and 
regulatory responses, in a group of schoolchildren in an area in Gabon where S. haematobium 
is endemic.
Innate Immune Responses
In Chapters 2, 3 and 4 we have investigated innate immune responses directed against TLR 
and CLR ligands in S. haematobium-infected children and in uninfected controls by measuring 
cytokine responses against these ligands in either whole blood or PBMC cultures. We have 
found that while in PBMC cultures differences were observed to the TLR2/1 ligand Pam3, with 
higher levels of the pro-inflammatory cytokine TNF in S. haematobium infected children, this 
difference was no longer detectable when the same response was analyzed in whole blood 
cultures. The initial finding of an increased pro-inflammatory innate immune response in PBMC 
cultures to TLR stimulation (Chapter 3) was rather intriguing as schistosome infection has, 
for the most part, been characterized in terms of strong antigen-specific Th2 and regulatory 
responses resulting in immune hypo-responsiveness [6–8]. These findings challenged the 
predominant view of general immune suppression induced by the parasite and showed that 
hypo-responsiveness did not extend to innate immune responses in the context of single TLR 
ligation. However, when whole blood cultures were stimulated with the TLR ligands, we did not 




4). The differences between whole blood and PBMC cultures may result from differences in cell 
composition. Whole blood assays reflect an environment in which the different cell types in 
their in vivo ratios are present and contain cells such as erythrocytes, and granulocytes as well as 
plasma which may influence or contribute to the cytokine response measured [9]. Neutrophils 
and eosinophils in particular are known to produce many Th1/Th2/pro-inflammatory cytokines 
which may alter the cytokine milieu resulting in differences between total cytokines measured 
in whole blood and PBMC cultures [10,11]. Moreover, in whole blood assays the number of 
cells cultured is not known nor is it controlled for, and thus changes in the number of cytokine 
producing cells may be responsible for the differences observed rather than the ability of 
cells to produce cytokines. In contrast, PBMC cultures use the same number of cells for each 
individual thereby giving a more controlled measure of the functionality of the studied cells. 
Importantly, as shown in Chapter 4, the presence or absence of co-infections such as malaria 
can contribute to innate immune responsiveness; this infection can change with the season or 
the specific area of a study and thereby influence responses measured. 
In addition to TLR responses we also investigated two other classes of PRRs, the C-type 
lectin receptors (CLRs) (Chapters 2 and 4) and nucleotide-binding oligomerisation domain-like 
receptors (NLRs) (Chapter 2). Responses of these receptors cannot be studied on their own as 
most do not contain signaling domains and therefore do not lead to cytokine production. It 
has been proposed that innate immune responses can be fine-tuned via interaction between 
distinct PRRs [12,13]. An elegant way of studying their function is to look at the ability of these 
receptors to enhance or diminish TLR responses. While we found significant interactions between 
the different classes of PRRs, both synergistic and inhibitory, we did not find any differences in 
these responses between S. haematobium-infected and uninfected children. Nonetheless there 
is increasing evidence that schistosome antigen recognition by host C-type lectins plays an 
important role in shaping the immune response against infection [14]. Schistosomes express 
various carbohydrates containing glycoproteins on their surface and release glycan-rich E/S 
products that have been shown to bind to various CLRs, including DC-SIGN, MR, MGL [15] and 
Dectin-2 [16]. Furthermore, increased expression of DC-SIGN on DCs was recently shown to be 
required for Th17 cell differentiation in response to schistosome eggs and the development 
of immunopathology in a mouse model of S. mansoni infection [17]. It would be of interest to 
study responses to CLRs in PBMC cultures, or in well defined, specific cell subsets, incorporating 
flow cytometry to measure receptor expression on cells before and after stimulation. 
In Chapter 2 we compared responses between the different groups of schoolchildren 
from Gabon and an age-matched group of European children from the Netherlands to help 
us understand how the innate immune response can be affected by large geographical and 
environmental influences. We did not observe any differences in the interaction between the 
different classes of PRRs between these groups; however we did find a significant difference 
in TLR responsiveness. Gabonese children had a lower pro-inflammatory response to poly(I:C) 
(TLR3 ligand), but a higher pro-inflammatory response to FSL-1 (TLR2/6 ligand), Pam3 (TLR2/1 
ligand) and LPS (TLR4 ligand) compared to Dutch children. Anti-inflammatory responses to 
Pam3 were also higher in Gabonese children. Differences in these responses may result from 




molecules involved downstream but it is also possible that environmental exposures shape 
the contrasting innate immune responses. Environmental exposures to viruses, bacteria and 
parasites may have played a role by resulting in an imprinted ‘memory’ which has recently 
been termed ‘trained innate immunity’ [22]. Differences between being born and raised in a 
high-income (Netherlands) versus a low-income (Gabon) country, dietary habits or vaccination 
schedules may have further played an important role. 
Adaptive Immune Responses
In Chapters 3 and 4 we investigated adaptive immune responses directed against schistosome 
soluble egg (SEA) and adult worm antigens (AWA) and in Chapter 5 we further extended this 
analysis to the vaccine-antigen Bacillus Calmette–Guérin (BCG). In Chapter 7 we carried out an 
extensive phenotypic investigation of the memory B cells subsets. 
We found that S. haematobium-infected children had significantly higher levels of IL-10 in 
response to SEA, and IL-5, IL-10 and IL-2 in response to AWA compared to the uninfected controls. 
Interestingly, IL-10 levels were increased in infected children irrespective of whether this cytokine 
was measured in whole blood (Chapter 4) or in PBMC cultures (Chapter 3) demonstrating the 
reproducibility of the increase in this anti-inflammatory regulatory response. Higher IL-10 
levels are in line with previous studies in S. haematobium [23,24] and filarial infection [25]. Anti-
schistosome treatment with praziquantel resulted in the increase of the levels of SEA and AWA 
specific IL-5 and IL-10, SEA specific TNF, and AWA specific IL-2 (Chapter 4). In Chapter 5 we used 
Principle Component Analysis (PCA) to describe global changes in cytokine responses following 
schistosome treatment in response to not only SEA and AWA stimulation but also to a third-
party antigen BCG. PCA allows the reduction of large datasets into summary variables termed 
principal components with each principal component representing variables that share a high 
level of correlation [26]. In the current study we identified two distinct principal components: 
principle component 1 (PC1) which reflects regulatory and Th2-polarized cytokine responses 
due to its positive loading with IL-5, IL-10 and IL-13 responses; and principle component 2 
(PC2) which reflects pro-inflammatory and Th1-polarized cytokine responses due to its positive 
loading with IFN-γ, IL-17 and TNF. We saw a significant increase in both PC1 and PC2 following 
treatment compared to baseline values. These results are in line with a number of short-term 
(weeks) as well as long-term (months) treatment studies, which likewise show enhanced antigen 
specific responses following removal of infection [27–31]. An increase in all four types of immune 
responses i.e. Th1, Th2, regulatory and pro-inflammatory, suggests that treatment results in the 
removal of general schistosome-mediated immunosuppression of adaptive responses, but 
may also in part be due to the release of previously cryptic antigens from the dying parasites 
resulting in boosting of the recall response [28,32]. Indeed repeated anthelminthic treatment 
and therefore by extension repeated exposure to antigen has been shown to result in greater 
cytokine production than single treatment [33]. Nonetheless strategies which would further 
disentangle immunosuppression and regulatory responses, from enhanced responses due to 
antigen release are warranted. The role of regulatory responses in schistosomes-induced hypo-
responsiveness is discussed in detail in the next section.




infection [34–36]. Multiple phenotypically distinct memory B cell (MBC) subsets have been 
characterized in humans [37–39]. The study presented in Chapter 7 of this thesis investigated the 
frequency of these subsets based on differential expression of CD27, CD21 and IgD. Frequencies 
of switched, double negative and activated MBCs, as well as a trend toward a higher percentage 
of atypical MBCs was observed in schistosome-infected children. A concomitant decrease of 
naïve B cells was also observed. These profiles were restored to those observed in uninfected 
children following treatment. It is of particular interest that double negative MBCs as well as 
the atypical MBCs were increased during infection as these two subsets have been linked to 
hypo-responsiveness and an exhausted phenotype in HIV- [39], in malaria-infected individuals 
[40,41], and in patients with systemic lupus erythematosus [42,43], a chronic autoimmune 
disease. Atypical MBCs have a decreased ability to differentiate into antibody secreting cells 
resulting in reduced pathogen-specific antibody responses in infected individuals. The capacity 
of these cells to produce schistosome-specific antibodies or the extent of their exhausted 
phenotype is currently not known. However, an increase in IgG+ double negative (CD27-IgD-) 
MBCs was observed in S. haematobium infected children which reflected the increase in total 
serum IgG4 levels. Following praziquantel treatment there was a concomitant decrease in the 
frequency of the DN MBCs and serum levels of IgG4, suggesting that the increase in IgG+ DN 
MBCs may be predominantly due to an increase in IgG4-expressing B cells during infection. As 
IgG4 is associated with susceptibility and IgE with resistance to schistosome infection, it would 
be of interest to study these isotypes on the different memory B cell populations in exposed 
but resistant individuals. 
Regulatory Responses
Recent studies have emphasized the significant role of the regulatory networks in the immune 
suppression induced by parasitic infections [6]. The role of regulatory T cells (Tregs) in particular 
has shown the multifaceted nature of this immune response. Accumulating evidence has shown 
that parasitic helminths induce Treg expansion and/or activity. These cells produce down-
modulatory cytokines such as IL-10 and TGF-β that lead to a dampened immune response 
[44,45]. These are in line with studies in murine models where the abrogation of Treg activity 
leads to recovery from chronic parasite infection by restoring immune function [46–48] 
In Chapter 4, in addition to measuring cytokine responses to schistosome-specific antigens 
we concurrently evaluated the frequency of CD4+CD25+FOXP3+ T cells. We found that the 
frequency of CD4+CD25+FOXP3+ T cells was significantly increased in S. haematobium-infected 
schoolchildren and reduced to ‘normal’ levels after praziquantel treatment. The differences 
between infection groups in the frequency of CD4+CD25+FOXP3+ T and the change in these 
over time showed an inverse pattern to antigen-specific cytokine responses. Using a linear 
mixed-effects model to assess the longitudinal association between CD4+CD25+FOXP3+ 
T cell levels and cytokine responses to schistosomal antigens we showed that the decrease 
in the frequency of CD4+CD25+FOXP3+ T cells over time following treatment is inversely 
associated with an increase in IL-5 and IL-10 cytokine production. Alongside the decrease in 
CD4+CD25+FOXP3+ T cells and the increase in antigen-specific cytokine responses we also 




treatment suggesting that hypo-responsiveness may also in part be linked to the memory T 
cell pool. However, as we did not have sufficient data across all time points for TEM frequencies 
we were not able to assess the longitudinal association between TEM and cytokine levels 
and CD4+CD25+FOXP3+ T cell frequencies. To further assess the functional contribution of 
CD4+CD25+FOXP3+ T cells to in vitro immune responses, we performed magnetic depletion of 
CD25hi cells and analysed cytokine responses before and after CD4+CD25+FOXP3+ T cell depletion 
at both pre- and post-treatment in Chapter 5. As in Chapter 4 we found a significant decrease 
in CD4+CD25+FOXP3+ T cells following treatment. Similar to evaluating adaptive cytokine 
responses in Chapter 4, here we also evaluated the effect of CD4+CD25+FOXP3+ T cell depletion 
on principal component 1 (IL-5, IL-10 and IL-13) and principal component 2 (IFN-γ, IL-17 and 
TNF). We found CD4+CD25+FOXP3+ T cell depletion resulted in increased values of both PC1 
and PC2 in infected individuals. Although levels of CD4+CD25+FOXP3+ T cells were decreased 
following treatment their suppressive capacity was intact: the depletion of the regulatory T 
cells at post treatment also led to increase in PC1 and PC2. We also evaluated the effect of 
CD4+CD25+FOXP3+ T cell depletion on cell proliferation. Interestingly, while CD4+CD25+FOXP3+ 
T cell depletion resulted in similar increase in cytokine production at both pre- and post-
treatment, proliferative responses were for the most part only significantly affected by 
CD4+CD25+FOXP3+ T cell depletion in infected individuals at pre-treatment. Following removal 
of infection CD4+CD25+FOXP3+ T cell depletion no longer suppressed cell proliferation. This 
suggests that while a reduction in CD4+CD25+FOXP3+ T cell numbers is sufficient to abrogate 
the suppressive qualities of CD4+CD25+FOXP3+ T cells on proliferation, the functional changes 
induced in CD4+CD25+FOXP3+ T cells by schistosome infection still persist in terms of their 
ability to influence the production of effector cytokines 6 weeks after treatment. Interestingly, 
an IL-10 producing CD8+CD25+FOXP3+ T cell population has also been recently described [49–
51] and as CD25+ cell depletion will, in addition to depleting CD4+CD25+FOXP3+ T cells, also 
deplete the CD8+CD25+FOXP3+ T cell population, future studies are needed to re-assess the 
relative contributions of these subsets. Moreover as FOXP3 expression may be transiently up-
regulated on activated CD4+ T cells [52], future studies will need to include more extensive 
panels of markers associated with suppressive T cell functions. 
Although much research has focused on the role of regulatory T cells it is likely that other 
immune cells are also involved. While predominantly characterized as being involved in 
humoral immunity through the production of antibodies, B lymphocytes possess multiple 
additional functions, including production of cytokines, for example IL-10 and TGF-β, and the 
ability to function as APCs through the expression of MHC class II molecules which are involved 
in presentation of antigens to T cells [53–55]. In addition, these cells express a variety of PRRs, 
in particular TLRs, which might be involved in the amplification and possible polarization of 
the signals given to T cells that are being activated by B cells [56–59]. They have been shown 
to be involved in immune tolerance and suppression of disease including inflammatory bowel 
disease, rheumatoid arthritis, experimental autoimmune encephalomyelitis and multiple 
sclerosis [55]. More importantly they have also been shown to be involved in the induction 
of immune regulation during parasitic infections, such as Toxoplasma gondii, Heligmosomides 




Figure 1. A schematic representation of innate, adaptive and regulatory immune responses in 
human schistosomiasis in Gabon. 
S. haematobium infection induces increased frequencies of regulatory B (Breg) and T (Treg) cell subsets 
which are associated with increased levels of IL-10 and hypo-responsiveness, possibly in effector memory 
T cells (TEM). In addition, exhausted B cell are also increased. Praziquantel treatment results in the reduction 
of regulatory and exhausted subsets, an increase in effector T cells and alleviation of suppressed antigen 
immune responses.
S.mansoni infection compared to wild-type mice [61]. Furthermore a number of regulatory B 
cell subsets (Bregs) have been characterised in humans [62–64] and in Chapter 6 we assessed 
the frequency of these subsets. We found no differences in the levels of CD24hiCD38hi or 
CD24hiCD27+, but we did observe a significant increase in the frequency of CD1dhi(CD5+) Bregs 
in schistosome infected children. The increase in CD1dhi(CD5+) Bregs was accompanied by an 
increase in IL-10-producing B cells in the total B cell population. In particular CD1dhi B cells from 
infected children produced more IL-10 as compared to uninfected children. Both the frequency 
of CD1dhi(CD5+) Bregs and total IL-10 levels decreased following treatment to levels comparable 
to the uninfected children. Schistosome-specific IL-10 in CD1dhi(CD5+) Bregs however were 
not down-regulated following treatment suggesting that a small population of schistosomes-




Immunosupression as a result of anergy
An alternative or perhaps a concurrent explanation for suppression of antigen-specific cytokine 
responses by regulatory cells during schistosome infection is an intrinsic unresponsive or 
hypo-responsive state of the T cells. T cell anergy has been described during chronic helminth 
infection in both mice and humans, where CD4+ Th2 cells develop an intrinsically unresponsive 
functional state [45]. The hypo-responsiveness in Th2 cells has been shown to be dependent 
on the up-regulation of the expression of the E3 ubiquitin ligase GRAIL (gene related to anergy 
in lymphocytes). Removal of Th2 cells from antigen exposure results in the down-regulation 
of GRAIL and a dramatic restoration of function [65]. Mouse studies have also shown a role for 
a number of inhibitory receptors, including PD-1 and TIM-1, and expression of PD-1 ligands 
PD-L1 and PD-L2 by macrophages that inhibit T cell immunity in S. mansoni infection [66–68]. 
Future studies are needed to address the role of these molecules in human infections.
Spill-over suppression
The strong immunoregulatory network that induces immunosuppression during the course 
of schistosomiasis, and also during other helminth infections, can be both detrimental as well 
as beneficial. Spill-over suppression to third-party antigens may lead to impaired responses 
to infections, cancers or vaccines. Helminth infections induce a Th2 bias, while a strong Th1 
response is desirable during vaccination. Impaired Th1 responses to Bacille Calmette- Guérin 
(BCG), to tetanus toxoid, and to influenza virus have been seen in helminth infected individuals 
[69–71]. Another detrimental effect to be considered is that helminth infections may exert a 
negative role on cancer incidence or progression [72]. It is thought that a ‘healthy’ immune 
system can naturally control spontaneously arising tumours, and it has been shown that 
immune deficiencies can predispose to carcinogenesis [73], therefore an immunosuppressive 
environment induced by helminth infection may prevent the host from mounting an effective 
response against cancers or impair responses to anti-cancer therapeutics. The negative effects 
of helminths may also extend to responses to concurrent infections [74–76]. Protective immune 
responses against P. falciparum are associated with a Th1 response which leads to production 
of protective IgG1 and IgG3 antibodies [77,78]; Th1 responses can be down-regulated during 
chronic schistosome infection where responses are skewed towards Th2 [79]. With respect to 
clinical outcome of malaria, which is thought to result from strong pro-inflammatory response, 
there are studies that have shown a protective effect of helminths on malaria [80,81]. This is 
thought to be as a result of the ability of helminths to induce regulatory T cells which by down-
regulating strong inflammatory responses could prevent the incidence of clinical malaria.
On the other hand spill-over suppression to third party antigens might be beneficial 
against excessive inflammatory responses observed in allergies, asthma, autoimmune diseases 
and even cardiovascular diseases or metabolic disorders. A large number of epidemiological 
studies on the prevalence of allergies in helminth infected individuals have shown a negative 
association between helminth infections and allergies (in particular skin reactivity to allergens) 
[82,83]. Various helminth species have also been shown to limit inflammatory activity in a 
variety of diseases including inflammatory bowel disease (IBD), multiple sclerosis (MS), type 




disease (CVD) [84,85] .The protective role during helminth infections has for the most part been 
linked with the induction of the regulatory network [86]. A number of clinical trials with either 
Trichuris suis (the pig whipworm) eggs or Necator americanus (human hookworm) live worms 
have been conducted and several are currently underway investigating the effects on MS, IBD, 
allergic rhinitis, celiac disease and even autism [86]. Ideally however, specific helminth-derived 
molecules would be needed for therapeutic application to remove the negative aspects of 
helminth infections in these treatment strategies.
Concluding remarks and future perspectives
The studies described in this thesis have demonstrated the interconnectedness between 
the various arms of the immune response mounted against and induced by S. haematobium 
infection. By showing that regulatory T cells are linked to effector responses in schistosomiasis 
and that schistosomes can induce regulatory B cells, the scene is set for future studies to 
determine antigen specificity of these cells as well as ways to control their activity.
 As regulatory responses have been shown to be not only important in chronic infectious 
disease, but also in chronic inflammatory diseases the knowledge gained here may be of 
substantial value to the health of those living in both low- to middle-income countries as well 
as high-income countries. Specifically, a number of important issues need to be considered: 
 - Regulatory responses induced by helminth infections can affect immune responses 
to vaccines. Therefore helminth status should be an important consideration for vaccination 
programs and trials; deworming is needed for optimal vaccine efficacy.
 - Targeted drug therapy and population-based treatment programs are currently 
advocated by multiple agencies, including the WHO, as major components of schistosomiasis 
control strategies. Mass drug administration programs are also in place to treat other 
helminth infections. However, as deworming might be positively associated with allergy and 
inflammatory diseases it is imperative that follow-up studies on immunological parameters in 
individuals from endemic settings are conducted to monitor the effects on the development of 
inflammatory conditions. 
 - Extensive characterisation of immune response during infection will furthermore 
pave the way for more successful vaccine development against schistosomiasis which is 
sorely needed as re-infection rates are extremely high in endemic settings and repeated drug 
treatment may lead to drug-resistant schistosomiasis.
The use of novel high-dimensional technologies such as trancriptomics, metabolomics 
and microbiomics will further improve our understanding and give a more complete picture of 
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Parasitic infections have been a human companion for millennia and currently a quarter of 
the world’s population are infected with helminth worms. The long co-existence of worms and 
humans has profoundly influenced the human immune response. A healthy immune response 
will have a fine balance between effector mechanism directed against invading pathogens 
and regulatory mechanisms which keep the effector mechanisms in check and protect the 
body from tissue damage and inflammation. As our immune system has evolved to function in 
pathogen-rich environments, recent improvements in healthcare and hygiene may contribute 
to increased incidence of allergy, autoimmune disorders, cardiovascular diseases and other 
inflammatory conditions observed in Westernized countries today. It has been proposed that 
the decrease in infectious diseases is directly related to the increase in these disorders due 
to insufficient education of the immune system and an underdeveloped regulatory response. 
Chronic helminth infections, including schistosomiasis, have been shown to induce regulatory 
mechanisms, and the protective effect of helminth infections is very likely due to the down-
regulation of the immune response by the parasite to ensure its own survival, which extends 
to bystander antigens i.e. allergens or self-antigens. However, down- regulation of the immune 
response, while protective against innocuous challenges, may also adversely affect immune 
responses against other pathogens, the efficacy of drug treatments or vaccine responses. 
The mechanisms and consequences of immunomodulation induced by helminth infections 
are therefore of tremendous interest, as a better understanding of these will contribute towards 
new possibilities for control of infection and pathology and therapeutic applications in the 
treatment or even prevention of hyper-inflammatory disorders.
The work presented in this thesis is an investigation of the immune responses induced by 
chronic schistosomiasis in Gabonese schoolchildren. By investigating concurrently various 
aspects of the immune response we are able to gain a more in-depth  understanding of the 
dynamic changes brought about by infection. 
In Chapter 1, the background and context of the research is described, the study population 
and the area are introduced and the study objectives are outlined.
In Chapter 2, we compare innate immune responses to several classes of pathogen 
recognition receptors (PRRs) between semi-urban and rural African schoolchildren and 
European schoolchildren using identical reagents and experimental protocols in order to 
assess whether innate responses are affected by environmental factors. We show that while 
differences in response to Toll-like receptors (TLRs) stimulation are present, no differences to 
C-type lectin receptors (CLRs) or nucleotide-binding oligomerisation domain-like receptors 
(NLRs) were detected. Possible explanations for the differences in cytokine production 
observed in response to TLR ligands including variations in TLR expression levels, differences 
in downstream signalling pathways or differential exposure to viruses, bacteria and parasites 
are discussed.
Chapter 3 addresses differences in innate or non-specific and adaptive or specific  immune 
responses in peripheral blood mononuclear cells (PBMCs) between S. haematobium-infected 
schoolchildren and uninfected controls. We find that innate immune responses are pro-





responses play an important role in adaptive immune hypo-responsiveness, a hallmark of 
chronic schistosomiasis, and we show that immune hypo-responsiveness induced by S. 
haematobium infection does not extend to innate immune responses.
In Chapter 4, we compare whole blood immune responses of S. haematobium-infected 
children before and after treatment with praziquantel and in parallel include uninfected children 
as controls. We find that innate immune responses do not differ between infection groups. 
The difference in innate responses observed between Chapters 3 and 4 may be explained by 
differences in cell composition in  whole blood (in Chapter 4) versus PBMC (in Chapter 3). With 
respect to adaptive immune responses, infected children recognized schistosomal antigens, 
whereas uninfected children did not. Moreover, we show that antigen-specific responses that 
are seen in infected children are significantly increased following removal of infection. We 
provide evidence that regulatory T cells (CD4+CD25+FoxP3+) which were higher in infected 
children, decreased following anti-schistosome treatment and this decrease is associated with 
an increase in adaptive immune responses. These results for the first time provide evidence for 
the association between schistosome infection, regulatory T cells and antigen-specific immune 
hypo-responsiveness in humans.
In Chapter 5, we further expand our analysis of regulatory T cells and investigate the role of 
CD4+CD25+FoxP3+ regulatory T cells on cell proliferation and cytokine production in response 
to antigens in PBMCs before and after praziquantel treatment. We use principal component 
analysis (PCA), a data reduction approach, to study cytokine responses globally. We show that 
schistosome infection is associated with increased frequencies of Treg cells, which decrease 
following treatment. The reduction in Treg frequencies was accompanied by an increase in 
cytokine responses following treatment. Treg depletion studies confirm the inhibitory nature of 
these cells as their depletion resulted in increased cytokine production both at pre-treatment 
and post-treatment. Proliferative responses for the most part were not as significantly affected 
as cytokine responses.
We next address the role of B cells in the course of schistsome infection. In Chapter 6, we 
show novel data that schistosomiasis induces regulatory B cell (Breg) cells which like regulatory 
T cells are negative regulators of immune responses. We show that Gabonese schoolchildren 
have an elevated population of CD1dhi B cells and that these cells produce elevated levels of 
IL-10. Importantly, after anti-schistosome treatment the frequency of these cells is reduced to 
levels comparable to the uninfected children. 
In Chapter 7, we show that in addition to altered frequencies of Bregs, the frequency 
of memory B cell (MBC) subsets is increased in infected schoolchildren. At the functional 
level, these cells, while more activated,  have reduced proliferation and pro-inflammatory 
cytokine production. Treatment resulted for the most part in restoration of function. Results 
in this chapter show that S.haematobium infection leads to significant changes in the B cell 
compartment both at the phenotypic and functional level.
Finally, in Chapter 8, the findings of this thesis are summarized. The interaction between 
innate, adaptive and regulatory responses is discussed and in particular emphasis is placed on 
regulatory responses. As regulatory responses have been shown to be not only important in 




here may be of substantial value to the health of those living with infection and those currently 





Mensen dragen al millennia lang parasieten met zich mee en momenteel is een kwart 
van de wereldbevolking geïnfecteerd met wormen. Aangezien mensen in de loop van 
de evolutie voortdurend bloot zijn gesteld aan een rijke microbiële omgeving, ligt het in 
de lijn der verwachting dat de relatie van mensen tot ‘hun’ wormen gezien kan worden 
als één met commensalen en het afweersysteem ook ontwikkeld is om optimaal te 
functioneren in de voortdurende aanwezigheid van deze commensalen. Een gezonde 
afweerreactie wordt gekenmerkt door een balans tussen ontstekingsreacties gericht tegen 
binnendringende ziekteverwekkers, genaamd pathogenen, en tolerantieprocessen die deze 
ontstekingsreacties in toom moeten houden wanneer de pathogenen opgeruimd zijn. Deze 
tolerantiemechanismen beschermen het lichaam tegen weefselschade veroorzaakt door de 
ontstekingsreacties. In de afgelopen decennia is de gezondheidzorg en hygiëne in de westerse 
wereld enorm verbeterd, maar tegelijkertijd nam het aantal gevallen van ontstekingsziekten 
zoals allergieën, auto-immuunziekten en hart- en vaatziekten enorm toe. Verondersteld 
wordt dat een direct verband bestaat tussen de toename in deze ontstekingsziekten en de 
afname in infectieziekten. Aangezien ons afweersysteem is geëvolueerd om te functioneren 
in een pathogeenrijke omgeving, vermoedt men dat door de afname van infectieziekten het 
afweersysteem, en dan met name de aanmaak van tolerantieprocessen, onvoldoende wordt 
getraind. Daarentegen komen deze typische westerse ontstekingsziekten nog weinig voor in 
ontwikkelingslanden, maar komen er nog wel veel parasitaire infecties voor. Het is aangetoond 
dat chronische worminfecties, waaronder schistosomiasis, tolerantieprocessen kunnen 
opwekken. Het beschermende effect van worminfecties wordt vermoedelijk veroorzaakt 
door onderdrukking van ontstekingsreacties, waarmee de parasiet zijn eigen overleving 
veilig stelt. Deze tolerantieprocessen zouden ook neveneffecten veroorzaken, zoals een 
verminderde ontstekingsreactie op onschuldige allergenen zoals huisstofmijt en graspollen en 
lichaamseigen stoffen. Hoewel deze tolerantieprocessen op een positieve manier beschermen 
tegen overbodige reacties op onschuldige stoffen, zouden ook ontstekingsreacties tegen 
andere pathogenen en de effectiviteit van medicijnen en vaccins op een nadelige manier 
beïnvloed kunnen worden.
Onderzoek naar de mechanismen en gevolgen van de opgewekte ontstekingsreacties 
veroorzaakt door worminfecties zijn van groot belang, aangezien een beter begrip ervan kan 
bijdragen aan nieuwe mogelijkheden om infecties en weefselschade te beheersen en om zo 
typische westerse ontstekingsziekten te behandelen of zelfs te voorkomen.
Dit proefschrift beschrijft onderzoek naar afweerreacties tegen chronische schistosomiasis 
in Gabonese schoolkinderen. Door gelijktijdig verschillende aspecten van de afweerreacties 
te onderzoeken, zijn we in staat de dynamische veranderingen veroorzaakt door de infecties, 
beter te begrijpen.
In hoofdstuk 1 wordt de achtergrond en context van het onderzoek beschreven, worden 
de studiepopulatie en het studiegebied geïntroduceerd en worden de studiedoelstellingen 
uiteengezet. 
In hoofdstuk 2 vergelijken we de aangeboren of aspecifieke afweerreacties in het bloed van 




gebruik van identieke reagentia en experimentele protocollen. De stimulatie van verschillende 
soorten receptoren die pathogenen herkennen, zoals  Toll-‘like’-receptoren (TLR), C-type-
lectine-receptoren (CLR) en nucleotide-bindende-oligomerisatie-domein-‘like’-receptoren 
(NLR), werd onderzocht zodat kon worden vastgesteld of aangeboren afweerreacties beïnvloed 
werden door omgevingsfactoren. We tonen aan dat, hoewel er verschillen waren in reacties 
op stimulatie van TLR, er geen verschillen werden gedetecteerd bij CLR of NLR receptoren. 
In dit hoofdstuk worden mogelijke verklaringen besproken voor de verschillen in productie 
van cytokines (signaalstoffen) die zijn waargenomen in reactie op TLR stimulaties, waaronder 
mogelijke verschillen in de genexpressie van de TLR receptoren, verschillen in onderliggende 
signaleringsroutes of verschillende blootstelling aan virussen, bacteriën en parasieten.
Hoofdstuk 3 richt zich op verschillen in aangeboren (of aspecifieke) en verworven (of 
adaptieve) ontstekingsreacties in witte bloedcellen uit veneus bloed tussen S. haematobium-
geïnfecteerde en ongeïnfecteerde schoolkinderen. We hebben gevonden dat aangeboren 
afweerreacties ontstekingsbevorderend werken en verworven reacties ontstekingsremmend. 
We tonen aan dat de ontstekingsremmende reacties, ofwel tolerantieprocessen, die een 
belangrijke rol spelen in immuunhyporesponsiviteit van adaptieve of verworven afweerreacties 
bij chronische schistosomiasis, zich niet uitstrekken tot aangeboren afweerreacties.
In hoofdstuk 4 vergelijken we afweerreacties in volbloedkweken van S. haematobium-
geïnfecteerde kinderen voor en na behandeling met praziquantel en in parallel met 
ongeïnfecteerde kinderen als controles. We tonen aan dat aangeboren afweerreacties niet 
verschillen binnen de infectiegroepen. Het verschil in aangeboren afweerreacties tussen 
hoofdstuk 3 en 4 zou verklaard kunnen worden door verschillen in celsamenstelling in het 
bloed (in hoofdstuk 4) en in de geïsoleerde witte bloedcellen (in hoofdstuk 3). In het geval 
van de verworven afweerreacties herkenden de cellen van geïnfecteerde kinderen de 
moleculen van schistosoom-wormen, terwijl de cellen van niet-geïnfecteerde kinderen dat 
niet deden. Bovendien hebben we aangetoond dat de reacties gericht tegen wormmoleculen 
in geïnfecteerde kinderen significant waren toegenomen na behandeling van infectie. We 
vonden een hoger percentage van regulatoire T cellen (een groep van tolerantie-bevorderende 
witte bloedcellen, gekarakteriseerd door de expressie van markers CD4+CD25+FOXP3+), in 
geïnfecteerde kinderen, wat vervolgens weer afnam na een behandeling tegen schistsomiasis. 
Deze afname was geassocieerd met een toename in verworven afweerreacties. Deze resultaten 
bieden voor het eerst bewijs voor de associatie tussen schistosoma-infecties, regulatoire T 
cellen en worm-specifieke immuunhyporesponsiviteit in mensen.
In hoofdstuk 5 breiden we onze analyse van regulatoire T cellen verder uit en onderzoeken 
we de rol van CD4+CD25+FOXP3+ regulatoire T cellen in celdeling en cytokineproductie in reactie 
op wormmoleculen in witte bloedcellen voor en na praziquantel behandeling. We gebruiken 
principale-componentenanalyse (PCA), een datareductie-benadering, om de verschillende 
cytokines in het algemeen te bestuderen. We hebben aangetoond dat schistosoom-infectie 
is geassocieerd met hogere frequenties regulatoire T cellen, die daalden na behandeling. De 
afname in regulatoire-T–cel-frequenties ging gepaard met een toename in cytokineproductie 
tijdens behandeling. Studies waarin de regulatoire T cellen werden verwijderd, bevestigden het 




veroorzaakte zowel voor als na behandeling. In de meeste gevallen was celdeling veel minder 
sterk beïnvloed in vergelijking met de productie van verschillende cytokines.
We hebben ons daarna gericht op de rol van B cellen in het verloop van schistosoom-infectie. 
In hoofdstuk 6 tonen we aan dat schistosomiasis leidt tot meer regulatoire B cellen (Breg), 
witte bloedcellen die net als regulatoire T cellen afweerreacties onderdrukken. We bewezen 
dat Gabonese schoolkinderen een verhoogd percentage CD1dhi Breg cellen in het bloed 
hebben en dat deze cellen meer van het onderdrukkende cytokine IL-10 produceerden. Een 
belangrijke bevinding was dat de frequentie van deze cellen was verlaagd na een schistosoom-
behandeling tot een vergelijkbaar niveau als gevonden in niet-geïnfecteerde kinderen.
In hoofdstuk 7 laten we zien dat naast veranderde Breg-frequenties, de frequentie van 
geheugen-B-cellen is toegenomen in geïnfecteerde schoolkinderen. Hoewel deze cellen meer 
geactiveerd lijken, zijn de celdeling en de productie van ontstekingsbevorderende cytokines 
in deze cellen verminderd. De behandeling van de kinderen voor hun wormen resulteerde 
grotendeels in functieherstel van deze cellen. De resultaten in dit hoofdstuk laten zien dat een 
infectie met S. haematobium leidt tot significante veranderingen in het B-cel-compartiment, 
zowel op fenotypisch als functioneel gebied.
Ten slotte worden in hoofdstuk 8 de bevindingen van dit proefschrift samengevat. De 
interactie tussen aangeboren- en verworven afweerreacties en tolerantieprocessen worden 
besproken, waarbij de nadruk wordt gelegd op kenmerken van de tolerantieprocessen. 
Aangezien er is aangetoond dat tolerantieprocessen niet alleen belangrijk zijn voor chronische 
infectieziekten, maar ook voor chronische ontstekingsziekten, kan de kennis hier opgedaan 
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